JP2024005458A - Composition for skin formulation, and skin formulation - Google Patents
Composition for skin formulation, and skin formulation Download PDFInfo
- Publication number
- JP2024005458A JP2024005458A JP2022105644A JP2022105644A JP2024005458A JP 2024005458 A JP2024005458 A JP 2024005458A JP 2022105644 A JP2022105644 A JP 2022105644A JP 2022105644 A JP2022105644 A JP 2022105644A JP 2024005458 A JP2024005458 A JP 2024005458A
- Authority
- JP
- Japan
- Prior art keywords
- sodium
- manufactured
- acid
- skin
- examples
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 59
- 238000009472 formulation Methods 0.000 title abstract 7
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims abstract description 82
- 229910052708 sodium Inorganic materials 0.000 claims abstract description 69
- 239000002280 amphoteric surfactant Substances 0.000 claims abstract description 60
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims abstract description 41
- 150000003839 salts Chemical class 0.000 claims abstract description 31
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract description 24
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 19
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims abstract description 14
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical group [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims abstract description 13
- 125000003342 alkenyl group Chemical group 0.000 claims abstract description 9
- 125000004436 sodium atom Chemical group 0.000 claims abstract description 8
- 238000002360 preparation method Methods 0.000 claims description 84
- ZXVOCOLRQJZVBW-UHFFFAOYSA-N azane;ethanol Chemical compound N.CCO ZXVOCOLRQJZVBW-UHFFFAOYSA-N 0.000 claims description 4
- NVLRFXKSQQPKAD-UHFFFAOYSA-N tricarbon Chemical group [C]=C=[C] NVLRFXKSQQPKAD-UHFFFAOYSA-N 0.000 claims description 4
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 abstract description 54
- 229960001340 histamine Drugs 0.000 abstract description 27
- GSEJCLTVZPLZKY-UHFFFAOYSA-O triethanolammonium Chemical compound OCC[NH+](CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-O 0.000 abstract description 8
- 230000002401 inhibitory effect Effects 0.000 abstract description 4
- -1 n-octyl group Chemical group 0.000 description 162
- 239000011734 sodium Substances 0.000 description 88
- 210000003491 skin Anatomy 0.000 description 80
- 239000000047 product Substances 0.000 description 70
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 58
- 238000006116 polymerization reaction Methods 0.000 description 50
- 208000003251 Pruritus Diseases 0.000 description 49
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 43
- 235000014113 dietary fatty acids Nutrition 0.000 description 41
- 239000000194 fatty acid Substances 0.000 description 41
- 229930195729 fatty acid Natural products 0.000 description 41
- 239000000126 substance Substances 0.000 description 36
- 239000007864 aqueous solution Substances 0.000 description 31
- 210000004209 hair Anatomy 0.000 description 31
- 239000003921 oil Substances 0.000 description 31
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 30
- 235000019198 oils Nutrition 0.000 description 30
- 150000004665 fatty acids Chemical class 0.000 description 29
- 239000002537 cosmetic Substances 0.000 description 27
- 230000000052 comparative effect Effects 0.000 description 25
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 24
- 239000003240 coconut oil Substances 0.000 description 24
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 22
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 20
- 239000006071 cream Substances 0.000 description 19
- 239000004205 dimethyl polysiloxane Substances 0.000 description 18
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 18
- 230000007803 itching Effects 0.000 description 18
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 18
- 239000006210 lotion Substances 0.000 description 15
- 239000000243 solution Substances 0.000 description 15
- AEDQNOLIADXSBB-UHFFFAOYSA-N 3-(dodecylazaniumyl)propanoate Chemical compound CCCCCCCCCCCCNCCC(O)=O AEDQNOLIADXSBB-UHFFFAOYSA-N 0.000 description 14
- 238000000034 method Methods 0.000 description 14
- 239000000843 powder Substances 0.000 description 14
- 239000003795 chemical substances by application Substances 0.000 description 13
- 239000000306 component Substances 0.000 description 13
- 229940008099 dimethicone Drugs 0.000 description 13
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 12
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
- 235000019864 coconut oil Nutrition 0.000 description 12
- 239000000523 sample Substances 0.000 description 12
- 210000004761 scalp Anatomy 0.000 description 12
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 11
- 235000010724 Wisteria floribunda Nutrition 0.000 description 11
- 239000002253 acid Substances 0.000 description 11
- 239000003814 drug Substances 0.000 description 11
- 229960003237 betaine Drugs 0.000 description 10
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 10
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 10
- 235000019832 sodium triphosphate Nutrition 0.000 description 10
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 9
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 8
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 8
- BAPJBEWLBFYGME-UHFFFAOYSA-N Methyl acrylate Chemical compound COC(=O)C=C BAPJBEWLBFYGME-UHFFFAOYSA-N 0.000 description 8
- 229910052799 carbon Inorganic materials 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- 210000002615 epidermis Anatomy 0.000 description 8
- 150000002148 esters Chemical class 0.000 description 8
- 238000011156 evaluation Methods 0.000 description 8
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 8
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 8
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 8
- 239000003208 petroleum Substances 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 7
- 229920001577 copolymer Polymers 0.000 description 7
- 125000004122 cyclic group Chemical group 0.000 description 7
- 230000001815 facial effect Effects 0.000 description 7
- 229920001296 polysiloxane Polymers 0.000 description 7
- 229910052700 potassium Inorganic materials 0.000 description 7
- 239000011591 potassium Substances 0.000 description 7
- 239000008213 purified water Substances 0.000 description 7
- 230000001629 suppression Effects 0.000 description 7
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 6
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- FPVVYTCTZKCSOJ-UHFFFAOYSA-N Ethylene glycol distearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCOC(=O)CCCCCCCCCCCCCCCCC FPVVYTCTZKCSOJ-UHFFFAOYSA-N 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- NWGKJDSIEKMTRX-AAZCQSIUSA-N Sorbitan monooleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NWGKJDSIEKMTRX-AAZCQSIUSA-N 0.000 description 6
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 6
- 125000002947 alkylene group Chemical group 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 239000000499 gel Substances 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 238000005259 measurement Methods 0.000 description 6
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 6
- 239000002674 ointment Substances 0.000 description 6
- 229920000642 polymer Polymers 0.000 description 6
- 229920000137 polyphosphoric acid Polymers 0.000 description 6
- 239000002453 shampoo Substances 0.000 description 6
- 239000002904 solvent Substances 0.000 description 6
- 238000011282 treatment Methods 0.000 description 6
- 238000005406 washing Methods 0.000 description 6
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 5
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 5
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 5
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 5
- 238000002835 absorbance Methods 0.000 description 5
- 150000001298 alcohols Chemical class 0.000 description 5
- 229910052783 alkali metal Inorganic materials 0.000 description 5
- 239000004359 castor oil Substances 0.000 description 5
- 235000019438 castor oil Nutrition 0.000 description 5
- POULHZVOKOAJMA-UHFFFAOYSA-M dodecanoate Chemical compound CCCCCCCCCCCC([O-])=O POULHZVOKOAJMA-UHFFFAOYSA-M 0.000 description 5
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 5
- 238000005886 esterification reaction Methods 0.000 description 5
- 235000011187 glycerol Nutrition 0.000 description 5
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 5
- 229940100608 glycol distearate Drugs 0.000 description 5
- 229940070765 laurate Drugs 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 5
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 5
- GCLGEJMYGQKIIW-UHFFFAOYSA-H sodium hexametaphosphate Chemical compound [Na]OP1(=O)OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])O1 GCLGEJMYGQKIIW-UHFFFAOYSA-H 0.000 description 5
- 235000019982 sodium hexametaphosphate Nutrition 0.000 description 5
- 235000019830 sodium polyphosphate Nutrition 0.000 description 5
- 229950004959 sorbitan oleate Drugs 0.000 description 5
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 description 5
- 229960004418 trolamine Drugs 0.000 description 5
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 4
- ULQISTXYYBZJSJ-UHFFFAOYSA-N 12-hydroxyoctadecanoic acid Chemical compound CCCCCCC(O)CCCCCCCCCCC(O)=O ULQISTXYYBZJSJ-UHFFFAOYSA-N 0.000 description 4
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 4
- VKPSKYDESGTTFR-UHFFFAOYSA-N 2,2,4,6,6-pentamethylheptane Chemical compound CC(C)(C)CC(C)CC(C)(C)C VKPSKYDESGTTFR-UHFFFAOYSA-N 0.000 description 4
- KIHBGTRZFAVZRV-UHFFFAOYSA-N 2-Hydroxyoctadecanoic acid Natural products CCCCCCCCCCCCCCCCC(O)C(O)=O KIHBGTRZFAVZRV-UHFFFAOYSA-N 0.000 description 4
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 description 4
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 4
- 229910019142 PO4 Inorganic materials 0.000 description 4
- 235000019484 Rapeseed oil Nutrition 0.000 description 4
- 206010040880 Skin irritation Diseases 0.000 description 4
- 229920002125 Sokalan® Polymers 0.000 description 4
- 229920002472 Starch Polymers 0.000 description 4
- 235000021355 Stearic acid Nutrition 0.000 description 4
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 4
- 229940024606 amino acid Drugs 0.000 description 4
- 235000001014 amino acid Nutrition 0.000 description 4
- 239000003945 anionic surfactant Substances 0.000 description 4
- 239000003963 antioxidant agent Substances 0.000 description 4
- 235000006708 antioxidants Nutrition 0.000 description 4
- YSJGOMATDFSEED-UHFFFAOYSA-M behentrimonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCCCCCC[N+](C)(C)C YSJGOMATDFSEED-UHFFFAOYSA-M 0.000 description 4
- 239000003093 cationic surfactant Substances 0.000 description 4
- 239000002738 chelating agent Substances 0.000 description 4
- 239000003086 colorant Substances 0.000 description 4
- 230000003750 conditioning effect Effects 0.000 description 4
- DIOQZVSQGTUSAI-UHFFFAOYSA-N decane Chemical compound CCCCCCCCCC DIOQZVSQGTUSAI-UHFFFAOYSA-N 0.000 description 4
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 230000003203 everyday effect Effects 0.000 description 4
- 210000004709 eyebrow Anatomy 0.000 description 4
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 4
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 4
- 235000014655 lactic acid Nutrition 0.000 description 4
- 239000004310 lactic acid Substances 0.000 description 4
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 4
- 235000013336 milk Nutrition 0.000 description 4
- 239000008267 milk Substances 0.000 description 4
- 210000004080 milk Anatomy 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 239000002736 nonionic surfactant Substances 0.000 description 4
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 4
- 229960002446 octanoic acid Drugs 0.000 description 4
- 235000021317 phosphate Nutrition 0.000 description 4
- 239000003755 preservative agent Substances 0.000 description 4
- 239000011541 reaction mixture Substances 0.000 description 4
- 230000036556 skin irritation Effects 0.000 description 4
- 231100000475 skin irritation Toxicity 0.000 description 4
- UGTZMIPZNRIWHX-UHFFFAOYSA-K sodium trimetaphosphate Chemical compound [Na+].[Na+].[Na+].[O-]P1(=O)OP([O-])(=O)OP([O-])(=O)O1 UGTZMIPZNRIWHX-UHFFFAOYSA-K 0.000 description 4
- 239000008107 starch Substances 0.000 description 4
- 235000019698 starch Nutrition 0.000 description 4
- 239000008117 stearic acid Substances 0.000 description 4
- 230000004083 survival effect Effects 0.000 description 4
- 239000002562 thickening agent Substances 0.000 description 4
- DUXYWXYOBMKGIN-UHFFFAOYSA-N trimyristin Chemical compound CCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCC DUXYWXYOBMKGIN-UHFFFAOYSA-N 0.000 description 4
- UNXRWKVEANCORM-UHFFFAOYSA-I triphosphate(5-) Chemical compound [O-]P([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O UNXRWKVEANCORM-UHFFFAOYSA-I 0.000 description 4
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 3
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 3
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 description 3
- IJALWSVNUBBQRA-UHFFFAOYSA-N 4-Isopropyl-3-methylphenol Chemical compound CC(C)C1=CC=C(O)C=C1C IJALWSVNUBBQRA-UHFFFAOYSA-N 0.000 description 3
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 3
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 3
- 239000004166 Lanolin Substances 0.000 description 3
- 239000005639 Lauric acid Substances 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- ZSXGLVDWWRXATF-UHFFFAOYSA-N N,N-dimethylformamide dimethyl acetal Chemical compound COC(OC)N(C)C ZSXGLVDWWRXATF-UHFFFAOYSA-N 0.000 description 3
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 235000018936 Vitellaria paradoxa Nutrition 0.000 description 3
- 241001135917 Vitellaria paradoxa Species 0.000 description 3
- RSWGJHLUYNHPMX-ONCXSQPRSA-N abietic acid Chemical compound C([C@@H]12)CC(C(C)C)=CC1=CC[C@@H]1[C@]2(C)CCC[C@@]1(C)C(O)=O RSWGJHLUYNHPMX-ONCXSQPRSA-N 0.000 description 3
- 229960001631 carbomer Drugs 0.000 description 3
- 229960000541 cetyl alcohol Drugs 0.000 description 3
- 239000002826 coolant Substances 0.000 description 3
- 239000008406 cosmetic ingredient Substances 0.000 description 3
- 229920006037 cross link polymer Polymers 0.000 description 3
- SMVRDGHCVNAOIN-UHFFFAOYSA-L disodium;1-dodecoxydodecane;sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O.CCCCCCCCCCCCOCCCCCCCCCCCC SMVRDGHCVNAOIN-UHFFFAOYSA-L 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 239000000686 essence Substances 0.000 description 3
- 230000032050 esterification Effects 0.000 description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 3
- 239000006260 foam Substances 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 229960002989 glutamic acid Drugs 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 239000003906 humectant Substances 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 229940119170 jojoba wax Drugs 0.000 description 3
- 235000019388 lanolin Nutrition 0.000 description 3
- 229940039717 lanolin Drugs 0.000 description 3
- 229940105132 myristate Drugs 0.000 description 3
- 125000000962 organic group Chemical group 0.000 description 3
- 239000003002 pH adjusting agent Substances 0.000 description 3
- 239000010452 phosphate Substances 0.000 description 3
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 3
- 238000004445 quantitative analysis Methods 0.000 description 3
- GHBFNMLVSPCDGN-UHFFFAOYSA-N rac-1-monooctanoylglycerol Chemical compound CCCCCCCC(=O)OCC(O)CO GHBFNMLVSPCDGN-UHFFFAOYSA-N 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 229940057910 shea butter Drugs 0.000 description 3
- 239000000344 soap Substances 0.000 description 3
- 239000007921 spray Substances 0.000 description 3
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 3
- 239000000516 sunscreening agent Substances 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 210000004243 sweat Anatomy 0.000 description 3
- TUNFSRHWOTWDNC-UHFFFAOYSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 3
- 239000006097 ultraviolet radiation absorber Substances 0.000 description 3
- 239000011787 zinc oxide Substances 0.000 description 3
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 2
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 2
- AVBJHQDHVYGQLS-AWEZNQCLSA-N (2s)-2-(dodecanoylamino)pentanedioic acid Chemical compound CCCCCCCCCCCC(=O)N[C@H](C(O)=O)CCC(O)=O AVBJHQDHVYGQLS-AWEZNQCLSA-N 0.000 description 2
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 2
- PSBDWGZCVUAZQS-UHFFFAOYSA-N (dimethylsulfonio)acetate Chemical compound C[S+](C)CC([O-])=O PSBDWGZCVUAZQS-UHFFFAOYSA-N 0.000 description 2
- FFJCNSLCJOQHKM-CLFAGFIQSA-N (z)-1-[(z)-octadec-9-enoxy]octadec-9-ene Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCCCCCCC\C=C/CCCCCCCC FFJCNSLCJOQHKM-CLFAGFIQSA-N 0.000 description 2
- 229940015975 1,2-hexanediol Drugs 0.000 description 2
- 229940058015 1,3-butylene glycol Drugs 0.000 description 2
- 229940043268 2,2,4,4,6,8,8-heptamethylnonane Drugs 0.000 description 2
- RKJGFHYCZPZJPE-UHFFFAOYSA-N 2,2-bis(16-methylheptadecanoyloxymethyl)butyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(CC)(COC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C RKJGFHYCZPZJPE-UHFFFAOYSA-N 0.000 description 2
- DGSZGZSCHSQXFV-UHFFFAOYSA-N 2,3-bis(2-ethylhexanoyloxy)propyl 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCC(OC(=O)C(CC)CCCC)COC(=O)C(CC)CCCC DGSZGZSCHSQXFV-UHFFFAOYSA-N 0.000 description 2
- DEKFZWMENCCOFU-LIKAHPKFSA-N 2-[(2r)-2-[(2r,3s,4r)-3,4-bis(2-hydroxyethoxy)oxolan-2-yl]-2-(2-hydroxyethoxy)ethoxy]ethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCOC[C@@H](OCCO)[C@H]1OC[C@@H](OCCO)[C@@H]1OCCO DEKFZWMENCCOFU-LIKAHPKFSA-N 0.000 description 2
- FKMHSNTVILORFA-UHFFFAOYSA-N 2-[2-(2-dodecoxyethoxy)ethoxy]ethanol Chemical compound CCCCCCCCCCCCOCCOCCOCCO FKMHSNTVILORFA-UHFFFAOYSA-N 0.000 description 2
- TXBCBTDQIULDIA-UHFFFAOYSA-N 2-[[3-hydroxy-2,2-bis(hydroxymethyl)propoxy]methyl]-2-(hydroxymethyl)propane-1,3-diol Chemical compound OCC(CO)(CO)COCC(CO)(CO)CO TXBCBTDQIULDIA-UHFFFAOYSA-N 0.000 description 2
- BANXPJUEBPWEOT-UHFFFAOYSA-N 2-methyl-Pentadecane Chemical compound CCCCCCCCCCCCCC(C)C BANXPJUEBPWEOT-UHFFFAOYSA-N 0.000 description 2
- GTJOHISYCKPIMT-UHFFFAOYSA-N 2-methylundecane Chemical compound CCCCCCCCCC(C)C GTJOHISYCKPIMT-UHFFFAOYSA-N 0.000 description 2
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 2
- ZSNLEVJATWJBLU-UHFFFAOYSA-N 2-tert-butyl-2-methoxy-1,3-diphenylpropane-1,3-dione Chemical compound C=1C=CC=CC=1C(=O)C(C(C)(C)C)(OC)C(=O)C1=CC=CC=C1 ZSNLEVJATWJBLU-UHFFFAOYSA-N 0.000 description 2
- IXOCGRPBILEGOX-UHFFFAOYSA-N 3-[3-(dodecanoylamino)propyl-dimethylazaniumyl]-2-hydroxypropane-1-sulfonate Chemical compound CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC(O)CS([O-])(=O)=O IXOCGRPBILEGOX-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 239000004255 Butylated hydroxyanisole Substances 0.000 description 2
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 2
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 2
- 239000004215 Carbon black (E152) Substances 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 2
- 240000006497 Dianthus caryophyllus Species 0.000 description 2
- 235000009355 Dianthus caryophyllus Nutrition 0.000 description 2
- IUMSDRXLFWAGNT-UHFFFAOYSA-N Dodecamethylcyclohexasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 IUMSDRXLFWAGNT-UHFFFAOYSA-N 0.000 description 2
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 2
- 239000006145 Eagle's minimal essential medium Substances 0.000 description 2
- FMRHJJZUHUTGKE-UHFFFAOYSA-N Ethylhexyl salicylate Chemical compound CCCCC(CC)COC(=O)C1=CC=CC=C1O FMRHJJZUHUTGKE-UHFFFAOYSA-N 0.000 description 2
- 229920002907 Guar gum Polymers 0.000 description 2
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 2
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 2
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 2
- SGVYKUFIHHTIFL-UHFFFAOYSA-N Isobutylhexyl Natural products CCCCCCCC(C)C SGVYKUFIHHTIFL-UHFFFAOYSA-N 0.000 description 2
- RRHGJUQNOFWUDK-UHFFFAOYSA-N Isoprene Natural products CC(=C)C=C RRHGJUQNOFWUDK-UHFFFAOYSA-N 0.000 description 2
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 2
- 244000062730 Melissa officinalis Species 0.000 description 2
- 235000010654 Melissa officinalis Nutrition 0.000 description 2
- BACYUWVYYTXETD-UHFFFAOYSA-N N-Lauroylsarcosine Chemical compound CCCCCCCCCCCC(=O)N(C)CC(O)=O BACYUWVYYTXETD-UHFFFAOYSA-N 0.000 description 2
- 235000019482 Palm oil Nutrition 0.000 description 2
- OQILCOQZDHPEAZ-UHFFFAOYSA-N Palmitinsaeure-octylester Natural products CCCCCCCCCCCCCCCC(=O)OCCCCCCCC OQILCOQZDHPEAZ-UHFFFAOYSA-N 0.000 description 2
- 101000611641 Rattus norvegicus Protein phosphatase 1 regulatory subunit 15A Proteins 0.000 description 2
- 108010077895 Sarcosine Proteins 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- IYFATESGLOUGBX-YVNJGZBMSA-N Sorbitan monopalmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O IYFATESGLOUGBX-YVNJGZBMSA-N 0.000 description 2
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 2
- VBIIFPGSPJYLRR-UHFFFAOYSA-M Stearyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)C VBIIFPGSPJYLRR-UHFFFAOYSA-M 0.000 description 2
- IHUMNXSBUOIDQI-UHFFFAOYSA-N Triethanolamine myristate Chemical compound OCCN(CCO)CCO.CCCCCCCCCCCCCC(O)=O IHUMNXSBUOIDQI-UHFFFAOYSA-N 0.000 description 2
- ZJCCRDAZUWHFQH-UHFFFAOYSA-N Trimethylolpropane Chemical compound CCC(CO)(CO)CO ZJCCRDAZUWHFQH-UHFFFAOYSA-N 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- AQKOHYMKBUOXEB-RYNSOKOISA-N [(2R)-2-[(2R,3R,4S)-4-hydroxy-3-(16-methylheptadecanoyloxy)oxolan-2-yl]-2-(16-methylheptadecanoyloxy)ethyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCCCCCCCCCC(C)C)[C@H]1OC[C@H](O)[C@H]1OC(=O)CCCCCCCCCCCCCCC(C)C AQKOHYMKBUOXEB-RYNSOKOISA-N 0.000 description 2
- LWZFANDGMFTDAV-BURFUSLBSA-N [(2r)-2-[(2r,3r,4s)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] dodecanoate Chemical compound CCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O LWZFANDGMFTDAV-BURFUSLBSA-N 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 229940009098 aspartate Drugs 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 235000015278 beef Nutrition 0.000 description 2
- 229940075506 behentrimonium chloride Drugs 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000007844 bleaching agent Substances 0.000 description 2
- 235000019437 butane-1,3-diol Nutrition 0.000 description 2
- 235000019282 butylated hydroxyanisole Nutrition 0.000 description 2
- 239000010495 camellia oil Substances 0.000 description 2
- 150000007942 carboxylates Chemical class 0.000 description 2
- 229940081733 cetearyl alcohol Drugs 0.000 description 2
- 239000007809 chemical reaction catalyst Substances 0.000 description 2
- MRUAUOIMASANKQ-UHFFFAOYSA-N cocamidopropyl betaine Chemical compound CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC([O-])=O MRUAUOIMASANKQ-UHFFFAOYSA-N 0.000 description 2
- 229940073507 cocamidopropyl betaine Drugs 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- DTPCFIHYWYONMD-UHFFFAOYSA-N decaethylene glycol Chemical compound OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO DTPCFIHYWYONMD-UHFFFAOYSA-N 0.000 description 2
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 2
- XXJWXESWEXIICW-UHFFFAOYSA-N diethylene glycol monoethyl ether Chemical compound CCOCCOCCO XXJWXESWEXIICW-UHFFFAOYSA-N 0.000 description 2
- GQOKIYDTHHZSCJ-UHFFFAOYSA-M dimethyl-bis(prop-2-enyl)azanium;chloride Chemical compound [Cl-].C=CC[N+](C)(C)CC=C GQOKIYDTHHZSCJ-UHFFFAOYSA-M 0.000 description 2
- REZZEXDLIUJMMS-UHFFFAOYSA-M dimethyldioctadecylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCCCC REZZEXDLIUJMMS-UHFFFAOYSA-M 0.000 description 2
- 108010067755 dinitrophenyl-bovine serum albumin Proteins 0.000 description 2
- 229960000735 docosanol Drugs 0.000 description 2
- JRBPAEWTRLWTQC-UHFFFAOYSA-N dodecylamine Chemical compound CCCCCCCCCCCCN JRBPAEWTRLWTQC-UHFFFAOYSA-N 0.000 description 2
- 239000010696 ester oil Substances 0.000 description 2
- GJQLBGWSDGMZKM-UHFFFAOYSA-N ethylhexyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(CC)CCCCC GJQLBGWSDGMZKM-UHFFFAOYSA-N 0.000 description 2
- 210000000887 face Anatomy 0.000 description 2
- 239000012091 fetal bovine serum Substances 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 238000004817 gas chromatography Methods 0.000 description 2
- 229940087068 glyceryl caprylate Drugs 0.000 description 2
- 229940075529 glyceryl stearate Drugs 0.000 description 2
- 239000000665 guar gum Substances 0.000 description 2
- 235000010417 guar gum Nutrition 0.000 description 2
- 229960002154 guar gum Drugs 0.000 description 2
- 239000008233 hard water Substances 0.000 description 2
- DCAYPVUWAIABOU-UHFFFAOYSA-N hexadecane Chemical compound CCCCCCCCCCCCCCCC DCAYPVUWAIABOU-UHFFFAOYSA-N 0.000 description 2
- WYVGZXIHGGQSQN-UHFFFAOYSA-N hexadecanoate;tris(2-hydroxyethyl)azanium Chemical compound OCCN(CCO)CCO.CCCCCCCCCCCCCCCC(O)=O WYVGZXIHGGQSQN-UHFFFAOYSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- IIRDTKBZINWQAW-UHFFFAOYSA-N hexaethylene glycol Chemical compound OCCOCCOCCOCCOCCOCCO IIRDTKBZINWQAW-UHFFFAOYSA-N 0.000 description 2
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 description 2
- 229920002674 hyaluronan Polymers 0.000 description 2
- 229960003160 hyaluronic acid Drugs 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 150000002430 hydrocarbons Chemical class 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 2
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 2
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 2
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 2
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- 229940071190 laureth sulfosuccinate Drugs 0.000 description 2
- 229940057905 laureth-3 Drugs 0.000 description 2
- 229940071085 lauroyl glutamate Drugs 0.000 description 2
- 239000000865 liniment Substances 0.000 description 2
- 229940041616 menthol Drugs 0.000 description 2
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 2
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 2
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 2
- 229960002216 methylparaben Drugs 0.000 description 2
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 2
- 239000008239 natural water Substances 0.000 description 2
- LYRFLYHAGKPMFH-UHFFFAOYSA-N octadecanamide Chemical compound CCCCCCCCCCCCCCCCCC(N)=O LYRFLYHAGKPMFH-UHFFFAOYSA-N 0.000 description 2
- 229960001679 octinoxate Drugs 0.000 description 2
- 239000002540 palm oil Substances 0.000 description 2
- 229960005323 phenoxyethanol Drugs 0.000 description 2
- XOJVVFBFDXDTEG-UHFFFAOYSA-N pristane Chemical compound CC(C)CCCC(C)CCCC(C)CCCC(C)C XOJVVFBFDXDTEG-UHFFFAOYSA-N 0.000 description 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
- DCBSHORRWZKAKO-UHFFFAOYSA-N rac-1-monomyristoylglycerol Chemical compound CCCCCCCCCCCCCC(=O)OCC(O)CO DCBSHORRWZKAKO-UHFFFAOYSA-N 0.000 description 2
- 239000004576 sand Substances 0.000 description 2
- 229940043230 sarcosine Drugs 0.000 description 2
- 108700004121 sarkosyl Proteins 0.000 description 2
- 229920002545 silicone oil Polymers 0.000 description 2
- FQENQNTWSFEDLI-UHFFFAOYSA-J sodium diphosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])([O-])=O FQENQNTWSFEDLI-UHFFFAOYSA-J 0.000 description 2
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 2
- 159000000000 sodium salts Chemical class 0.000 description 2
- 229910052938 sodium sulfate Inorganic materials 0.000 description 2
- 235000011152 sodium sulphate Nutrition 0.000 description 2
- 239000008234 soft water Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 229950006451 sorbitan laurate Drugs 0.000 description 2
- 235000011067 sorbitan monolaureate Nutrition 0.000 description 2
- 229950003429 sorbitan palmitate Drugs 0.000 description 2
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 229940117986 sulfobetaine Drugs 0.000 description 2
- 230000000475 sunscreen effect Effects 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 239000003760 tallow Substances 0.000 description 2
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 2
- 235000019818 tetrasodium diphosphate Nutrition 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 2
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 2
- 229960000401 tranexamic acid Drugs 0.000 description 2
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 2
- PUVAFTRIIUSGLK-UHFFFAOYSA-M trimethyl(oxiran-2-ylmethyl)azanium;chloride Chemical compound [Cl-].C[N+](C)(C)CC1CO1 PUVAFTRIIUSGLK-UHFFFAOYSA-M 0.000 description 2
- 229940118594 trimethylolpropane triisostearate Drugs 0.000 description 2
- UNXRWKVEANCORM-UHFFFAOYSA-N triphosphoric acid Chemical compound OP(O)(=O)OP(O)(=O)OP(O)(O)=O UNXRWKVEANCORM-UHFFFAOYSA-N 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 230000002087 whitening effect Effects 0.000 description 2
- 239000000230 xanthan gum Substances 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- 235000010493 xanthan gum Nutrition 0.000 description 2
- 229940082509 xanthan gum Drugs 0.000 description 2
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 2
- JWZZKOKVBUJMES-UHFFFAOYSA-N (+-)-Isoprenaline Chemical compound CC(C)NCC(O)C1=CC=C(O)C(O)=C1 JWZZKOKVBUJMES-UHFFFAOYSA-N 0.000 description 1
- WCDDVEOXEIYWFB-VXORFPGASA-N (2s,3s,4r,5r,6r)-3-[(2s,3r,5s,6r)-3-acetamido-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5,6-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@@H]1C[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](C(O)=O)O[C@@H](O)[C@H](O)[C@H]1O WCDDVEOXEIYWFB-VXORFPGASA-N 0.000 description 1
- BJDAUCLANVMIOB-UHFFFAOYSA-N (3-decanoyloxy-2,2-dimethylpropyl) decanoate Chemical compound CCCCCCCCCC(=O)OCC(C)(C)COC(=O)CCCCCCCCC BJDAUCLANVMIOB-UHFFFAOYSA-N 0.000 description 1
- KZRXPHCVIMWWDS-AWEZNQCLSA-N (4S)-4-amino-5-dodecanoyloxy-5-oxopentanoic acid Chemical compound CCCCCCCCCCCC(=O)OC(=O)[C@@H](N)CCC(O)=O KZRXPHCVIMWWDS-AWEZNQCLSA-N 0.000 description 1
- KAKVFSYQVNHFBS-UHFFFAOYSA-N (5-hydroxycyclopenten-1-yl)-phenylmethanone Chemical compound OC1CCC=C1C(=O)C1=CC=CC=C1 KAKVFSYQVNHFBS-UHFFFAOYSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical compound FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 1
- QMMJWQMCMRUYTG-UHFFFAOYSA-N 1,2,4,5-tetrachloro-3-(trifluoromethyl)benzene Chemical compound FC(F)(F)C1=C(Cl)C(Cl)=CC(Cl)=C1Cl QMMJWQMCMRUYTG-UHFFFAOYSA-N 0.000 description 1
- PQUXFUBNSYCQAL-UHFFFAOYSA-N 1-(2,3-difluorophenyl)ethanone Chemical compound CC(=O)C1=CC=CC(F)=C1F PQUXFUBNSYCQAL-UHFFFAOYSA-N 0.000 description 1
- DURPTKYDGMDSBL-UHFFFAOYSA-N 1-butoxybutane Chemical compound CCCCOCCCC DURPTKYDGMDSBL-UHFFFAOYSA-N 0.000 description 1
- CMCBDXRRFKYBDG-UHFFFAOYSA-N 1-dodecoxydodecane Chemical compound CCCCCCCCCCCCOCCCCCCCCCCCC CMCBDXRRFKYBDG-UHFFFAOYSA-N 0.000 description 1
- FDCJDKXCCYFOCV-UHFFFAOYSA-N 1-hexadecoxyhexadecane Chemical compound CCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCC FDCJDKXCCYFOCV-UHFFFAOYSA-N 0.000 description 1
- TYTGWHZODQKWEF-UHFFFAOYSA-N 1-o-dodecyl 4-o-sulfo butanedioate Chemical compound CCCCCCCCCCCCOC(=O)CCC(=O)OS(O)(=O)=O TYTGWHZODQKWEF-UHFFFAOYSA-N 0.000 description 1
- HBXWUCXDUUJDRB-UHFFFAOYSA-N 1-octadecoxyoctadecane Chemical compound CCCCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCCCC HBXWUCXDUUJDRB-UHFFFAOYSA-N 0.000 description 1
- RZRNAYUHWVFMIP-KTKRTIGZSA-N 1-oleoylglycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-KTKRTIGZSA-N 0.000 description 1
- DHGBAFGZLVRESL-UHFFFAOYSA-N 14-methylpentadecyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCC(C)C DHGBAFGZLVRESL-UHFFFAOYSA-N 0.000 description 1
- LGEZTMRIZWCDLW-UHFFFAOYSA-N 14-methylpentadecyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCC(C)C LGEZTMRIZWCDLW-UHFFFAOYSA-N 0.000 description 1
- YICVJSOYNBZJAK-UHFFFAOYSA-N 14-methylpentadecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCC(C)C YICVJSOYNBZJAK-UHFFFAOYSA-N 0.000 description 1
- VCLJODPNBNEBKW-UHFFFAOYSA-N 2,2,4,4,6,8,8-heptamethylnonane Chemical compound CC(C)(C)CC(C)CC(C)(C)CC(C)(C)C VCLJODPNBNEBKW-UHFFFAOYSA-N 0.000 description 1
- QOOJEEZYYXGPAO-UHFFFAOYSA-N 2,2-bis(2-ethylhexanoyloxymethyl)butyl 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCC(CC)(COC(=O)C(CC)CCCC)COC(=O)C(CC)CCCC QOOJEEZYYXGPAO-UHFFFAOYSA-N 0.000 description 1
- AEQDJSLRWYMAQI-UHFFFAOYSA-N 2,3,9,10-tetramethoxy-6,8,13,13a-tetrahydro-5H-isoquinolino[2,1-b]isoquinoline Chemical compound C1CN2CC(C(=C(OC)C=C3)OC)=C3CC2C2=C1C=C(OC)C(OC)=C2 AEQDJSLRWYMAQI-UHFFFAOYSA-N 0.000 description 1
- XFOQWQKDSMIPHT-UHFFFAOYSA-N 2,3-dichloro-6-(trifluoromethyl)pyridine Chemical compound FC(F)(F)C1=CC=C(Cl)C(Cl)=N1 XFOQWQKDSMIPHT-UHFFFAOYSA-N 0.000 description 1
- 239000000263 2,3-dihydroxypropyl (Z)-octadec-9-enoate Substances 0.000 description 1
- GIXFALHDORQSOQ-UHFFFAOYSA-N 2,4,6,8-tetrahydroxy-1,3,5,7,2$l^{5},4$l^{5},6$l^{5},8$l^{5}-tetraoxatetraphosphocane 2,4,6,8-tetraoxide Chemical compound OP1(=O)OP(O)(=O)OP(O)(=O)OP(O)(=O)O1 GIXFALHDORQSOQ-UHFFFAOYSA-N 0.000 description 1
- OUNZARDETXBPIX-UHFFFAOYSA-N 2-(2-dodecoxyethoxy)acetic acid Chemical compound CCCCCCCCCCCCOCCOCC(O)=O OUNZARDETXBPIX-UHFFFAOYSA-N 0.000 description 1
- XCQFTFZCTGZCNP-UHFFFAOYSA-N 2-(2-ethylhexanoyloxy)ethyl 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCCOC(=O)C(CC)CCCC XCQFTFZCTGZCNP-UHFFFAOYSA-N 0.000 description 1
- XNWGIRJLJBVXDO-UHFFFAOYSA-N 2-(2-ethylhexylamino)propanoic acid Chemical compound CCCCC(CC)CNC(C)C(O)=O XNWGIRJLJBVXDO-UHFFFAOYSA-N 0.000 description 1
- FLPJVCMIKUWSDR-UHFFFAOYSA-N 2-(4-formylphenoxy)acetamide Chemical compound NC(=O)COC1=CC=C(C=O)C=C1 FLPJVCMIKUWSDR-UHFFFAOYSA-N 0.000 description 1
- BKUWWVKLLKXDJK-UHFFFAOYSA-N 2-(dimethylamino)icosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCC(N(C)C)C(O)=O BKUWWVKLLKXDJK-UHFFFAOYSA-N 0.000 description 1
- XPALGXXLALUMLE-UHFFFAOYSA-N 2-(dimethylamino)tetradecanoic acid Chemical compound CCCCCCCCCCCCC(N(C)C)C(O)=O XPALGXXLALUMLE-UHFFFAOYSA-N 0.000 description 1
- DHYWSAPLZYWZSZ-UHFFFAOYSA-N 2-(dimethylazaniumyl)hexadecanoate Chemical compound CCCCCCCCCCCCCCC(N(C)C)C(O)=O DHYWSAPLZYWZSZ-UHFFFAOYSA-N 0.000 description 1
- NDHKAEBPGBKCIO-UHFFFAOYSA-N 2-(hexadecylamino)propanoic acid Chemical compound CCCCCCCCCCCCCCCCNC(C)C(O)=O NDHKAEBPGBKCIO-UHFFFAOYSA-N 0.000 description 1
- YBRJTUFWBLSLHY-UHFFFAOYSA-N 2-[2-(2-octadecanoyloxyethoxy)ethoxy]ethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCOCCOCCOC(=O)CCCCCCCCCCCCCCCCC YBRJTUFWBLSLHY-UHFFFAOYSA-N 0.000 description 1
- YPDCDBRKWQYBPV-UHFFFAOYSA-N 2-[2-(dodecanoylamino)ethyl-(2-hydroxyethyl)amino]acetic acid;sodium Chemical compound [Na].CCCCCCCCCCCC(=O)NCCN(CCO)CC(O)=O YPDCDBRKWQYBPV-UHFFFAOYSA-N 0.000 description 1
- MQFYRUGXOJAUQK-UHFFFAOYSA-N 2-[2-[2-(2-octadecanoyloxyethoxy)ethoxy]ethoxy]ethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCOCCOCCOCCOC(=O)CCCCCCCCCCCCCCCCC MQFYRUGXOJAUQK-UHFFFAOYSA-N 0.000 description 1
- NLMKTBGFQGKQEV-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-hexadecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO NLMKTBGFQGKQEV-UHFFFAOYSA-N 0.000 description 1
- ACCAIGJKLCJFHP-UQKRIMTDSA-N 2-[bis(2-hydroxyethyl)amino]ethanol;(2s)-2-(dodecanoylamino)pentanedioic acid Chemical compound OCCN(CCO)CCO.CCCCCCCCCCCC(=O)N[C@H](C(O)=O)CCC(O)=O ACCAIGJKLCJFHP-UQKRIMTDSA-N 0.000 description 1
- GWEBEJYKXBMRJL-UHFFFAOYSA-N 2-[bis(2-hydroxyethyl)amino]ethanol;1-dodecoxydodecane;sulfuric acid Chemical compound OS(O)(=O)=O.OCCN(CCO)CCO.CCCCCCCCCCCCOCCCCCCCCCCCC GWEBEJYKXBMRJL-UHFFFAOYSA-N 0.000 description 1
- HVYJSOSGTDINLW-UHFFFAOYSA-N 2-[dimethyl(octadecyl)azaniumyl]acetate Chemical compound CCCCCCCCCCCCCCCCCC[N+](C)(C)CC([O-])=O HVYJSOSGTDINLW-UHFFFAOYSA-N 0.000 description 1
- KKMIHKCGXQMFEU-UHFFFAOYSA-N 2-[dimethyl(tetradecyl)azaniumyl]acetate Chemical compound CCCCCCCCCCCCCC[N+](C)(C)CC([O-])=O KKMIHKCGXQMFEU-UHFFFAOYSA-N 0.000 description 1
- YIWUKEYIRIRTPP-UHFFFAOYSA-N 2-ethylhexan-1-ol Chemical compound CCCCC(CC)CO YIWUKEYIRIRTPP-UHFFFAOYSA-N 0.000 description 1
- VDHIEQOYPSVNIM-UHFFFAOYSA-N 2-hexyldecyl 2-ethylhexanoate Chemical compound CCCCCCCCC(CCCCCC)COC(=O)C(CC)CCCC VDHIEQOYPSVNIM-UHFFFAOYSA-N 0.000 description 1
- JVXJFNLEXLGQIO-UHFFFAOYSA-N 2-hexyldecyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(CCCCCC)CCCCCCCC JVXJFNLEXLGQIO-UHFFFAOYSA-N 0.000 description 1
- OYINQIKIQCNQOX-UHFFFAOYSA-M 2-hydroxybutyl(trimethyl)azanium;chloride Chemical compound [Cl-].CCC(O)C[N+](C)(C)C OYINQIKIQCNQOX-UHFFFAOYSA-M 0.000 description 1
- ICIDSZQHPUZUHC-UHFFFAOYSA-N 2-octadecoxyethanol Chemical compound CCCCCCCCCCCCCCCCCCOCCO ICIDSZQHPUZUHC-UHFFFAOYSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- BGRXBNZMPMGLQI-UHFFFAOYSA-N 2-octyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC BGRXBNZMPMGLQI-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- FRPAVHFNOFSNDR-UHFFFAOYSA-N 3-(2,4-dioxo-1,3-thiazolidin-3-yl)propanoic acid Chemical compound OC(=O)CCN1C(=O)CSC1=O FRPAVHFNOFSNDR-UHFFFAOYSA-N 0.000 description 1
- KTCCLEVCNRHWQL-UHFFFAOYSA-N 3-(2-oxotridecylamino)propanoic acid;sodium Chemical compound [Na].CCCCCCCCCCCC(=O)CNCCC(O)=O KTCCLEVCNRHWQL-UHFFFAOYSA-N 0.000 description 1
- AZKSAVLVSZKNRD-UHFFFAOYSA-M 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide Chemical compound [Br-].S1C(C)=C(C)N=C1[N+]1=NC(C=2C=CC=CC=2)=NN1C1=CC=CC=C1 AZKSAVLVSZKNRD-UHFFFAOYSA-M 0.000 description 1
- CQNPUURJIXLXGJ-UHFFFAOYSA-N 3-(decylamino)propanoic acid Chemical compound CCCCCCCCCCNCCC(O)=O CQNPUURJIXLXGJ-UHFFFAOYSA-N 0.000 description 1
- YLLULQCFYBZRIZ-UHFFFAOYSA-N 3-(heptylamino)propanoic acid Chemical compound CCCCCCCNCCC(O)=O YLLULQCFYBZRIZ-UHFFFAOYSA-N 0.000 description 1
- GJVVIWWPEAZPHI-UHFFFAOYSA-N 3-(hexylamino)propanoic acid Chemical compound CCCCCCNCCC(O)=O GJVVIWWPEAZPHI-UHFFFAOYSA-N 0.000 description 1
- RALBCJDALOCDRB-UHFFFAOYSA-N 3-(octadec-1-enylamino)propanoic acid Chemical compound C(=CCCCCCCCCCCCCCCCC)NCCC(=O)O RALBCJDALOCDRB-UHFFFAOYSA-N 0.000 description 1
- BKTMEKOLXCZRFW-UHFFFAOYSA-N 3-(octadecylamino)propanoic acid Chemical compound CCCCCCCCCCCCCCCCCCNCCC(O)=O BKTMEKOLXCZRFW-UHFFFAOYSA-N 0.000 description 1
- CZOIUKWGJCDTGF-UHFFFAOYSA-N 3-(octylamino)propanoic acid Chemical compound CCCCCCCCNCCC(O)=O CZOIUKWGJCDTGF-UHFFFAOYSA-N 0.000 description 1
- NXLIWIHBINBLLP-UHFFFAOYSA-N 3-(pentadecylamino)propanoic acid Chemical compound C(CCNCCCCCCCCCCCCCCC)(=O)O NXLIWIHBINBLLP-UHFFFAOYSA-N 0.000 description 1
- HKJKXDULJBGDED-UHFFFAOYSA-N 3-(tetradecylamino)propanoic acid Chemical compound CCCCCCCCCCCCCCNCCC(O)=O HKJKXDULJBGDED-UHFFFAOYSA-N 0.000 description 1
- MWFCHAVNWRNLPA-UHFFFAOYSA-N 3-(tridecylazaniumyl)propanoate Chemical compound CCCCCCCCCCCCC[NH2+]CCC([O-])=O MWFCHAVNWRNLPA-UHFFFAOYSA-N 0.000 description 1
- UNWFFCPRJXMCNV-UHFFFAOYSA-N 3-[dodecanoyl(methyl)amino]propanoic acid Chemical compound CCCCCCCCCCCC(=O)N(C)CCC(O)=O UNWFFCPRJXMCNV-UHFFFAOYSA-N 0.000 description 1
- WGVGLSURTKMQQC-UHFFFAOYSA-N 3-aminopropyl-ethyl-dimethylazanium Chemical compound CC[N+](C)(C)CCCN WGVGLSURTKMQQC-UHFFFAOYSA-N 0.000 description 1
- XPFCZYUVICHKDS-UHFFFAOYSA-N 3-methylbutane-1,3-diol Chemical compound CC(C)(O)CCO XPFCZYUVICHKDS-UHFFFAOYSA-N 0.000 description 1
- RZRNAYUHWVFMIP-GDCKJWNLSA-N 3-oleoyl-sn-glycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@H](O)CO RZRNAYUHWVFMIP-GDCKJWNLSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- FBNAWLJSQORPAX-UHFFFAOYSA-N 4-methyl-3-propan-2-ylphenol Chemical compound CC(C)C1=CC(O)=CC=C1C FBNAWLJSQORPAX-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- XZIIFPSPUDAGJM-UHFFFAOYSA-N 6-chloro-2-n,2-n-diethylpyrimidine-2,4-diamine Chemical compound CCN(CC)C1=NC(N)=CC(Cl)=N1 XZIIFPSPUDAGJM-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- SGHZXLIDFTYFHQ-UHFFFAOYSA-L Brilliant Blue Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 SGHZXLIDFTYFHQ-UHFFFAOYSA-L 0.000 description 1
- 241000195940 Bryophyta Species 0.000 description 1
- MVWUZNXZHFTRRO-UHFFFAOYSA-N CCCCCCCCCNCCC(O)=O Chemical compound CCCCCCCCCNCCC(O)=O MVWUZNXZHFTRRO-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 235000003392 Curcuma domestica Nutrition 0.000 description 1
- 244000008991 Curcuma longa Species 0.000 description 1
- 244000007835 Cyamopsis tetragonoloba Species 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- RGHNJXZEOKUKBD-SQOUGZDYSA-M D-gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O RGHNJXZEOKUKBD-SQOUGZDYSA-M 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- 235000004866 D-panthenol Nutrition 0.000 description 1
- 239000011703 D-panthenol Substances 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- RDOFJDLLWVCMRU-UHFFFAOYSA-N Diisobutyl adipate Chemical compound CC(C)COC(=O)CCCCC(=O)OCC(C)C RDOFJDLLWVCMRU-UHFFFAOYSA-N 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical class [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- ORAWFNKFUWGRJG-UHFFFAOYSA-N Docosanamide Chemical compound CCCCCCCCCCCCCCCCCCCCCC(N)=O ORAWFNKFUWGRJG-UHFFFAOYSA-N 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- 238000008157 ELISA kit Methods 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- PVNIQBQSYATKKL-UHFFFAOYSA-N Glycerol trihexadecanoate Natural products CCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCC PVNIQBQSYATKKL-UHFFFAOYSA-N 0.000 description 1
- DCXXMTOCNZCJGO-UHFFFAOYSA-N Glycerol trioctadecanoate Natural products CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 1
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 1
- CMBYOWLFQAFZCP-UHFFFAOYSA-N Hexyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCCCCC CMBYOWLFQAFZCP-UHFFFAOYSA-N 0.000 description 1
- XPJVKCRENWUEJH-UHFFFAOYSA-N Isobutylparaben Chemical compound CC(C)COC(=O)C1=CC=C(O)C=C1 XPJVKCRENWUEJH-UHFFFAOYSA-N 0.000 description 1
- CMHMMKSPYOOVGI-UHFFFAOYSA-N Isopropylparaben Chemical compound CC(C)OC(=O)C1=CC=C(O)C=C1 CMHMMKSPYOOVGI-UHFFFAOYSA-N 0.000 description 1
- 239000011786 L-ascorbyl-6-palmitate Substances 0.000 description 1
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- 229920002884 Laureth 4 Polymers 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 241000208467 Macadamia Species 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 238000006845 Michael addition reaction Methods 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- QGCUAFIULMNFPJ-UHFFFAOYSA-N Myristamidopropyl betaine Chemical compound CCCCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC([O-])=O QGCUAFIULMNFPJ-UHFFFAOYSA-N 0.000 description 1
- QZXSMBBFBXPQHI-UHFFFAOYSA-N N-(dodecanoyl)ethanolamine Chemical compound CCCCCCCCCCCC(=O)NCCO QZXSMBBFBXPQHI-UHFFFAOYSA-N 0.000 description 1
- SUZRRICLUFMAQD-UHFFFAOYSA-N N-Methyltaurine Chemical compound CNCCS(O)(=O)=O SUZRRICLUFMAQD-UHFFFAOYSA-N 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- 241000772415 Neovison vison Species 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 241000282320 Panthera leo Species 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 229920002565 Polyethylene Glycol 400 Polymers 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920002367 Polyisobutene Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical group CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 1
- 235000019774 Rice Bran oil Nutrition 0.000 description 1
- XKGDWZQXVZSXAO-ADYSOMBNSA-N Ricinoleic Acid methyl ester Chemical compound CCCCCC[C@@H](O)C\C=C/CCCCCCCC(=O)OC XKGDWZQXVZSXAO-ADYSOMBNSA-N 0.000 description 1
- XKGDWZQXVZSXAO-SFHVURJKSA-N Ricinolsaeure-methylester Natural products CCCCCC[C@H](O)CC=CCCCCCCCC(=O)OC XKGDWZQXVZSXAO-SFHVURJKSA-N 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 241000270666 Testudines Species 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- DOOTYTYQINUNNV-UHFFFAOYSA-N Triethyl citrate Chemical compound CCOC(=O)CC(O)(C(=O)OCC)CC(=O)OCC DOOTYTYQINUNNV-UHFFFAOYSA-N 0.000 description 1
- PHYFQTYBJUILEZ-UHFFFAOYSA-N Trioleoylglycerol Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(OC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC PHYFQTYBJUILEZ-UHFFFAOYSA-N 0.000 description 1
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 1
- HOQCVZHXKCEGTC-CPNOTHRPSA-N [(2R,3R,4S,5R,6R)-6-[(2S,3S,4S,5R)-3,4-dihydroxy-2,5-bis(16-methylheptadecanoyloxymethyl)oxolan-2-yl]oxy-3,5-dihydroxy-4-(16-methylheptadecanoyloxy)oxan-2-yl]methyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OC[C@H]1O[C@@](COC(=O)CCCCCCCCCCCCCCC(C)C)(O[C@H]2O[C@H](COC(=O)CCCCCCCCCCCCCCC(C)C)[C@@H](O)[C@H](OC(=O)CCCCCCCCCCCCCCC(C)C)[C@H]2O)[C@@H](O)[C@@H]1O HOQCVZHXKCEGTC-CPNOTHRPSA-N 0.000 description 1
- XKMYWNHZAQUEPY-YZGJEOKZSA-N [(3s,8s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl] 12-hydroxyoctadecanoate Chemical compound C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)CCCCCCCCCCC(O)CCCCCC)C1 XKMYWNHZAQUEPY-YZGJEOKZSA-N 0.000 description 1
- DRRMRHKHTQRWMB-UHFFFAOYSA-N [3-(2-ethylhexanoyloxy)-2,2-bis(2-ethylhexanoyloxymethyl)propyl] 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCC(COC(=O)C(CC)CCCC)(COC(=O)C(CC)CCCC)COC(=O)C(CC)CCCC DRRMRHKHTQRWMB-UHFFFAOYSA-N 0.000 description 1
- OWRMXHRUFYLLQP-UHFFFAOYSA-N [3-[2,3-bis(16-methylheptadecanoyloxy)propoxy]-2-hydroxypropyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(O)COCC(OC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C OWRMXHRUFYLLQP-UHFFFAOYSA-N 0.000 description 1
- NPTLAYTZMHJJDP-KTKRTIGZSA-N [3-[3-[3-[3-[3-[3-[3-[3-[3-(2,3-dihydroxypropoxy)-2-hydroxypropoxy]-2-hydroxypropoxy]-2-hydroxypropoxy]-2-hydroxypropoxy]-2-hydroxypropoxy]-2-hydroxypropoxy]-2-hydroxypropoxy]-2-hydroxypropoxy]-2-hydroxypropyl] (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(O)COCC(O)COCC(O)COCC(O)COCC(O)COCC(O)COCC(O)COCC(O)COCC(O)COCC(O)CO NPTLAYTZMHJJDP-KTKRTIGZSA-N 0.000 description 1
- CMPDPBDUZTUXAD-UHFFFAOYSA-N [3-hydroxy-2-(16-methylheptadecanoyloxy)propyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(CO)OC(=O)CCCCCCCCCCCCCCC(C)C CMPDPBDUZTUXAD-UHFFFAOYSA-N 0.000 description 1
- QILXPCHTWXAUHE-UHFFFAOYSA-N [Na].NCCN Chemical compound [Na].NCCN QILXPCHTWXAUHE-UHFFFAOYSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- QVFOGJXHRGAFSH-UHFFFAOYSA-N acetic acid;1-dodecoxydodecane Chemical compound CC(O)=O.CCCCCCCCCCCCOCCCCCCCCCCCC QVFOGJXHRGAFSH-UHFFFAOYSA-N 0.000 description 1
- 229940048053 acrylate Drugs 0.000 description 1
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 238000012644 addition polymerization Methods 0.000 description 1
- 239000003470 adrenal cortex hormone Substances 0.000 description 1
- 230000001919 adrenal effect Effects 0.000 description 1
- 230000001780 adrenocortical effect Effects 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 125000005250 alkyl acrylate group Chemical group 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- ALYNCZNDIQEVRV-UHFFFAOYSA-N aniline-p-carboxylic acid Natural products NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 235000010385 ascorbyl palmitate Nutrition 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- XNEFYCZVKIDDMS-UHFFFAOYSA-N avobenzone Chemical compound C1=CC(OC)=CC=C1C(=O)CC(=O)C1=CC=C(C(C)(C)C)C=C1 XNEFYCZVKIDDMS-UHFFFAOYSA-N 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 229940092738 beeswax Drugs 0.000 description 1
- 235000010290 biphenyl Nutrition 0.000 description 1
- 239000004305 biphenyl Substances 0.000 description 1
- 125000006267 biphenyl group Chemical group 0.000 description 1
- HGKOWIQVWAQWDS-UHFFFAOYSA-N bis(16-methylheptadecyl) 2-hydroxybutanedioate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CC(O)C(=O)OCCCCCCCCCCCCCCCC(C)C HGKOWIQVWAQWDS-UHFFFAOYSA-N 0.000 description 1
- WMNULTDOANGXRT-UHFFFAOYSA-N bis(2-ethylhexyl) butanedioate Chemical compound CCCCC(CC)COC(=O)CCC(=O)OCC(CC)CCCC WMNULTDOANGXRT-UHFFFAOYSA-N 0.000 description 1
- ATAJZVDXFMMOFG-UHFFFAOYSA-N bis(2-heptylundecyl) hexanedioate Chemical compound CCCCCCCCCC(CCCCCCC)COC(=O)CCCCC(=O)OCC(CCCCCCC)CCCCCCCCC ATAJZVDXFMMOFG-UHFFFAOYSA-N 0.000 description 1
- PPOZILIWLOFYOG-UHFFFAOYSA-N bis(2-hexyldecyl) hexanedioate Chemical compound CCCCCCCCC(CCCCCC)COC(=O)CCCCC(=O)OCC(CCCCCC)CCCCCCCC PPOZILIWLOFYOG-UHFFFAOYSA-N 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
- 229940043253 butylated hydroxyanisole Drugs 0.000 description 1
- 229940067596 butylparaben Drugs 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- MRUAUOIMASANKQ-UHFFFAOYSA-O carboxymethyl-[3-(dodecanoylamino)propyl]-dimethylazanium Chemical compound CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC(O)=O MRUAUOIMASANKQ-UHFFFAOYSA-O 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 239000012185 ceresin wax Substances 0.000 description 1
- 229940074979 cetyl palmitate Drugs 0.000 description 1
- ONTQJDKFANPPKK-UHFFFAOYSA-L chembl3185981 Chemical compound [Na+].[Na+].CC1=CC(C)=C(S([O-])(=O)=O)C=C1N=NC1=CC(S([O-])(=O)=O)=C(C=CC=C2)C2=C1O ONTQJDKFANPPKK-UHFFFAOYSA-L 0.000 description 1
- 239000007810 chemical reaction solvent Substances 0.000 description 1
- 229940072104 cholesteryl hydroxystearate Drugs 0.000 description 1
- KXKPYJOVDUMHGS-OSRGNVMNSA-N chondroitin sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](OS(O)(=O)=O)[C@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](C(O)=O)O1 KXKPYJOVDUMHGS-OSRGNVMNSA-N 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 229940071124 cocoyl glutamate Drugs 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 239000003246 corticosteroid Substances 0.000 description 1
- 229960001334 corticosteroids Drugs 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 235000003373 curcuma longa Nutrition 0.000 description 1
- AZSFNUJOCKMOGB-UHFFFAOYSA-N cyclotriphosphoric acid Chemical compound OP1(=O)OP(O)(=O)OP(O)(=O)O1 AZSFNUJOCKMOGB-UHFFFAOYSA-N 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- SASYSVUEVMOWPL-NXVVXOECSA-N decyl oleate Chemical compound CCCCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC SASYSVUEVMOWPL-NXVVXOECSA-N 0.000 description 1
- 239000011928 denatured alcohol Substances 0.000 description 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
- 229960003957 dexamethasone Drugs 0.000 description 1
- 229940075557 diethylene glycol monoethyl ether Drugs 0.000 description 1
- 229940096810 diethylhexyl sebacate Drugs 0.000 description 1
- 229940105984 diethylhexyl succinate Drugs 0.000 description 1
- 229940031769 diisobutyl adipate Drugs 0.000 description 1
- 229940031569 diisopropyl sebacate Drugs 0.000 description 1
- OGQYPPBGSLZBEG-UHFFFAOYSA-N dimethyl(dioctadecyl)azanium Chemical compound CCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCCCC OGQYPPBGSLZBEG-UHFFFAOYSA-N 0.000 description 1
- VJHINFRRDQUWOJ-UHFFFAOYSA-N dioctyl sebacate Chemical compound CCCCC(CC)COC(=O)CCCCCCCCC(=O)OCC(CC)CCCC VJHINFRRDQUWOJ-UHFFFAOYSA-N 0.000 description 1
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 description 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-N diphosphoric acid Chemical compound OP(O)(=O)OP(O)(O)=O XPPKVPWEQAFLFU-UHFFFAOYSA-N 0.000 description 1
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 description 1
- XFKBBSZEQRFVSL-UHFFFAOYSA-N dipropan-2-yl decanedioate Chemical compound CC(C)OC(=O)CCCCCCCCC(=O)OC(C)C XFKBBSZEQRFVSL-UHFFFAOYSA-N 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical class [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 description 1
- 229940079886 disodium lauryl sulfosuccinate Drugs 0.000 description 1
- GLSRFBDXBWZNLH-UHFFFAOYSA-L disodium;2-chloroacetate;2-(4,5-dihydroimidazol-1-yl)ethanol;hydroxide Chemical compound [OH-].[Na+].[Na+].[O-]C(=O)CCl.OCCN1CCN=C1 GLSRFBDXBWZNLH-UHFFFAOYSA-L 0.000 description 1
- JMGZBMRVDHKMKB-UHFFFAOYSA-L disodium;2-sulfobutanedioate Chemical compound [Na+].[Na+].OS(=O)(=O)C(C([O-])=O)CC([O-])=O JMGZBMRVDHKMKB-UHFFFAOYSA-L 0.000 description 1
- KHIQYZGEUSTKSB-UHFFFAOYSA-L disodium;4-dodecoxy-4-oxo-3-sulfobutanoate Chemical compound [Na+].[Na+].CCCCCCCCCCCCOC(=O)C(S(O)(=O)=O)CC([O-])=O.CCCCCCCCCCCCOC(=O)C(S(O)(=O)=O)CC([O-])=O KHIQYZGEUSTKSB-UHFFFAOYSA-L 0.000 description 1
- YVIGPQSYEAOLAD-UHFFFAOYSA-L disodium;dodecyl phosphate Chemical compound [Na+].[Na+].CCCCCCCCCCCCOP([O-])([O-])=O YVIGPQSYEAOLAD-UHFFFAOYSA-L 0.000 description 1
- 229940102552 disteardimonium hectorite Drugs 0.000 description 1
- 239000004664 distearyldimethylammonium chloride (DHTDMAC) Substances 0.000 description 1
- 229940073551 distearyldimonium chloride Drugs 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- WRKMVSNZQMTYCV-UHFFFAOYSA-N dodecyl 3-aminopropanoate;sodium Chemical compound [Na].CCCCCCCCCCCCOC(=O)CCN WRKMVSNZQMTYCV-UHFFFAOYSA-N 0.000 description 1
- YRIUSKIDOIARQF-UHFFFAOYSA-N dodecyl benzenesulfonate Chemical compound CCCCCCCCCCCCOS(=O)(=O)C1=CC=CC=C1 YRIUSKIDOIARQF-UHFFFAOYSA-N 0.000 description 1
- GVGUFUZHNYFZLC-UHFFFAOYSA-N dodecyl benzenesulfonate;sodium Chemical compound [Na].CCCCCCCCCCCCOS(=O)(=O)C1=CC=CC=C1 GVGUFUZHNYFZLC-UHFFFAOYSA-N 0.000 description 1
- TVACALAUIQMRDF-UHFFFAOYSA-N dodecyl dihydrogen phosphate Chemical compound CCCCCCCCCCCCOP(O)(O)=O TVACALAUIQMRDF-UHFFFAOYSA-N 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical compound CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 description 1
- 229940043264 dodecyl sulfate Drugs 0.000 description 1
- 229940071161 dodecylbenzenesulfonate Drugs 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 230000005518 electrochemistry Effects 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 1
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 1
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 229940050410 gluconate Drugs 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 150000002314 glycerols Chemical class 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 229940074050 glyceryl myristate Drugs 0.000 description 1
- 229940100242 glycol stearate Drugs 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 239000008266 hair spray Substances 0.000 description 1
- 239000008269 hand cream Substances 0.000 description 1
- KWLMIXQRALPRBC-UHFFFAOYSA-L hectorite Chemical compound [Li+].[OH-].[OH-].[Na+].[Mg+2].O1[Si]2([O-])O[Si]1([O-])O[Si]([O-])(O1)O[Si]1([O-])O2 KWLMIXQRALPRBC-UHFFFAOYSA-L 0.000 description 1
- 229910000271 hectorite Inorganic materials 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 description 1
- PXDJXZJSCPSGGI-UHFFFAOYSA-N hexadecanoic acid hexadecyl ester Natural products CCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC PXDJXZJSCPSGGI-UHFFFAOYSA-N 0.000 description 1
- XJNUECKWDBNFJV-UHFFFAOYSA-N hexadecyl 2-ethylhexanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC XJNUECKWDBNFJV-UHFFFAOYSA-N 0.000 description 1
- 229940100463 hexyl laurate Drugs 0.000 description 1
- 210000003630 histaminocyte Anatomy 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 229940014041 hyaluronate Drugs 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 229960004337 hydroquinone Drugs 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 239000002563 ionic surfactant Substances 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- 229940078568 isocetyl myristate Drugs 0.000 description 1
- 229940078545 isocetyl stearate Drugs 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- KUVMKLCGXIYSNH-UHFFFAOYSA-N isopentadecane Natural products CCCCCCCCCCCCC(C)C KUVMKLCGXIYSNH-UHFFFAOYSA-N 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 229940075495 isopropyl palmitate Drugs 0.000 description 1
- NFIDBGJMFKNGGQ-UHFFFAOYSA-N isopropylmethylphenol Natural products CC(C)CC1=CC=CC=C1O NFIDBGJMFKNGGQ-UHFFFAOYSA-N 0.000 description 1
- 229940113094 isopropylparaben Drugs 0.000 description 1
- 229940075468 lauramidopropyl betaine Drugs 0.000 description 1
- 229940061515 laureth-4 Drugs 0.000 description 1
- 229940094506 lauryl betaine Drugs 0.000 description 1
- 229940071180 lauryl sulfosuccinate Drugs 0.000 description 1
- 235000021388 linseed oil Nutrition 0.000 description 1
- 239000000944 linseed oil Substances 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 229940049920 malate Drugs 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 229940044591 methyl glucose dioleate Drugs 0.000 description 1
- 229960001047 methyl salicylate Drugs 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 239000003595 mist Substances 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- RZRNAYUHWVFMIP-UHFFFAOYSA-N monoelaidin Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-UHFFFAOYSA-N 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 235000011929 mousse Nutrition 0.000 description 1
- 229940043348 myristyl alcohol Drugs 0.000 description 1
- 125000001421 myristyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229940078812 myristyl myristate Drugs 0.000 description 1
- ZUHZZVMEUAUWHY-UHFFFAOYSA-N n,n-dimethylpropan-1-amine Chemical compound CCCN(C)C ZUHZZVMEUAUWHY-UHFFFAOYSA-N 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- KKBOOQDFOWZSDC-UHFFFAOYSA-N n-[2-(diethylamino)ethyl]octadecanamide Chemical compound CCCCCCCCCCCCCCCCCC(=O)NCCN(CC)CC KKBOOQDFOWZSDC-UHFFFAOYSA-N 0.000 description 1
- SEWKYPOSEQRMLM-UHFFFAOYSA-N n-[2-(dimethylamino)ethyl]docosanamide Chemical compound CCCCCCCCCCCCCCCCCCCCCC(=O)NCCN(C)C SEWKYPOSEQRMLM-UHFFFAOYSA-N 0.000 description 1
- DVEKCXOJTLDBFE-UHFFFAOYSA-N n-dodecyl-n,n-dimethylglycinate Chemical compound CCCCCCCCCCCC[N+](C)(C)CC([O-])=O DVEKCXOJTLDBFE-UHFFFAOYSA-N 0.000 description 1
- 125000003136 n-heptyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 125000001196 nonadecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- YZUUTMGDONTGTN-UHFFFAOYSA-N nonaethylene glycol Chemical compound OCCOCCOCCOCCOCCOCCOCCOCCOCCO YZUUTMGDONTGTN-UHFFFAOYSA-N 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 229940048869 o-cymen-5-ol Drugs 0.000 description 1
- ZHALDANPYXAMJF-UHFFFAOYSA-N octadecanoate;tris(2-hydroxyethyl)azanium Chemical compound OCC[NH+](CCO)CCO.CCCCCCCCCCCCCCCCCC([O-])=O ZHALDANPYXAMJF-UHFFFAOYSA-N 0.000 description 1
- 229940073665 octyldodecyl myristate Drugs 0.000 description 1
- 229940049964 oleate Drugs 0.000 description 1
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- BARWIPMJPCRCTP-UHFFFAOYSA-N oleic acid oleyl ester Natural products CCCCCCCCC=CCCCCCCCCOC(=O)CCCCCCCC=CCCCCCCCC BARWIPMJPCRCTP-UHFFFAOYSA-N 0.000 description 1
- BARWIPMJPCRCTP-CLFAGFIQSA-N oleyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC BARWIPMJPCRCTP-CLFAGFIQSA-N 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 239000003346 palm kernel oil Substances 0.000 description 1
- 235000019865 palm kernel oil Nutrition 0.000 description 1
- 229940101267 panthenol Drugs 0.000 description 1
- 235000020957 pantothenol Nutrition 0.000 description 1
- 239000011619 pantothenol Substances 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 235000011837 pasties Nutrition 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 229940088608 peg-9 polydimethylsiloxyethyl dimethicone Drugs 0.000 description 1
- YKNWIILGEFFOPE-UHFFFAOYSA-N pentacosane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCC YKNWIILGEFFOPE-UHFFFAOYSA-N 0.000 description 1
- 235000019477 peppermint oil Nutrition 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N phenylbenzene Natural products C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000059 polyethylene glycol stearate Polymers 0.000 description 1
- 229940062000 polyglyceryl-2 triisostearate Drugs 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 235000015277 pork Nutrition 0.000 description 1
- UJLZCNZPJMYEKF-UHFFFAOYSA-M potassium;2-aminopropanoate Chemical compound [K+].CC(N)C([O-])=O UJLZCNZPJMYEKF-UHFFFAOYSA-M 0.000 description 1
- PYJBVGYZXWPIKK-UHFFFAOYSA-M potassium;tetradecanoate Chemical compound [K+].CCCCCCCCCCCCCC([O-])=O PYJBVGYZXWPIKK-UHFFFAOYSA-M 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 150000003141 primary amines Chemical class 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 229940005657 pyrophosphoric acid Drugs 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 239000008165 rice bran oil Substances 0.000 description 1
- XKGDWZQXVZSXAO-UHFFFAOYSA-N ricinoleic acid methyl ester Natural products CCCCCCC(O)CC=CCCCCCCCC(=O)OC XKGDWZQXVZSXAO-UHFFFAOYSA-N 0.000 description 1
- 239000001331 rosmarinus officinalis leaf Substances 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 238000006748 scratching Methods 0.000 description 1
- 230000002393 scratching effect Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 229940047670 sodium acrylate Drugs 0.000 description 1
- 229940096501 sodium cocoamphoacetate Drugs 0.000 description 1
- BTURAGWYSMTVOW-UHFFFAOYSA-M sodium dodecanoate Chemical compound [Na+].CCCCCCCCCCCC([O-])=O BTURAGWYSMTVOW-UHFFFAOYSA-M 0.000 description 1
- 229940080264 sodium dodecylbenzenesulfonate Drugs 0.000 description 1
- 239000000176 sodium gluconate Substances 0.000 description 1
- 235000012207 sodium gluconate Nutrition 0.000 description 1
- 229940005574 sodium gluconate Drugs 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 229940082004 sodium laurate Drugs 0.000 description 1
- KSAVQLQVUXSOCR-UHFFFAOYSA-M sodium lauroyl sarcosinate Chemical compound [Na+].CCCCCCCCCCCC(=O)N(C)CC([O-])=O KSAVQLQVUXSOCR-UHFFFAOYSA-M 0.000 description 1
- 229940045790 sodium lauryl glycol carboxylate Drugs 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 229940045845 sodium myristate Drugs 0.000 description 1
- RYYKJJJTJZKILX-UHFFFAOYSA-M sodium octadecanoate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC([O-])=O RYYKJJJTJZKILX-UHFFFAOYSA-M 0.000 description 1
- 229940045920 sodium pyrrolidone carboxylate Drugs 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- UIGBPGNEWMRLGK-UHFFFAOYSA-M sodium;2-(2-hydroxydodecoxy)acetate Chemical compound [Na+].CCCCCCCCCCC(O)COCC([O-])=O UIGBPGNEWMRLGK-UHFFFAOYSA-M 0.000 description 1
- GOJYXPWOUJYXJC-UHFFFAOYSA-M sodium;2-[1-(2-hydroxyethyl)-2-undecyl-4,5-dihydroimidazol-1-ium-1-yl]acetate;hydroxide Chemical compound [OH-].[Na+].CCCCCCCCCCCC1=NCC[N+]1(CCO)CC([O-])=O GOJYXPWOUJYXJC-UHFFFAOYSA-M 0.000 description 1
- ZEZSZCSSTDPVDM-UHFFFAOYSA-M sodium;2-aminopropanoate Chemical compound [Na+].CC(N)C([O-])=O ZEZSZCSSTDPVDM-UHFFFAOYSA-M 0.000 description 1
- HYRLWUFWDYFEES-UHFFFAOYSA-M sodium;2-oxopyrrolidine-1-carboxylate Chemical compound [Na+].[O-]C(=O)N1CCCC1=O HYRLWUFWDYFEES-UHFFFAOYSA-M 0.000 description 1
- JUQGWKYSEXPRGL-UHFFFAOYSA-M sodium;tetradecanoate Chemical compound [Na+].CCCCCCCCCCCCCC([O-])=O JUQGWKYSEXPRGL-UHFFFAOYSA-M 0.000 description 1
- 235000002316 solid fats Nutrition 0.000 description 1
- 229940035044 sorbitan monolaurate Drugs 0.000 description 1
- 239000001593 sorbitan monooleate Substances 0.000 description 1
- 235000011069 sorbitan monooleate Nutrition 0.000 description 1
- 229940035049 sorbitan monooleate Drugs 0.000 description 1
- 239000001587 sorbitan monostearate Substances 0.000 description 1
- 235000011076 sorbitan monostearate Nutrition 0.000 description 1
- 229940035048 sorbitan monostearate Drugs 0.000 description 1
- 229950011392 sorbitan stearate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- 229940032147 starch Drugs 0.000 description 1
- 229940037312 stearamide Drugs 0.000 description 1
- 229940100459 steareth-20 Drugs 0.000 description 1
- 229940012831 stearyl alcohol Drugs 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 150000003871 sulfonates Chemical class 0.000 description 1
- 150000003460 sulfonic acids Chemical class 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- BORJONZPSTVSFP-UHFFFAOYSA-N tetradecyl 2-hydroxypropanoate Chemical compound CCCCCCCCCCCCCCOC(=O)C(C)O BORJONZPSTVSFP-UHFFFAOYSA-N 0.000 description 1
- DZKXJUASMGQEMA-UHFFFAOYSA-N tetradecyl tetradecanoate Chemical compound CCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCC DZKXJUASMGQEMA-UHFFFAOYSA-N 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 235000015961 tonic Nutrition 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 229960000716 tonics Drugs 0.000 description 1
- 150000005691 triesters Chemical class 0.000 description 1
- 229940029614 triethanolamine stearate Drugs 0.000 description 1
- 239000001069 triethyl citrate Substances 0.000 description 1
- VMYFZRTXGLUXMZ-UHFFFAOYSA-N triethyl citrate Natural products CCOC(=O)C(O)(C(=O)OCC)C(=O)OCC VMYFZRTXGLUXMZ-UHFFFAOYSA-N 0.000 description 1
- 235000013769 triethyl citrate Nutrition 0.000 description 1
- 229940072029 trilaureth-4 phosphate Drugs 0.000 description 1
- SCRSFLUHMDMRFP-UHFFFAOYSA-N trimethyl-(methyl-octyl-trimethylsilyloxysilyl)oxysilane Chemical compound CCCCCCCC[Si](C)(O[Si](C)(C)C)O[Si](C)(C)C SCRSFLUHMDMRFP-UHFFFAOYSA-N 0.000 description 1
- 229940113164 trimyristin Drugs 0.000 description 1
- 235000013976 turmeric Nutrition 0.000 description 1
- 125000002948 undecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 239000010497 wheat germ oil Substances 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
Abstract
Description
本発明は、皮膚製剤用の組成物及び皮膚用製剤に関する。 The present invention relates to compositions for dermatological preparations and dermatological preparations.
皮膚のかゆみは、日常生活の中で頻発する感覚の一つである。かゆみが引き起こす掻破行動は、かゆみを増強するだけでなく、皮膚炎などの症状も悪化させるため、かゆみを抑制できない場合はQOL低下につながることが知られている。
かゆみを抑制する皮膚用製剤として、副腎皮質ホルモン剤(ステロイド)等が知られている。
Itchy skin is one of the sensations that frequently occur in daily life. It is known that the scratching behavior caused by itch not only intensifies the itch but also worsens symptoms such as dermatitis, leading to a decline in QOL if itch cannot be suppressed.
Adrenal corticosteroids (steroids) and the like are known as skin preparations that suppress itching.
しかしながら、副腎皮質ホルモンは皮膚刺激性が強く、「医薬品、医療機器等の品質、有効性及び安全性の確保等に関する法律」で規定される化粧品及び医薬部外品には使用できない。(非特許文献1) However, adrenocortical hormones are highly irritating to the skin and cannot be used in cosmetics and quasi-drugs as stipulated by the ``Act on Assuring the Quality, Efficacy, and Safety of Pharmaceuticals, Medical Devices, etc.''. (Non-patent document 1)
本発明は、ヒスタミン遊離抑制効果に優れ、かつ、化粧料、医薬部外品、医薬品に配合可能な皮膚用製剤を得ることができる組成物及び皮膚用製剤を提供することを目的とする。 An object of the present invention is to provide a composition and a skin preparation that have an excellent effect of suppressing histamine release and can be incorporated into cosmetics, quasi-drugs, and pharmaceuticals.
本発明者らは、上記目的を達成するために鋭意検討した結果、本発明に到達した。すなわち本発明は、下記の一般式(1)で表される両性界面活性剤(A)と、
リン酸の重縮合物及び/又はその塩とを含有する皮膚用製剤用組成物、及び皮膚用製剤である。
A skin preparation composition and a skin preparation containing a polycondensate of phosphoric acid and/or a salt thereof.
本発明の皮膚製剤用の組成物及び皮膚用製剤は、ヒスタミン遊離抑制効果に優れるため、かゆみ抑制効果が高い。 The composition for skin preparations and skin preparations of the present invention have an excellent effect of suppressing histamine release, and therefore have a high effect of suppressing itch.
以下、本発明を詳述する。
本願における皮膚用製剤には、「医薬品、医療機器等の品質、有効性及び安全性の確保等に関する法律」で規定する化粧品、医薬部外品及び医薬品のうち、ヒトの皮膚に塗布又は散布等するものが含まれる。
これらのうち、化粧品としては、頭皮用化粧料、頭皮以外の皮膚化粧料、浴用化粧品、リップケア用化粧品、ボディパウダー等が挙げられる。医薬品としては、軟膏及び液状の皮膚外用剤等が挙げられる。
The present invention will be explained in detail below.
Skin preparations in this application include cosmetics, quasi-drugs, and pharmaceuticals stipulated in the "Act on Assuring the Quality, Efficacy, and Safety of Pharmaceuticals, Medical Devices, etc.," such as those applied or sprayed on human skin. Includes things that do.
Among these, cosmetics include scalp cosmetics, skin cosmetics other than scalp cosmetics, bath cosmetics, lip care cosmetics, body powder, and the like. Pharmaceutical products include ointments and liquid skin preparations.
<両性界面活性剤(A)>
本願第一の発明である皮膚製剤用の組成物は一般式(1)で表される両性界面活性剤(A)を含有する。
<Ampholytic surfactant (A)>
The composition for skin preparation, which is the first invention of the present application, contains an amphoteric surfactant (A) represented by the general formula (1).
一般式(1)において、R1は炭素数6~25のアルキル基又はアルケニル基を表す。
炭素数6~25のアルキル基としては、n-ヘキシル基、n-ヘプチル基、n-オクチル基、イソオクチル基、2-エチルヘキシル基、n-ノニル基、イソノニル基、n-デシル基、イソデシル基、ウンデシル基、n-ドデシル基、イソドデシル基、n-トリデシル基、イソトリデシル基、n-テトラデシル基、イソテトラデシル基、n-ヘキサデシル基、イソヘキサデシル基、n-ステアリル基、イソステアリル基、n-ノナデシル基、n-イコシル基及びn-テトラコシル基等が挙げられる。
炭素数6~25のアルケニル基としては、n-ヘキセニル基、n-ヘプテニル基、n-オクテニル基、n-デセニル基、イソデセニル基、n-ウンデセニル基、n-ドデセニル基、n-テトラデセニル基、イソヘキサデセニル基、n-オクタデセニル基及びn-オクタデカジエニル基等が挙げられる。
R1のうち、皮膚製剤用の組成物及び皮膚用製剤のヒスタミン遊離抑制効果の観点から、好ましくは炭素数6~20のアルキル基又は炭素数6~20のアルケニル基であり、さらに好ましくは炭素数8~18のアルキル基又は炭素数8~18のアルケニル基である。
In general formula (1), R 1 represents an alkyl group or alkenyl group having 6 to 25 carbon atoms.
Examples of the alkyl group having 6 to 25 carbon atoms include n-hexyl group, n-heptyl group, n-octyl group, isooctyl group, 2-ethylhexyl group, n-nonyl group, isononyl group, n-decyl group, isodecyl group, Undecyl group, n-dodecyl group, isododecyl group, n-tridecyl group, isotridecyl group, n-tetradecyl group, isotetradecyl group, n-hexadecyl group, isohexadecyl group, n-stearyl group, isostearyl group, n- Examples include nonadecyl group, n-icosyl group and n-tetracosyl group.
Examples of alkenyl groups having 6 to 25 carbon atoms include n-hexenyl group, n-heptenyl group, n-octenyl group, n-decenyl group, isodecenyl group, n-undecenyl group, n-dodecenyl group, n-tetradecenyl group, iso Examples include hexadecenyl group, n-octadecenyl group, and n-octadecadienyl group.
Of R 1 , from the viewpoint of suppressing histamine release in compositions for skin preparations and skin preparations, preferably an alkyl group having 6 to 20 carbon atoms or an alkenyl group having 6 to 20 carbon atoms, more preferably a carbon It is an alkyl group having 8 to 18 carbon atoms or an alkenyl group having 8 to 18 carbon atoms.
一般式(1)において、Xは水素原子又は炭素数1~3のアルキル基を表す。
炭素数1~3のアルキル基としては、メチル基、エチル基及びプロピル基等が挙げられる。
Xのうち、皮膚製剤用の組成物及び皮膚用製剤のヒスタミン遊離抑制効果の観点から、好ましくは水素原子又はメチル基であり、さらに好ましくは水素原子である。
In the general formula (1), X represents a hydrogen atom or an alkyl group having 1 to 3 carbon atoms.
Examples of the alkyl group having 1 to 3 carbon atoms include methyl group, ethyl group, and propyl group.
Among X, from the viewpoint of suppressing histamine release in compositions for skin preparations and skin preparations, preferably a hydrogen atom or a methyl group, and more preferably a hydrogen atom.
一般式(1)において、M1は水素原子、ナトリウム原子、カリウム原子又はトリエタノールアンモニウムである。
M1のうち、皮膚製剤用の組成物及び皮膚用製剤のヒスタミン遊離抑制効果の観点から、好ましくはナトリウム原子又はトリエタノールアンモニウムであり、さらに好ましくはナトリウム原子である。
In general formula (1), M 1 is a hydrogen atom, a sodium atom, a potassium atom, or triethanolammonium.
Among M1 , from the viewpoint of suppressing histamine release in compositions for skin preparations and skin preparations, sodium atoms or triethanolammonium are preferable, and sodium atoms are more preferable.
一般式(1)において、nは1又は2の整数を表す。
nは皮膚製剤用の組成物及び皮膚用製剤のヒスタミン遊離抑制効果の観点から、好ましくは2である。
In general formula (1), n represents an integer of 1 or 2.
n is preferably 2 from the viewpoint of suppressing histamine release in compositions for skin preparations and skin preparations.
一般式(1)で示される両性界面活性剤(A)の具体例としては、β-ヘキシルアミノプロピオン酸ナトリウム、β-へプチルアミノプロピオン酸ナトリウム、β-オクチルアミノプロピオン酸ナトリウム、β-イソオクチルアミノプロピオン酸ナトリウム、β-2-エチルヘキシルアミノプロピオン酸ナトリウム、β-ノニルアミノプロピオン酸ナトリウム、β-イソノニルアミノプロピオン酸ナトリウム、β-デシルアミノプロピオン酸ナトリウム、β-イソデシルアミノプロピオン酸ナトリウム、β-ウンデシルアミノプロピオン酸ナトリウム、β-ドデシルアミノプロピオン酸ナトリウム、β-ドデシルアミノプロピオン酸カリウム、β-ドデシルアミノプロピオン酸トリエタノールアンモニウム、β-ヤシ油脂肪酸アミノプロピオン酸ナトリウム(ヤシ油脂肪酸とは、ヤシ油から得られる脂肪酸のことを示し、炭素数8~18の分布を持つ脂肪酸を主成分とする混合脂肪酸である)、β-ヤシ油脂肪酸アミノコミノプロピオン酸トリエタノールアンモニウム、β-イソドデシルアミノプロピオン酸ナトリウム、β-トリデシルアミノプロピオン酸ナトリウム、β-テトラデシルアミノプロピオン酸ナトリウム、β-ペンタデシルアミノプロピオン酸ナトリウム、β-イソペンタデシルアミノプロピオン酸ナトリウム、β-イソテトラデシルアミノプロピオン酸ナトリウム、β-ヘキサデシルアミノプロピオン酸ナトリウム、β-イソヘキサデシルアミノプロピオン酸ナトリウム、β-ステアリルアミノプロピオン酸ナトリウム、β-イソステアリルアミノプロピオン酸ナトリウム、β-ノナデシルアミノプロピオン酸ナトリウム、β-イコシルアミノプロピオン酸ナトリウム、β-テトラコシルアミノプロピオン酸ナトリウム、β-ヘキセニルアミノプロピオン酸ナトリウム、β-ヘプテニルアミノプロピオン酸ナトリウム、β-オクテニルアミノプロピオン酸ナトリウム、β-デセニルアミノプロピオン酸ナトリウム、β-イソデセニルアミノプロピオン酸ナトリウム、β-ウンデセニルアミノプロピオン酸ナトリウム、β-ドデセニルアミノプロピオン酸ナトリウム、β-テトラドデセニルアミノプロピオン酸ナトリウム、β-イソヘキサデセニルアミノプロピオン酸ナトリウム、β-オクタデセニルアミノプロピオン酸ナトリウム及びβ-オクタデカジエニルアミノプロピオン酸ナトリウムが挙げられる。
これらのうち1種を単独で用いても2種以上を併用してもよい。
Specific examples of the amphoteric surfactant (A) represented by general formula (1) include sodium β-hexylaminopropionate, sodium β-heptylaminopropionate, sodium β-octylaminopropionate, β-isooctyl Sodium aminopropionate, sodium β-2-ethylhexylaminopropionate, sodium β-nonylaminopropionate, sodium β-isononylaminopropionate, sodium β-decylaminopropionate, sodium β-isodecylaminopropionate, β - Sodium undecylaminopropionate, sodium β-dodecylaminopropionate, potassium β-dodecylaminopropionate, triethanolammonium β-dodecylaminopropionate, sodium β-coconut oil fatty acid aminopropionate (coconut oil fatty acid is Refers to fatty acids obtained from coconut oil, and is a mixed fatty acid mainly composed of fatty acids with a distribution of carbon numbers of 8 to 18), β-coconut oil fatty acid aminocominopropionate triethanolammonium, β-isododecylamino Sodium propionate, Sodium β-tridecylaminopropionate, Sodium β-tetradecylaminopropionate, Sodium β-pentadecylaminopropionate, Sodium β-isopentadecylaminopropionate, Sodium β-isotetradecylaminopropionate , β-sodium hexadecylaminopropionate, sodium β-isohexadecylaminopropionate, sodium β-stearylaminopropionate, sodium β-isostearylaminopropionate, sodium β-nonadecylaminopropionate, β-icosyl Sodium aminopropionate, sodium β-tetracosylaminopropionate, sodium β-hexenylaminopropionate, sodium β-heptenylaminopropionate, sodium β-octenylaminopropionate, sodium β-decenylaminopropionate , β-isodecenylaminopropionate sodium, β-undecenylaminopropionate sodium, β-dodecenylaminopropionate sodium, β-tetradodecenylaminopropionate sodium, β-isohexade Sodium senylaminopropionate, sodium β-octadecenylaminopropionate and sodium β-octadecadienylaminopropionate are mentioned.
One of these may be used alone or two or more may be used in combination.
一般式(1)で示される両性界面活性剤(A)としては、皮膚製剤用の組成物及び皮膚用製剤のヒスタミン遊離抑制効果の観点から、好ましくはβ-ドデシルアミノプロピオン酸ナトリウム、β-ドデシルアミノプロピオン酸カリウム、及びβ-ドデシルアミノプロピオン酸トリエタノールアンモニウムであり、さらに好ましくはβ-ドデシルアミノプロピオン酸ナトリウムである。
また、β-ドデシルアミノプロピオン酸ナトリウム、β-ドデシルアミノプロピオン酸カリウム、及びβ-ドデシルアミノプロピオン酸トリエタノールアンモニウムを構成成分とすることからβ-ヤシ油脂肪酸アミノプロピオン酸ナトリウム、β-ヤシ油脂肪酸アミノプロピオン酸カリウム、及びβ-ヤシ油脂肪酸アミノプロピオン酸トリエタノールアンモニウムもそれぞれ好ましく、β-ヤシ油脂肪酸アミノプロピオン酸ナトリウムもさらに好ましい。
The amphoteric surfactant (A) represented by the general formula (1) is preferably sodium β-dodecylaminopropionate, β-dodecyl These are potassium aminopropionate and triethanolammonium β-dodecylaminopropionate, and more preferably sodium β-dodecylaminopropionate.
In addition, since the constituent components are sodium β-dodecylaminopropionate, potassium β-dodecylaminopropionate, and triethanolammonium β-dodecylaminopropionate, sodium β-coconut oil fatty acid aminopropionate, β-coconut oil fatty acid Potassium aminopropionate and triethanolammonium β-coco fatty acid aminopropionate are also preferred, and sodium β-coco fatty acid aminopropionate is even more preferred.
一般式(1)で表される両性界面活性剤(A)は、特開2008-162914号公報等に記載の公知の方法で得ることができ、炭素数6~25の1級アミン1モルに対してアクリル酸メチル1モルをマイケル付加させて、マイケル付加物を得た後、水酸化ナトリウム等のアルカリ性化合物でマイケル付加物を加水分解すること等によって得ることができる。
例えば、好ましくは50~150℃、より好ましくは70~100℃で炭素数6~25の1級アミン1モルに対し、アクリル酸メチル1.17モルを滴下することで反応を行い、アルカリで加水分解することによって、両性界面活性剤(A)を含む両性界面活性剤水溶液が得られる。
The amphoteric surfactant (A) represented by the general formula (1) can be obtained by a known method described in JP-A-2008-162914, etc. It can be obtained by subjecting 1 mole of methyl acrylate to Michael addition to obtain a Michael adduct, and then hydrolyzing the Michael adduct with an alkaline compound such as sodium hydroxide.
For example, the reaction is carried out by dropping 1.17 mol of methyl acrylate to 1 mol of a primary amine having 6 to 25 carbon atoms at preferably 50 to 150°C, more preferably 70 to 100°C, followed by hydration with an alkali. By decomposition, an amphoteric surfactant aqueous solution containing the amphoteric surfactant (A) is obtained.
前述の方法によって得られた両性界面活性剤水溶液に含まれる両性界面活性剤(A)の含有量の測定は、両性界面活性剤水溶液をN,N-ジメチルホルムアミドジメチルアセタールを用いて後述の方法でメチルエステル化することでエステルに変換してからメチルエステル化処理後の溶液に含まれるエステルをガスクロマトグラフィー[以下、GCと略記することがある]を用いた下記の<両性界面活性剤水溶液のGCによる定量分析方法>によって定量することで行う。 The content of the amphoteric surfactant (A) contained in the amphoteric surfactant aqueous solution obtained by the above method can be determined by measuring the amphoteric surfactant aqueous solution with N,N-dimethylformamide dimethyl acetal by the method described below. After converting into ester by methyl esterification, the ester contained in the solution after methyl esterification was analyzed using gas chromatography [hereinafter sometimes abbreviated as GC]. Quantitative analysis method using GC>
<両性界面活性剤水溶液のGCによる定量分析方法>
両性界面活性剤水溶液(80g)に塩酸(35重量%水溶液、富士フィルム和光純薬(株))を加えてpH2にし、さらに石油エーテル(富士フィルム和光純薬(株)製)20gを加えて混合し、両性界面活性剤水溶液に含まれる両性界面活性剤(A)を石油エーテルに抽出する。
次いで、200mLの分液漏斗を用いて水層と油層に分離し、油層を取り出す。ロータリーエバポレーター(回転数50rpm/min)を用いて、60℃の温浴中、圧力0.09MPaで油層を3時間減圧し、油層中に含まれる石油エーテルを留去する。石油エーテルを留去した後の残留物の重量を記録した後、残留物からサンプリングした試料(0.03g)にN,N-ジメチルホルムアミドジメチルアセタール(1g)を加え、60℃で15分加熱して前記残留物に含まれる両性界面活性剤(A)のメチルエステル化反応を行う。
得られた反応混合物を、下記の測定条件でGCによる分析を行い、メチルエステル化処理で得られた反応混合物中に含まれるエステルの含有量を測定することで、80gの両性界面活性剤水溶液に含まれるエステルのモル数を計算する。80gの両性界面活性剤水溶液に含まれる両性界面活性剤(A)のモル数を両性界面活性剤(A)の分子量に基づいて両性界面活性剤(A)の重量に換算し、80gのメチルエステル化処理前の両性界面活性剤水溶液に含まれる両性界面活性剤(A)の含有量とする。
<Quantitative analysis method by GC of amphoteric surfactant aqueous solution>
Add hydrochloric acid (35% by weight aqueous solution, Fuji Film Wako Pure Chemical Industries, Ltd.) to an amphoteric surfactant aqueous solution (80 g) to adjust the pH to 2, and then add 20 g of petroleum ether (manufactured by Fuji Film Wako Pure Chemical Industries, Ltd.) and mix. Then, the amphoteric surfactant (A) contained in the amphoteric surfactant aqueous solution is extracted into petroleum ether.
Next, the mixture is separated into an aqueous layer and an oil layer using a 200 mL separatory funnel, and the oil layer is taken out. Using a rotary evaporator (rotation speed 50 rpm/min), the oil layer is depressurized at a pressure of 0.09 MPa for 3 hours in a 60° C. hot bath to distill off petroleum ether contained in the oil layer. After recording the weight of the residue after distilling off the petroleum ether, N,N-dimethylformamide dimethyl acetal (1 g) was added to a sample (0.03 g) sampled from the residue and heated at 60°C for 15 minutes. Then, the amphoteric surfactant (A) contained in the residue is subjected to a methyl esterification reaction.
The obtained reaction mixture was analyzed by GC under the following measurement conditions, and the content of ester contained in the reaction mixture obtained by the methyl esterification treatment was measured. Calculate the number of moles of ester contained. The number of moles of the amphoteric surfactant (A) contained in 80 g of an amphoteric surfactant aqueous solution is converted to the weight of the amphoteric surfactant (A) based on the molecular weight of the amphoteric surfactant (A), and 80 g of methyl ester is calculated. The content of the amphoteric surfactant (A) contained in the amphoteric surfactant aqueous solution before chemical treatment.
[GC測定の条件]
装置:GC-9A((株)島津製作所製)
検出器:FID
GCパックドカラム:SE-30(ジメチルポリシロキサン含有量5重量%、内径3.2mm、長さ2.1m、GLサイエンス(株)製)
カラム温度:80℃から280℃まで昇温(昇温速度:10℃/min)
サンプル注入量:5μL
[GC measurement conditions]
Equipment: GC-9A (manufactured by Shimadzu Corporation)
Detector: FID
GC packed column: SE-30 (dimethylpolysiloxane content 5% by weight, inner diameter 3.2 mm, length 2.1 m, manufactured by GL Science Co., Ltd.)
Column temperature: Raise the temperature from 80°C to 280°C (heating rate: 10°C/min)
Sample injection volume: 5μL
<リン酸の重縮合物及びその塩>
本願第一の発明である皮膚製剤用の組成物はリン酸の重縮合物及び/又はその塩を含有する。
<Polycondensate of phosphoric acid and its salt>
The composition for skin preparation, which is the first invention of the present application, contains a polycondensate of phosphoric acid and/or a salt thereof.
リン酸の重縮合物とは、リン酸を構成単量体とするポリマーであり、ポリリン酸とも呼ばれることがある。
リン酸の重縮合物の構造としては、直鎖状のものでも、分岐鎖状のものでも、環状のものでも、網目状構造のものを用いてもよい。
このうち、皮膚製剤用の組成物及び皮膚用製剤のヒスタミン遊離抑制効果の観点から、直鎖状のもの又は環状のものが好ましく用いられる。
リン酸の重縮合物にかかるリン酸の重合度は皮膚用製剤用の組成物及び皮膚用製剤のヒスタミン遊離抑制効果の観点から、重合度が2~2000のものが好ましく用いられ、重合度が2~1000のものが更に好ましく用いられ、重合度3のものが特に好ましく用いられる。
環状のポリリン酸としては、トリメタリン酸、テトラメタリン酸、ペンタメタリン酸、ヘキサメタリン酸及び環状長鎖ポリリン酸(重合度30~1000)等が挙げられる。
直鎖状のポリリン酸としては、ピロリン酸、トリポリリン酸、テトラポリリン酸、ペンタポリリン酸、ヘキサポリリン酸、及び長鎖ポリリン酸(重合度30~1000)等が挙げられる。
リン酸の重縮合物としては、直鎖状のポリリン酸が好ましく、トリポリリン酸が最も好ましい。
A polycondensate of phosphoric acid is a polymer containing phosphoric acid as a constituent monomer, and is sometimes called polyphosphoric acid.
The structure of the polycondensate of phosphoric acid may be linear, branched, cyclic, or network-like.
Among these, linear or cyclic ones are preferably used from the viewpoint of suppressing histamine release in compositions for skin preparations and skin preparations.
The degree of polymerization of phosphoric acid in the polycondensate of phosphoric acid is preferably from 2 to 2000, from the viewpoint of suppressing histamine release in compositions for skin preparations and skin preparations. Those with a polymerization degree of 2 to 1,000 are more preferably used, and those with a polymerization degree of 3 are particularly preferably used.
Examples of the cyclic polyphosphoric acid include trimetaphosphoric acid, tetrametaphosphoric acid, pentametaphosphoric acid, hexametaphosphoric acid, and cyclic long-chain polyphosphoric acid (degree of polymerization 30 to 1000).
Examples of linear polyphosphoric acids include pyrophosphoric acid, tripolyphosphoric acid, tetrapolyphosphoric acid, pentapolyphosphoric acid, hexapolyphosphoric acid, and long-chain polyphosphoric acid (degree of polymerization 30 to 1000).
As the polycondensate of phosphoric acid, linear polyphosphoric acid is preferred, and tripolyphosphoric acid is most preferred.
また、リン酸の重縮合物の塩としては、アルカリ金属塩(リチウム、カリウム及びナトリウム等)、アルカリ土類金属塩(カルシウム及びマグネシウム等)、アンモニウム塩及びアミン塩等が挙げられる。なかでも、皮膚製剤用の組成物及び皮膚用製剤のヒスタミン遊離抑制効果の観点から、アルカリ金属塩が好ましく用いられ、ナトリウム塩が特に好ましく用いられる。 Examples of salts of polycondensates of phosphoric acid include alkali metal salts (lithium, potassium, sodium, etc.), alkaline earth metal salts (calcium, magnesium, etc.), ammonium salts, amine salts, and the like. Among these, alkali metal salts are preferably used, and sodium salts are particularly preferably used, from the viewpoint of suppressing histamine release in compositions for skin preparations and skin preparations.
リン酸の重縮合物は、リン酸を脱水縮合することで得ることができる。リン酸の重縮合物の塩は、リン酸を脱水縮合した後に水酸化ナトリウム等のアルカリ化合物で中和することで得ることもできるし、リン酸塩を脱水縮合して得ることもできる。
具体的な製造方法としては、「縮合リン酸塩類の製造」(植田四郎著,電気化学及び工業物理化学,11,30,1962)等に掲載の公知の方法で製造することができる。
A polycondensate of phosphoric acid can be obtained by dehydrating and condensing phosphoric acid. A salt of a polycondensate of phosphoric acid can be obtained by dehydrating and condensing phosphoric acid and then neutralizing it with an alkali compound such as sodium hydroxide, or it can also be obtained by dehydrating and condensing a phosphate.
As a specific manufacturing method, it can be manufactured by a known method such as that described in "Manufacture of condensed phosphates" (written by Shiro Ueda, Electrochemistry and Industrial Physical Chemistry, 11, 30, 1962).
リン酸の重縮合物及びその塩としては、市場から入手できるものを用いてもよい。
市場から入手できるリン酸の重縮合物及びその塩としては、トリポリリン酸ナトリウム[燐化学工業(株)製又はミテジマ化学(株)製]、テトラポリリン酸ナトリウム[燐化学工業(株)製]、ヘキサメタリン酸ナトリウム[燐化学工業(株)製又はオルガノフードテック(株)製]、ペンタポリリン酸ナトリウム[太平化学産業(株)製]、重合度30~1000のポリリン酸ナトリウム[商品名:長鎖ポリリン酸ナトリウム{燐化学工業(株)製}]、トリメタリン酸三ナトリウム[米山化学工業(株)製]、ピロリン酸四ナトリウム[オルガノフードテック(株)製]及びトリポリリン酸カリウム[オルガノフードテック(株)製]等が挙げられる。
As the phosphoric acid polycondensate and its salt, commercially available products may be used.
Commercially available polycondensates of phosphoric acid and their salts include sodium tripolyphosphate [manufactured by Rin Kagaku Kogyo Co., Ltd. or Mitejima Kagaku Co., Ltd.], sodium tetrapolyphosphate [manufactured by Rin Kagaku Kogyo Co., Ltd.], Sodium hexametaphosphate [manufactured by Rin Kagaku Kogyo Co., Ltd. or Organo Food Tech Co., Ltd.], sodium pentapolyphosphate [manufactured by Taihei Kagaku Sangyo Co., Ltd.], sodium polyphosphate with a degree of polymerization of 30 to 1000 [product name: long chain Sodium polyphosphate {manufactured by Rin Kagaku Kogyo Co., Ltd.}], trisodium trimetaphosphate [manufactured by Yoneyama Chemical Co., Ltd.], tetrasodium pyrophosphate [manufactured by Organo Food Tech Co., Ltd.], and potassium tripolyphosphate [manufactured by Organo Food Tech Co., Ltd.] Co., Ltd.], etc.
これらのリン酸の重縮合物及びその塩のうち、皮膚製剤用の組成物及び皮膚用製剤のヒスタミン遊離抑制効果の観点から、直鎖又は環状のリン酸の重縮合物のアルカリ金属塩が好ましく用いられ、その具体例としては、トリポリリン酸ナトリウム、テトラポリリン酸ナトリウム、ヘキサメタリン酸ナトリウム、ペンタポリリン酸ナトリウム、重合度30~1000のポリリン酸ナトリウム、トリメタリン酸三ナトリウム、ピロリン酸四ナトリウム及びトリポリリン酸カリウムが挙げられ、重合度3~6の直鎖又は環状のリン酸の重縮合物のアルカリ金属塩がさらに好ましく用いられ、その具体例としては、トリポリリン酸ナトリウム、テトラポリリン酸ナトリウム、ヘキサメタリン酸ナトリウム、ペンタポリリン酸ナトリウム及びトリポリリン酸カリウムが挙げられ、トリポリリン酸のアルカリ金属塩が特に好ましく用いられ、その具体例としては、トリポリリン酸ナトリウムが挙げられる。 Among these polycondensates of phosphoric acid and their salts, from the viewpoint of suppressing histamine release in compositions for skin preparations and skin preparations, alkali metal salts of linear or cyclic polycondensates of phosphoric acid are preferred. Specific examples include sodium tripolyphosphate, sodium tetrapolyphosphate, sodium hexametaphosphate, sodium pentapolyphosphate, sodium polyphosphate with a degree of polymerization of 30 to 1000, trisodium trimetaphosphate, tetrasodium pyrophosphate, and potassium tripolyphosphate. Alkali metal salts of linear or cyclic polycondensates of phosphoric acid with a degree of polymerization of 3 to 6 are more preferably used, and specific examples thereof include sodium tripolyphosphate, sodium tetrapolyphosphate, sodium hexametaphosphate, Sodium pentapolyphosphate and potassium tripolyphosphate are mentioned, and alkali metal salts of tripolyphosphate are particularly preferably used, and a specific example thereof is sodium tripolyphosphate.
<皮膚製剤用の組成物>
本願第一の発明である皮膚製剤用の組成物は、前記両性界面活性剤(A)とリン酸の重縮合物及び/又はその塩とを含んでいれば、任意の他の成分を含んでいてもよく、なかでも水を含むことが好ましい。
本願第一の発明である皮膚製剤用の組成物は、皮膚用製剤の原料又は皮膚用製剤として用いることができる。
<Composition for skin preparation>
The composition for skin preparation, which is the first invention of the present application, does not contain any other components as long as it contains the amphoteric surfactant (A) and the polycondensate of phosphoric acid and/or its salt. Among them, it is preferable to include water.
The composition for skin preparations, which is the first invention of the present application, can be used as a raw material for skin preparations or as a skin preparation.
皮膚製剤用の組成物の合計重量に基づく前記両性界面活性剤(A)の重量割合はヒスタミン遊離抑制効果の観点から、0.003~10重量%であることが好ましく、さらに好ましくは0.003~9重量%である。 The weight proportion of the amphoteric surfactant (A) based on the total weight of the composition for skin preparations is preferably 0.003 to 10% by weight, more preferably 0.003% by weight from the viewpoint of suppressing histamine release. ~9% by weight.
皮膚製剤用の組成物の合計重量に基づくリン酸の重縮合物及びその塩の合計重量割合は、ヒスタミン遊離抑制効果の観点から、0.003~10重量%であることが好ましく、さらに好ましくは0.003~9重量%である。 The total weight proportion of the polycondensate of phosphoric acid and its salt based on the total weight of the composition for skin preparations is preferably 0.003 to 10% by weight, more preferably It is 0.003 to 9% by weight.
皮膚製剤用の組成物に含まれる前記両性界面活性剤(A)の重量に対するリン酸の重縮合物及びその塩の合計重量割合は、ヒスタミン遊離抑制効果の観点の観点から、0.1~1000重量%であることが好ましく、さらに好ましくは100~500重量%である。 The total weight ratio of the phosphoric acid polycondensate and its salt to the weight of the amphoteric surfactant (A) contained in the composition for skin preparations is 0.1 to 1000 from the viewpoint of the histamine release inhibiting effect. It is preferably % by weight, more preferably 100 to 500% by weight.
皮膚製剤用の組成物が水を含む場合リン酸の重縮合物及びその塩溶解性の観点から、水の含有割合は皮膚製剤用の組成物の合計重量に基づいて10~95重量%であることが好ましく、さらに好ましくは30~90重量%である。 When the composition for skin preparations contains water, the content of water is 10 to 95% by weight based on the total weight of the composition for skin preparations, from the viewpoint of solubility of polycondensates of phosphoric acid and its salts. It is preferably 30 to 90% by weight, and more preferably 30 to 90% by weight.
皮膚製剤用の組成物に含まれる水としては、両性界面活性剤(A)の合成を行う際の反応溶媒として用いた水をそのまま含んでいてもよく、所定の重量割合となるように常水、精製水の他、硬水、軟水、天然水、海洋深層水、温泉水、電解アルカリイオン水、電解酸性イオン水、イオン交換水及びクラスター水等と両性界面活性剤(A)とリン酸の重縮合物及びその塩とを混合しても良い。 The water contained in the composition for skin preparations may directly contain the water used as a reaction solvent when synthesizing the amphoteric surfactant (A), or may contain ordinary water at a predetermined weight ratio. In addition to purified water, hard water, soft water, natural water, deep ocean water, hot spring water, electrolyzed alkaline ionized water, electrolyzed acidic ionized water, ion-exchanged water, cluster water, etc., combined with amphoteric surfactant (A) and phosphoric acid The condensate and its salt may be mixed.
皮膚製剤用の組成物に含まれる任意の他の成分としては、後述の皮膚用製剤に含まれる、両性界面活性剤(A)以外の両性界面活性剤、アニオン性界面活性剤、カチオン性界面活性剤、ノニオン性界面活性剤溶剤、油性成分、水、溶剤、保湿剤、キレート剤、コンディショニング剤、増粘剤、美白剤、pH調整剤、清涼剤、着色料、紫外線散乱剤、紫外線吸収剤、防腐剤及び酸化防止剤等の公知の化粧料成分が挙げられる。
また、皮膚製剤用の組成物は、両性界面活性剤(A)及びリン酸の重縮合物及び/又はその塩の合成を行った際の未反応物及び反応触媒の残渣等を含んでいても良い。
Any other components contained in the composition for skin preparations include amphoteric surfactants other than the amphoteric surfactant (A), anionic surfactants, and cationic surfactants contained in the skin preparations described below. agent, nonionic surfactant solvent, oily component, water, solvent, humectant, chelating agent, conditioning agent, thickener, whitening agent, pH adjuster, cooling agent, coloring agent, ultraviolet scattering agent, ultraviolet absorber, Known cosmetic ingredients such as preservatives and antioxidants may be mentioned.
In addition, the composition for skin preparations may contain unreacted substances and residues of the reaction catalyst during the synthesis of the amphoteric surfactant (A) and the polycondensate of phosphoric acid and/or its salt. good.
皮膚製剤用の組成物は、両性界面活性剤(A)、リン酸の重縮合物及び/又はその塩並びに必要により用いる水等を所定の割合となるように、攪拌装置を備えた公知の混合装置で混合すること等により得ることが出来る。撹拌装置としては、ヘンシェルミキサー、ボールミル、ジェットミル、ニーダー、プラネタリーミキサー、サンドミル、アトライター、リボンブレンダー、ディスパーミキサー及びホモミキサー等が挙げられ、ディスパーミキサーを好ましく用いることができる。 The composition for skin preparations is prepared by mixing an amphoteric surfactant (A), a polycondensate of phosphoric acid and/or its salt, and water used as necessary in a predetermined ratio using a known mixing method using a stirring device. It can be obtained by mixing in a device or the like. Examples of the stirring device include a Henschel mixer, a ball mill, a jet mill, a kneader, a planetary mixer, a sand mill, an attritor, a ribbon blender, a disper mixer, a homo mixer, and the like, with a disper mixer being preferably used.
<皮膚用製剤>
本願第二の発明である皮膚用製剤は、前記両性界面活性剤(A)とリン酸の重縮合物及び/又はその塩を含む皮膚用製剤である。
皮膚用製剤としては、化粧料及び医薬品が含まれる。
化粧料としては、頭皮用化粧料、頭皮用以外の化粧料、浴用化粧料、リップケア化粧料及びボディパウダー等が挙げられ、医薬部外品として市販されている化粧料も含まれる。
<Skin preparations>
The second invention of the present application is a skin preparation containing a polycondensate of the amphoteric surfactant (A) and phosphoric acid and/or a salt thereof.
Dermatological preparations include cosmetics and pharmaceuticals.
Examples of cosmetics include scalp cosmetics, non-scalp cosmetics, bath cosmetics, lip care cosmetics, and body powders, and also includes cosmetics marketed as quasi-drugs.
頭皮用化粧品としては、整髪料(ヘアオイル、スタイリング料、セット料、ヘアスティック、ポマード、ヘアクリーム、ヘアミルク、ヘアワックス、ヘアスプレー、ヘアミスト及びヘアフォーム等)、養毛料(トニック、ヘアローション 、ヘアエッセンス、ヘアトリートメント、ヘアコンディショナー及びヘアパック等)、頭皮料(頭皮用トリートメント等)、洗髪料(シャンプー及び洗髪粉等)及びヘアリンス等が挙げられる。 Scalp cosmetics include hair styling products (hair oil, styling products, setting products, hair sticks, pomades, hair creams, hair milk, hair wax, hair spray, hair mist, hair foam, etc.), hair nourishing products (tonics, hair lotions, hair essences, etc.) , hair treatments, hair conditioners, hair packs, etc.), scalp products (scalp treatments, etc.), hair washing products (shampoos, hair washing powders, etc.), and hair rinses.
頭皮以外の皮膚用化粧品としては、化粧水(スキンローション、ローション、柔軟化粧水、収れん化粧水及びアストリンゼント等)、化粧液(保湿液、美容液及びエッセンス等)、クリーム(油性クリーム、中油性クリーム及び弱油性クリーム等)、乳液(ミルクローション、スキンミルク及びミルク等)、日焼け止め化粧品(UVケアクリーム、UVケアジェル、サンタン及びサンスクリーン剤等)、洗浄料(洗顔料、クレンジング、洗粉、クレンザー、メークアップリムーバー、メーク落とし、フェースウォッシュ、フェイシャルソープ、スクラブボディシャンプー、ボディソープ、ボディウォッシュ及びハンドソープ等)、髭剃り用化粧品(プレシェービング及びアフターシェービング等)、パック、ボディリンス及びマッサージ料等)が挙げられる。 Cosmetics for skin other than the scalp include lotions (skin lotions, lotions, softening lotions, astringent lotions, astringents, etc.), lotions (moisturizing lotions, serums, essences, etc.), and creams (oil-based creams, medium-oil-based creams, etc.). and mild oil-based creams, etc.), emulsions (milk lotions, skin milk, milk, etc.), sunscreen cosmetics (UV care creams, UV care gels, suntan and sunscreen agents, etc.), cleaning products (facial washes, cleansing, powder washes, cleansers, (makeup remover, makeup remover, face wash, facial soap, scrub body shampoo, body soap, body wash, hand soap, etc.), shaving cosmetics (pre-shave, aftershave, etc.), packs, body rinse, massage fees, etc.) can be mentioned.
メイクアップ用化粧料としては、ファンデーション(フェースカラー及びコンシーラー等)、化粧下地(メークアップベース、メークアッププライマー及びプレメークアップ等)、おしろい(フェースパウダー、ルーセントパウダー、フィニッシュパウダー、ハイライト及びシェーディング等)、口紅(リップスティック、リップルージュ、リップカラー、リップペンシル、練紅、リップグロス及びリップライナー等)、アイメークアップ(アイシャドウ、アイカラー、アイライナー、眉墨、アイブロー、アイブローペンシル及びアイブローブラッシュマスカラ等)等が挙げられる Cosmetics for makeup include foundations (face color and concealer, etc.), makeup bases (makeup base, makeup primer, pre-makeup, etc.), powders (face powder, lucent powder, finishing powder, highlights, shading, etc.) ), lipstick (lipstick, lip rouge, lip color, lip pencil, lipstick, lip gloss, lip liner, etc.), eye makeup (eyeshadow, eye color, eyeliner, eyebrow ink, eyebrow, eyebrow pencil, eyebrow blush mascara, etc.) ) etc.
浴用化粧品としては、バスソルト、バスオイル、バスエッセンス、バブルバス及びフォームバス等が挙げられる。 Examples of bath cosmetics include bath salts, bath oils, bath essences, bubble baths, foam baths, and the like.
リップケア化粧品としては、リップトリートメント、リップクリーム、リップバーム及びリップオイル等が挙げられる。 Lip care cosmetics include lip treatments, lip balms, lip balms, lip oils, and the like.
ボディパウダーとしては、タルカムパウダー、バスパウダー、パフュームパウダー、ベビーパウダー及び天瓜粉等が挙げられる。 Examples of body powder include talcum powder, bath powder, perfume powder, baby powder, and turmeric powder.
皮膚用製剤の剤型としては、スプレー(ポンプ式スプレー又はエアロゾル)、フォーム、ジェル、ジェル・スプレー、ローション、クリーム、ムース、パック、シート、軟膏、貼付剤、懸濁液又はパウダー等が挙げられる。 Dosage forms of dermatological preparations include sprays (pump sprays or aerosols), foams, gels, gel sprays, lotions, creams, mousses, packs, sheets, ointments, patches, suspensions, or powders. .
皮膚用製剤の合計重量に基づく前記両性界面活性剤(A)の重量割合は、ヒスタミン遊離抑制効果の観点から、0.001~10重量%であることが好ましく、さらに好ましくは0.05~10重量%である。 The weight proportion of the amphoteric surfactant (A) based on the total weight of the skin preparation is preferably 0.001 to 10% by weight, more preferably 0.05 to 10% by weight from the viewpoint of histamine release inhibiting effect. Weight%.
皮膚用製剤の合計重量に基づくリン酸の重縮合物及びその塩の合計重量割合は、ヒスタミン遊離抑制効果の観点から、0.001~10重量%であることが好ましく、さらに好ましくは0.05~10重量%である。 The total weight proportion of the polycondensate of phosphoric acid and its salt based on the total weight of the skin preparation is preferably 0.001 to 10% by weight, more preferably 0.05% by weight from the viewpoint of suppressing histamine release. ~10% by weight.
皮膚用製剤に含まれる前記両性界面活性剤(A)の重量に対するリン酸の重縮合物及びその塩の合計重量割合は、ヒスタミン遊離抑制効果の観点から、0.1~5000重量%であることが好ましく、さらに好ましくは1~3000重量%である。 The total weight ratio of the phosphoric acid polycondensate and its salt to the weight of the amphoteric surfactant (A) contained in the skin preparation should be 0.1 to 5000% by weight from the viewpoint of the histamine release inhibiting effect. is preferable, and more preferably 1 to 3000% by weight.
本発明の皮膚用製剤は、前記両性界面活性剤(A)とリン酸の重縮合物及びその塩の他に、任意の他の成分を含有していてもよい。
任意の他の成分としては、両性界面活性剤(A)以外の両性界面活性剤、アニオン性界面活性剤、カチオン性界面活性剤、ノニオン性界面活性剤溶剤、油性成分、水、溶剤、保湿剤、キレート剤、コンディショニング剤、増粘剤、美白剤、pH調整剤、清涼剤、着色料、紫外線散乱剤、紫外線吸収剤、防腐剤及び酸化防止剤等の公知の化粧料成分が挙げられる。
また、皮膚用製剤は、両性界面活性剤(A)の合成を行った際の未反応物及び反応触媒の残渣等を含んでいても良い。
The skin preparation of the present invention may contain any other component in addition to the polycondensate of the amphoteric surfactant (A) and phosphoric acid and its salt.
Optional other components include amphoteric surfactants other than the amphoteric surfactant (A), anionic surfactants, cationic surfactants, nonionic surfactant solvents, oily components, water, solvents, and humectants. , chelating agents, conditioning agents, thickeners, whitening agents, pH adjusters, refreshing agents, coloring agents, ultraviolet scattering agents, ultraviolet absorbers, preservatives, antioxidants, and other known cosmetic ingredients.
Further, the skin preparation may contain unreacted substances and residues of the reaction catalyst during the synthesis of the amphoteric surfactant (A).
両性界面活性剤(A)以外の両性界面活性剤としては、アルキルジメチル酢酸ベタイン、脂肪酸アミドプロピルベタイン、アルキルイミダゾリニウムベタイン、スルホベタイン型両性界面活性剤及びアミノ酸系界面活性剤等が挙げられる。 Examples of amphoteric surfactants other than the amphoteric surfactant (A) include alkyldimethylacetate betaines, fatty acid amidopropyl betaines, alkylimidazolinium betaines, sulfobetaine type amphoteric surfactants, and amino acid type surfactants.
アルキルジメチル酢酸ベタインとしては、ラウリルジメチルアミノ酢酸ベタイン[別名:ラウリルベタイン]、ミリスチルジメチルアミノ酢酸ベタイン[別名:ミリスチルベタイン]及びステアリルジメチルアミノ酢酸ベタイン[別名:ステアリルベタイン]等が挙げられる。 Examples of the alkyldimethylaminoacetic acid betaine include lauryldimethylaminoacetic acid betaine [alias: laurylbetaine], myristyldimethylaminoacetic acid betaine [alias: myristylbetaine], and stearyldimethylaminoacetic acid betaine [alias: stearylbetaine].
脂肪酸アミドプロピルベタインとしては、ラウリン酸アミドプロピルベタイン[別名:ラウラミドプロピルベタイン]、ミリスチン酸アミドプロピルベタイン[別名:ミリスタミドプロピルベタイン]、イソステアリン酸アミドプロピルベタイン及びヤシ油脂肪酸アミドプロピルベタイン[別名:コカミドプロピルベタイン]等が挙げられる。 Examples of fatty acid amidopropyl betaine include amidopropyl betaine laurate [also known as lauramidopropyl betaine], amidopropyl betaine myristate [also known as myristamidopropyl betaine], amidopropyl betaine isostearate, and amidopropyl betaine coconut oil fatty acid [also known as: cocamidopropyl betaine] and the like.
アルキルイミダゾリニウムベタインとしてはN-ラウロイル-N’-カルボキシメチル-N’-ヒドロキシエチルエチレンジアミンナトリウム[別名:ラウロアンホ酢酸Na]及びN-ヤシ油脂肪酸アシル-N’-カルボキシメチル-N’-ヒドロキシエチルエチレンジアミンナトリウム[別名:ココアンホ酢酸Na]等が挙げられる。 Alkylimidazolinium betaines include N-lauroyl-N'-carboxymethyl-N'-hydroxyethylethylenediamine sodium [also known as sodium lauroamphoacetate] and N-coco fatty acid acyl-N'-carboxymethyl-N'-hydroxyethyl Examples include sodium ethylenediamine [also known as sodium cocoamphoacetate].
スルホベタイン型両性界面活性剤としては、ラウラミドプロピルヒドロキシスルタイン及びコカミドプロピルヒドロキシスルタイン等が挙げられる。 Examples of the sulfobetaine type amphoteric surfactants include lauramidopropylhydroxysultaine and cocamidopropylhydroxysultaine.
アミノ酸系界面活性剤としては、ラウリルアスパラギン酸ナトリウム、ミリスチルアスパラギン酸ナトリウム、ラウリル-β-アミノプロピオン酸ナトリウム及びラウロイルメチル-β-アラニンナトリウム[別名:ラウロイルメチルアラニンNa]等が挙げられる。 Examples of amino acid surfactants include sodium lauryl aspartate, sodium myristyl aspartate, sodium lauryl-β-aminopropionate, sodium lauroylmethyl-β-alanine [also known as: Na lauroylmethylalanine], and the like.
アニオン性界面活性剤としては、エーテルカルボン酸又はその塩、硫酸エステル塩、スルホン酸塩、リン酸エステル塩、脂肪酸塩及びアシル化アミノ酸塩等が挙げられる。 Examples of the anionic surfactant include ether carboxylic acids or salts thereof, sulfate ester salts, sulfonates, phosphate ester salts, fatty acid salts, and acylated amino acid salts.
エーテルカルボン酸塩又はその塩としては、ポリオキシエチレン(平均重合度4)ラウリルエーテルカルボン酸ナトリウム[別名:ラウレス-4カルボン酸Na]、ポリオキシエチレン(平均重合度6)ラウリルエーテルカルボン酸ナトリウム[別名:ラウレス-6カルボン酸Na]、ポリオキシエチレン(平均重合度4)トリデシルエーテルカルボン酸ナトリウム[別名:トリデセス-4カルボン酸Na]及びポリオキシエチレン(平均重合度7)トリデシルエーテルカルボン酸ナトリウム[別名:トリデセス-7カルボン酸Na]等が挙げられる。 Ether carboxylic acid salts or salts thereof include polyoxyethylene (average degree of polymerization 4) sodium lauryl ether carboxylate [also known as Na laureth-4 carboxylate], polyoxyethylene (average degree of polymerization 6) sodium lauryl ether carboxylate [ Other names: Sodium laureth-6 carboxylate], polyoxyethylene (average degree of polymerization 4) sodium tridecyl ether carboxylate [other name: Na trideceth-4 carboxylate] and polyoxyethylene (average degree of polymerization 7) tridecyl ether carboxylic acid Examples include sodium [also known as: Na trideceth-7 carboxylate].
硫酸エステル塩としては、ラウリル硫酸ナトリウム[別名:ラウリル硫酸Na]、ポリオキシエチレン(平均重合度3)ラウリルエーテル硫酸ナトリウム[別名:ラウレス-3硫酸Na]、ポリオキシエチレン(平均重合度3)ラウリルエーテル硫酸トリエタノールアミン[別名:ラウレス-3硫酸TEA]、ポリオキシエチレン(平均重合度3)ヤシ油脂肪酸モノエタノールアミド硫酸ナトリウム[別名:PEG-3ヤシ脂肪酸アミドMEA硫酸Na]及びポリオキシエチレン(平均重合度3)アルキル(炭素数12-13)エーテル硫酸ナトリウム[別名:(C12,C13)パレス-3硫酸Na]等が挙げられる。 Sulfate ester salts include sodium lauryl sulfate [alias: Na lauryl sulfate], polyoxyethylene (average degree of polymerization 3) sodium lauryl ether sulfate [alias: Na laureth-3 sulfate], polyoxyethylene (average degree of polymerization 3) lauryl Ether sulfate triethanolamine [also known as laureth-3 sulfate TEA], polyoxyethylene (average degree of polymerization 3) coconut oil fatty acid monoethanolamide sodium sulfate [also known as PEG-3 coconut fatty acid amide MEA sulfate Na] and polyoxyethylene ( Average degree of polymerization 3) Alkyl (carbon number 12-13) ether sodium sulfate [also known as (C12, C13) Pareth-3 Na sulfate] and the like.
スルホン酸塩としてはドデシルベンゼンスルホン酸ナトリウム[別名:ドデシルベンゼンスルホン酸Na]、ポリオキシエチレン(平均重合度2)スルホコハク酸ラウリル二ナトリウム塩[別名:スルホコハク酸ラウレス2Na]、スルホコハク酸ラウリル二ナトリウム[別名:スルホコハク酸ラウリル2Na]及びポリオキシエチレン(平均重合度5)スルホコハク酸ラウロイルエタノールアミド二ナトリウム等が挙げられる。 Sulfonic acid salts include sodium dodecylbenzenesulfonate [also known as Na dodecylbenzenesulfonate], polyoxyethylene (average degree of polymerization 2) lauryl disodium sulfosuccinate [also known as 2Na laureth sulfosuccinate], and disodium lauryl sulfosuccinate [also known as 2Na laureth sulfosuccinate]. Other name: 2Na lauryl sulfosuccinate] and polyoxyethylene (average degree of polymerization 5) lauroylethanolamide disodium sulfosuccinate.
リン酸エステル塩としては、ラウリルリン酸ナトリウム[別名:ラウリルリン酸Na]及びポリオキシエチレンラウリルエーテルリン酸ナトリウム[別名:トリラウレス-4リン酸]等が挙げられる。 Examples of phosphate ester salts include sodium lauryl phosphate [also known as Na lauryl phosphate] and sodium polyoxyethylene lauryl ether phosphate [also known as trilaureth-4 phosphate].
脂肪酸塩としては、ミリスチン酸ナトリウム[別名:ミリスチン酸Na]、ミリスチン酸カリウム[別名:ミリスチン酸K]、ミリスチン酸トリエタノールアミン[別名:ミリスチン酸TEA]、ラウリン酸ナトリウム[別名:ラウリン酸Na]、ラウリン酸カリウム[別名:ラウリン酸K]、ラウリン酸トリエタノールアミン[別名:ラウリン酸TEA]、ステアリン酸ナトリウム[別名:ステアリン酸Na]、ステアリン酸トリエタノールアミン[別名:ステアリン酸TEA]、パルミチン酸ナトリウム[別名:パルミチン酸Na]及びパルミチン酸トリエタノールアミン[別名:パルミチン酸TEA]等が挙げられる。 Fatty acid salts include sodium myristate [also known as: Na myristate], potassium myristate [also known as K myristate], triethanolamine myristate [also known as TEA myristate], and sodium laurate [also known as Na laurate]. , potassium laurate [also known as K laurate], triethanolamine laurate [also known as TEA laurate], sodium stearate [also known as Na stearate], triethanolamine stearate [also known as TEA stearate], palmitin Examples include sodium acid [also known as: Na palmitate] and triethanolamine palmitate [also known as: TEA palmitate].
アシル化アミノ酸塩としては、N-ヤシ油脂肪酸メチルタウリンナトリウム[別名:ココイルメチルタウリンNa]、N-ヤシ油脂肪酸サルコシンナトリウム[別名:ココイルサルコシンNa]、N-ラウロイルサルコシンナトリウム[別名:ラウロイルサルコシンNa]、N-ヤシ油脂肪酸サルコシントリエタノールアミン[別名:アシルグルタミン酸TEA]、N-ヤシ油脂肪酸アシル-L-グルタミン酸トリエタノールアミン[別名:ココイルグルタミン酸TEA]、N-ヤシ油脂肪酸アシル-L-グルタミン酸ナトリウム[別名:ココイルグルタミン酸Na]及びラウロイル-L-グルタミン酸トリエタノールアミン[別名:ラウロイルグルタミン酸TEA]等が挙げられる。 Acylated amino acid salts include N-coconut oil fatty acid methyltaurate sodium [also known as cocoyl methyltaurine Na], N-coconut oil fatty acid sarcosine sodium [also known as cocoyl sarcosine Na], N-lauroyl sarcosine sodium [also known as lauroyl sarcosine Na] ], N-coconut oil fatty acid sarcosine triethanolamine [also known as acylglutamic acid TEA], N-coconut oil fatty acid acyl-L-glutamic acid triethanolamine [other name: cocoyl glutamic acid TEA], N-coconut oil fatty acid acyl-L-glutamic acid Examples include sodium [also known as: Na cocoyl glutamate] and lauroyl-L-glutamate triethanolamine [also known as: lauroyl glutamate TEA].
カチオン性界面活性剤としては、第4級アンモニウム塩及びアミン塩が挙げられる。 Cationic surfactants include quaternary ammonium salts and amine salts.
第4級アンモニウム塩としては、塩化ステアリルトリメチルアンモニウム[別名:ステアルトリモニウムクロリド]、塩化ベヘニルトリメチルアンモニウム[別名:ベヘントリモニウムクロリド]、塩化ジステアリルジメチルアンモニウム[別名:ジステアリルジモニウムクロリド]及びエチル硫酸ラノリン脂肪酸アミノプロピルエチルジメチルアンモニウム[別名:クオタニウム―33]等が挙げられる。 Quaternary ammonium salts include stearyltrimethylammonium chloride [alias: steartrimonium chloride], behenyltrimethylammonium chloride [alias: behentrimonium chloride], distearyldimethylammonium chloride [alias: distearyldimonium chloride], and ethyl Examples include lanolin sulfate fatty acid aminopropylethyldimethylammonium [also known as quaternium-33].
アミン塩としては、ステアリン酸ジエチルアミノエチルアミド[別名:ステアラミドエチルジエチルアミン]及びベヘン酸ジメチルアミノエチルアミド[別名:ベヘナミドプロピルジメチルアミン]等が挙げられる。 Examples of the amine salt include stearic acid diethylaminoethylamide [also known as stearamide ethyl diethylamine] and behenic acid dimethylaminoethylamide [also known as behenamide propyl dimethylamine].
ノニオン性界面活性剤としては、炭素数4~24のアルコールのアルキレンオキシド(炭素数2~8)付加物、炭素数8~24の脂肪酸とアルキレンオキシド(炭素数2~8)重合物とのエステル、多価(2価~10価)アルコールの高級脂肪酸エステルのアルキレンオキシド付加物、グリセリン脂肪酸エステル、ポリグリセリン脂肪酸エステル及び脂肪酸アルカノールアミド等が挙げられる。 Examples of nonionic surfactants include alkylene oxide (carbon numbers 2 to 8) adducts of alcohols having carbon numbers of 4 to 24, and esters of polymers of alkylene oxide (carbon numbers 2 to 8) and fatty acids having 8 to 24 carbon atoms. , alkylene oxide adducts of higher fatty acid esters of polyvalent (divalent to decavalent) alcohols, glycerin fatty acid esters, polyglycerin fatty acid esters, and fatty acid alkanolamides.
炭素数4~24のアルコールのアルキレンオキシド(炭素数2~8)付加物としては、ポリオキシエチレン(平均重合度10)ポリオキシプロピレン(平均重合度7)ブチルエーテル[別名:PPG-7ブテス-10]、ポリオキシエチレン(平均重合度20)ラウリルエーテル[別名:ラウレス-20]、ポリオキシエチレン(平均重合度20)オレイルエーテル[別名:オレス-20]、ポリオキシエチレン(平均重合度12)ポリオキシプロピレン(平均重合度2)セチルエーテル[別名:PPG-2セテス-12]及びポリオキシエチレンセテアリルエーテルとポリオキシエチレンオレイルエーテルの混合物[別名:セレトス-5]等が挙げられる。 Examples of alkylene oxide (carbon number 2 to 8) adducts of alcohols having 4 to 24 carbon atoms include polyoxyethylene (average degree of polymerization 10) polyoxypropylene (average degree of polymerization 7) butyl ether [other name: PPG-7 buteth-10 ], polyoxyethylene (average degree of polymerization 20) lauryl ether [also known as Laureth-20], polyoxyethylene (average degree of polymerization 20) oleyl ether [other name: Oles-20], polyoxyethylene (average degree of polymerization 12) poly Examples include oxypropylene (average degree of polymerization 2) cetyl ether [also known as: PPG-2 Ceteth-12] and a mixture of polyoxyethylene cetearyl ether and polyoxyethylene oleyl ether [also known as Ceretos-5].
炭素数8~24の脂肪酸とアルコール又はアルキレンオキシド(炭素数2~8)重合物とのエステルとしては、モノステアリン酸グリセリル[別名:ステアリン酸グリセリル]、モノカプリル酸グリセリル[別名:カプリル酸グリセリル]、モノミリスチン酸グリセリル[別名:ミリスチン酸グリセリル]、モノオレイン酸グリセリル[別名:オレイン酸グリセリル]、モノステアリン酸エチレングリコール[別名:ステアリン酸グリコール]、モノラウリン酸ソルビタン[別名:ラウリン酸ソルビタン]、モノパルミチン酸ソルビタン[別名:パルミチン酸ソルビタン]、モノステアリン酸ソルビタン[別名:ステアリン酸ソルビタン]、モノオレイン酸ソルビタン[別名:オレイン酸ソルビタン]、ヤシ油脂肪酸ソルビタン、モノオレイン酸ポリオキシエチレン(平均重合度6)ソルビタン[別名:オレイン酸PEG-6ソルビタン]、ポリオキシエチレン(平均重合度20)ステアリルエーテル[別名:ステアレス-20]、モノステアリン酸ポリオキシエチレングリコール(平均重合度23)[別名:ステアリン酸PEG-23]、ジステアリン酸ポリオキシエチレングリコール(平均重合度3)[別名:ジステアリン酸PEG-3]、ジステアリン酸ポリオキシエチレングリコール(平均重合度150)[別名:ジステアリン酸PEG-150]、ジステアリン酸ポリオキシエチレングリコール(平均重合度190)[別名:ジステアリン酸PEG-190]及びポリオキシエチレン(平均重合度60)硬化ヒマシ油[別名:PEG-60水添ヒマシ油]等が挙げられる。 Examples of esters of fatty acids having 8 to 24 carbon atoms and polymers of alcohols or alkylene oxides (having 2 to 8 carbon atoms) include glyceryl monostearate [also known as glyceryl stearate], glyceryl monocaprylate [also known as glyceryl caprylate] , glyceryl monomyristate [also known as glyceryl myristate], glyceryl monooleate [also known as glyceryl oleate], ethylene glycol monostearate [also known as glycol stearate], sorbitan monolaurate [also known as sorbitan laurate], mono Sorbitan palmitate [also known as sorbitan palmitate], sorbitan monostearate [also known as sorbitan stearate], sorbitan monooleate [also known as sorbitan oleate], coconut oil fatty acid sorbitan, polyoxyethylene monooleate (average degree of polymerization) 6) Sorbitan [other name: PEG-6 sorbitan oleate], polyoxyethylene (average degree of polymerization 20) stearyl ether [other name: Steareth-20], polyoxyethylene glycol monostearate (average degree of polymerization 23) [other name: stearin acid PEG-23], polyoxyethylene glycol distearate (average degree of polymerization 3) [also known as PEG-3 distearate], polyoxyethylene glycol distearate (average degree of polymerization 150) [also known as PEG-150 distearate], Examples include polyoxyethylene glycol distearate (average degree of polymerization 190) [also known as PEG-190 distearate] and polyoxyethylene (average degree of polymerization 60) hydrogenated castor oil [also known as PEG-60 hydrogenated castor oil].
多価(2価~10価)アルコールの高級脂肪酸エステルのアルキレンオキシド付加物としては、カプリル酸及びカプリン酸のグリセリンエステルにポリエチレンオキシド(平均重合度6)を付加重合したもの[別名:(カプリル酸/カプリン酸)PEG-6グリセリズ]、モノラウリン酸ポリオキシエチレン(平均重合度10)ソルビタン[別名:ラウリン酸PEG-10ソルビタン]、モノラウリン酸ポリオキシエチレン(平均重合度80)ソルビタン[別名:ラウリン酸PEG-80ソルビタン]、モノオレイン酸ポリオキシエチレン(平均重合度6)ソルビタン[別名:オレイン酸PEG-6ソルビタン]、モノオレイン酸ポリオキシエチレン(平均重合度3)ソルビタン[別名:オレイン酸PEG-3ソルビタン]、モノオレイン酸ポリオキシエチレン(平均重合度40)ソルビタン[別名:オレイン酸PEG-40ソルビタン]、モノステアリン酸ポリオキシエチレン(平均重合度6)ソルビタン[別名:ステアリン酸PEG-6ソルビタン]、モノステアリン酸ポリオキシエチレン(平均重合度40)ソルビタン[別名:ステアリン酸PEG-40ソルビタン]、トリイソステアリン酸ポリオキシエチレン(平均重合度160)ソルビタン[別名:トリイソステアリン酸PEG-160ソルビタン]並びにポリオキシエチレン(重合度120)ジオレイン酸メチルグルコシド[別名:ジオレイン酸PEG-120メチルグルコース]等が挙げられる。 Alkylene oxide adducts of higher fatty acid esters of polyhydric (divalent to decavalent) alcohols include addition polymerization of polyethylene oxide (average degree of polymerization 6) to glycerin esters of caprylic acid and capric acid [also known as (caprylic acid) / capric acid) PEG-6 glycerides], polyoxyethylene monolaurate (average degree of polymerization 10) sorbitan [also known as PEG-10 sorbitan laurate], polyoxyethylene monolaurate (average degree of polymerization 80) sorbitan [also known as lauric acid PEG-80 sorbitan], polyoxyethylene monooleate (average degree of polymerization 6) sorbitan [also known as PEG-6 sorbitan oleate], polyoxyethylene monooleate (average degree of polymerization 3) sorbitan [also known as PEG- oleate] 3 sorbitan], polyoxyethylene monooleate (average degree of polymerization 40) sorbitan [also known as PEG-40 sorbitan oleate], polyoxyethylene monostearate (average degree of polymerization 6) sorbitan [also known as PEG-6 sorbitan stearate] ], polyoxyethylene monostearate (average degree of polymerization 40) sorbitan [also known as PEG-40 sorbitan stearate], polyoxyethylene triisostearate (average degree of polymerization 160) sorbitan [also known as PEG-160 sorbitan triisostearate] and polyoxyethylene (degree of polymerization 120) methyl dioleate glucoside [also known as PEG-120 methyl glucose dioleate].
ポリグリセリン脂肪酸エステルとしては、モノオレイン酸デカグリセリル[別名:オレイン酸ポリグリセリル-10]、モノラウリン酸デカグリセリル[別名:ラウリン酸ポリグリセリル-10]、イソステアリン酸デカグリセリル[別名:イソステアリン酸ポリグリセリル-10]、ジステアリン酸ポリグリセリル[別名:ジステアリン酸ポリグリセリル-10]、ステアリン酸ポリグリセリル[別名:ステアリン酸ポリグリセリル-10]、ポリリシノレイン酸ヘキサグリセリル[別名:ポリリシノレイン酸ポリグリセリル-6]及びモノイソステアリン酸ジグリセリル[別名:イソステアリン酸ポリグリセリル-2]等が挙げられる。 Examples of polyglycerin fatty acid esters include decaglyceryl monooleate [also known as polyglyceryl oleate-10], decaglyceryl monolaurate [also known as polyglyceryl laurate], decaglyceryl isostearate [also known as polyglyceryl isostearate-10], Polyglyceryl distearate [also known as polyglyceryl distearate-10], polyglyceryl stearate [also known as polyglyceryl stearate-10], hexaglyceryl polyricinoleate [also known as polyglyceryl-6 polyricinoleate], and diglyceryl monoisostearate [also known as: Polyglyceryl-2 isostearate] and the like.
脂肪酸アルカノールアミドとしては、ヤシ油脂肪酸モノエタノールアミド[別名:コカミドMEA]、ヤシ油脂肪酸N-メチルエタノールアミド[別名:コカミドメチルMEA]及びヤシ油脂肪酸ジエタノールアミド[別名:コカミドDEA]等が挙げられる。 Examples of the fatty acid alkanolamide include coconut oil fatty acid monoethanolamide [also known as: cocamide MEA], coconut oil fatty acid N-methylethanolamide [also known as: cocamide methyl MEA], and coconut oil fatty acid diethanolamide [also known as: cocamide DEA].
水としては、常水、精製水の他、硬水、軟水、天然水、海洋深層水、温泉水、電解アルカリイオン水、電解酸性イオン水、イオン交換水及びクラスター水等が挙げられる。 Examples of water include ordinary water, purified water, hard water, soft water, natural water, deep ocean water, hot spring water, electrolyzed alkaline ionized water, electrolyzed acidic ionized water, ion exchange water, cluster water, and the like.
油性成分としては、液体油脂、固体油脂、炭化水素油、合成エステル油、シリコーン油及び精油等が挙げられる。 Examples of oily components include liquid oils, solid oils, hydrocarbon oils, synthetic ester oils, silicone oils, and essential oils.
液体油脂としては、アボガド油、ツバキ油、タートル油、マカデミア種子油、コーン油、ミンク油、オリーブ油、ナタネ油、卵黄油、ゴマ油、パーシック油、コムギ胚芽油、サザンカ油、ヒマシ油、アマニ油、サフラワー油、シロバナワタ種子油、ダイズ油、ピーナッツ油、チャ実油、コウスイガヤ油、コメヌカ油、ホホバ油、コメ胚芽油、トリ2-エチルヘキサン酸グリセリル[別名:トリエチルヘキサノイン]及びトリイソパルミチン酸グリセリル[別名:トリイソパルミチン]等が挙げられる。 Liquid oils include avocado oil, camellia oil, turtle oil, macadamia seed oil, corn oil, mink oil, olive oil, rapeseed oil, egg yolk oil, sesame oil, persic oil, wheat germ oil, sasanqua oil, castor oil, linseed oil, Safflower oil, cottonseed seed oil, soybean oil, peanut oil, tea seed oil, rice bran oil, jojoba oil, rice germ oil, glyceryl tri-2-ethylhexanoate [also known as triethylhexanoin], and triisopalmitic acid Examples include glyceryl [also known as triisopalmitine].
固体油脂としては、カカオ脂、ヤシ油、キャンデリラロウ、ミツロウ、シア脂、馬油、水添ヤシ油、パーム油、牛脂、ラノリン、水添牛脂、パーム核油、水添パーム油、豚脂、モクロウ及び水添ヒマシ油等が挙げられる。 Solid fats and oils include cacao butter, coconut oil, candelilla wax, beeswax, shea butter, horse oil, hydrogenated coconut oil, palm oil, beef tallow, lanolin, hydrogenated beef tallow, palm kernel oil, hydrogenated palm oil, pork fat. , Japanese owl oil, hydrogenated castor oil, and the like.
炭化水素油としては、2,2,4,6,6-ペンタメチルヘプタン[別名:イソドデカン]、2,2,4,4,6,8,8-ヘプタメチルノナン[別名:イソヘキサデカン]、ヘキサメチルテトラコサン[別名:スクワラン]、2,6,10,15,19,23-ヘキサメチルテトラコサ-2,6,10,14,18,22-ヘキサエン[別名:スクワレン]、ワセリン、パラフィン、水添ポリイソブテン、オゾケライト、2,6,10,14-テトラメチルペンタデカン、セレシン及びマイクロクリスタリンワックス等が挙げられる。 Hydrocarbon oils include 2,2,4,6,6-pentamethylheptane [also known as isododecane], 2,2,4,4,6,8,8-heptamethylnonane [also known as isohexadecane], and hexadecane. Methyltetracosane [also known as squalane], 2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene [also known as squalene], petrolatum, paraffin, water Examples include added polyisobutene, ozokerite, 2,6,10,14-tetramethylpentadecane, ceresin, and microcrystalline wax.
合成エステル油としては、ミリスチン酸イソプロピル、エチルヘキサン酸セチル、ミリスチン酸オクチルドデシル、パルミチン酸セチル、パルミチン酸イソプロピル、ステアリン酸ブチル、ラウリン酸ヘキシル、ミリスチン酸ミリスチル、オレイン酸デシル、エチルヘキサン酸ヘキシルデシル、乳酸セチル、乳酸ミリスチル、酢酸ラノリン、ステアリン酸イソセチル、イソステアリン酸イソセチル、ヒドロキシステアリン酸コレステリル、ジエチルヘキサン酸グリコール、ジカプリン酸ネオペンチルグリコール、カプリル酸とカプリン酸とグリセリンとのトリエステル[別名:トリ(カプリル酸/カプリン酸)グリセリル]、ヒドロキシステアリン酸、ヒドロキシステアリン酸、ステアリン酸及びロジン酸とジペンタエリスリトールとのヘキサエステル[別名:ヘキサ(ヒドロキシステアリン酸/ステアリン酸/ロジン酸)ジペンタエリスリチル]、リンゴ酸ジイソステアリル、ジイソステアリン酸グリセリル、トリ-2-エチルヘキサン酸トリメチロールプロパン、トリエチルヘキサン酸トリメチロールプロパン、テトラエチルヘキサン酸ペンタエリスリチル、トリイソステアリン酸トリメチロールプロパン、パルミチン酸エチルヘキシル、トリミリスチン酸グリセリル[別名:トリミリスチン]、リシノレイン酸メチル、オレイン酸オレイル、アジピン酸ジイソブチル、ラウロイルグルタミン酸とフィトステロールとオクチルドデカノールとのエステル[別名:ラウロイルグルタミン酸ジ(フィトステリル/オクチルドデシル)]、アジピン酸ジヘプチルウンデシル、ラウリン酸エチル、セバシン酸ジエチルヘキシル、ミリスチン酸イソセチル、パルミチン酸ヘキシルデシル、アジピン酸ジヘキシルデシル、セバシン酸ジイソプロピル、コハク酸ジエチルヘキシル、クエン酸トリエチル、トリイソステアリン酸ポリオキシエチレン(平均重合度3)トリメチロールプロパン[別名:トリイソステアリン酸PEG-3トリメチロールプロパン]、トリイソステアリン酸ジグリセリル[別名:トリイソステアリン酸ポリグリセリル-2]並びにテトライソステアリン酸スクロース等が挙げられる。 Synthetic ester oils include isopropyl myristate, cetyl ethylhexanoate, octyldodecyl myristate, cetyl palmitate, isopropyl palmitate, butyl stearate, hexyl laurate, myristyl myristate, decyl oleate, hexyldecyl ethylhexanoate, Cetyl lactate, myristyl lactate, lanolin acetate, isocetyl stearate, isocetyl isostearate, cholesteryl hydroxystearate, glycol diethylhexanoate, neopentyl glycol dicaprate, triester of caprylic acid, capric acid, and glycerin [also known as tri(capryl)] Glyceryl acid/capric acid], hydroxystearic acid, hydroxystearic acid, hexaester of stearic acid and rosin acid with dipentaerythritol [also known as: hexa(hydroxystearic acid/stearic acid/rosin acid) dipentaerythritol], dipentaerythrityl malate Isostearyl, glyceryl diisostearate, trimethylolpropane tri-2-ethylhexanoate, trimethylolpropane triethylhexanoate, pentaerythrityl tetraethylhexanoate, trimethylolpropane triisostearate, ethylhexyl palmitate, glyceryl trimyristate [other names: trimyristin], methyl ricinoleate, oleyl oleate, diisobutyl adipate, ester of lauroylglutamic acid, phytosterol, and octyldodecanol [also known as: di(phytosteryl/octyldodecyl) lauroylglutamate], diheptylundecyl adipate, lauric acid Ethyl, diethylhexyl sebacate, isocetyl myristate, hexyldecyl palmitate, dihexyldecyl adipate, diisopropyl sebacate, diethylhexyl succinate, triethyl citrate, polyoxyethylene triisostearate (average degree of polymerization 3), trimethylolpropane [ Other names include PEG-3 trimethylolpropane triisostearate], diglyceryl triisostearate [also known as polyglyceryl-2 triisostearate], and sucrose tetraisostearate.
シリコーン油としては、鎖状ポリシロキサン、環状ポリシロキサン及び変性ポリシロキサン(アミノ変性ポリシロキサン、ポリエーテル変性シロキサン、アルキル変性ポリシロキサン及びフッ素変性ポリシロキサン等)等が挙げられる。 Examples of the silicone oil include chain polysiloxanes, cyclic polysiloxanes, modified polysiloxanes (amino-modified polysiloxanes, polyether-modified siloxanes, alkyl-modified polysiloxanes, fluorine-modified polysiloxanes, etc.).
鎖状シロキサンとしては、メチルフェニルポリシロキサン[別名:ジフェニルジメチコン]、カプリリルメチコン、ジメチコン、ジビニルジメチルポリシロキサンで架橋したジメチルポリシロキサン[別名:(ジメチコン/ビニルジメチコン)クロスポリマー]及びフェニルビニルジメチルポリシロキサンで架橋したジメチルポリシロキサン共重合体[別名:(ジメチコン/フェニルビニルジメチコン)クロスポリマー]等が挙げられる、 Examples of chain siloxanes include methylphenylpolysiloxane [also known as diphenyl dimethicone], caprylylmethicone, dimethicone, dimethylpolysiloxane cross-linked with divinyldimethylpolysiloxane [also known as (dimethicone/vinyl dimethicone) crosspolymer], and phenylvinyl dimethyl polysiloxane. Dimethylpolysiloxane copolymer crosslinked with siloxane [also known as (dimethicone/phenylvinyl dimethicone) crosspolymer], etc.
環状シロキサンとしては、デカメチルシクロペンタシロキサン[別名:シクロペンタシロキサン]及びドデカメチルシクロヘキサシロキサン[別名:シクロヘキサシロキサン]等が挙げられる。 Examples of the cyclic siloxane include decamethylcyclopentasiloxane [also known as cyclopentasiloxane] and dodecamethylcyclohexasiloxane [also known as cyclohexasiloxane].
変性ポリシロキサンとしてはアミノプロピルジメチコン、アルキル(C26-28)ジメチコン、アルキル(C30-45)ジメチコン、ポリオキシエチレン(平均重合度10)・メチルポリシロキサン共重合体[別名:PEG-10ジメチコン]、ポリオキシエチレン(平均重合度12)・メチルポリシロキサン共重合体[別名:PEG-12ジメチコン]及びポリオキシエチレン(平均重合度9)ジメチルシロキシエチルジメチコン[別名:PEG-9ポリジメチルシロキシエチルジメチコン]等が挙げられる。 Modified polysiloxanes include aminopropyl dimethicone, alkyl (C26-28) dimethicone, alkyl (C30-45) dimethicone, polyoxyethylene (average degree of polymerization 10)/methylpolysiloxane copolymer [also known as PEG-10 dimethicone], Polyoxyethylene (average degree of polymerization 12)/methylpolysiloxane copolymer [also known as PEG-12 dimethicone] and polyoxyethylene (average degree of polymerization 9) dimethylsiloxyethyl dimethicone [also known as PEG-9 polydimethylsiloxyethyl dimethicone] etc.
溶剤としては、エタノール、イソプレンジオール[別名:イソペンチルジオール]、変性アルコール、ジプロピレングリコール[別名:DPG]、1,2-ヘキサンジオール[別名:1,2-ヘキサンジオール]、イソドデカン、イソプロパノール、酢酸ブチル、ジエチレングリコールモノエチルエーテル[別名:エトキシジグリコール]及びプロピレングリコール[別名:PG]等が挙げられる。 Solvents include ethanol, isoprene diol [also known as isopentyldiol], denatured alcohol, dipropylene glycol [also known as DPG], 1,2-hexanediol [also known as 1,2-hexanediol], isododecane, isopropanol, acetic acid. Examples include butyl, diethylene glycol monoethyl ether [also known as ethoxydiglycol], and propylene glycol [also known as PG].
保湿剤としては、グリセリン、1,3-ブチレングリコール[別名:BG]、硬化ナタネ油アルコール[別名:水添ナタネ油アルコール]、ソルビトール、酢酸ナトリウム[別名:乳酸Na]、ピロリドンカルボン酸ナトリウム[別名:PCN-Na]、ヒアルロン酸ナトリウム[別名:ヒアルロン酸Na]及びコンドロイチン硫酸ナトリウム[別名:コンドロイチン硫酸Na]等が挙げられる。 Moisturizers include glycerin, 1,3-butylene glycol [also known as BG], hydrogenated rapeseed oil alcohol [also known as hydrogenated rapeseed oil alcohol], sorbitol, sodium acetate [also known as sodium lactate], sodium pyrrolidone carboxylate [also known as :PCN-Na], sodium hyaluronate [also known as hyaluronate Na], and sodium chondroitin sulfate [also known as chondroitin sulfate Na].
キレート剤としては、エチレンジアミン四酢酸[別名:EDTA]、エチレンジアミン四酢酸の2ナトリウム塩[別名:EDTA-2Na]、グルコン酸、グルコン酸ナトリウム[別名:グルコン酸Na]及びアスコルビン酸等が挙げられる。 Examples of the chelating agent include ethylenediaminetetraacetic acid [also known as EDTA], disodium salt of ethylenediaminetetraacetic acid [also known as EDTA-2Na], gluconic acid, sodium gluconate [also known as Na gluconate], and ascorbic acid.
コンディショニング剤としては、ヒドロキシエチルセルロースに塩化グリシジルトリメチルアンモニウムを付加して得られる4級アンモニウム塩の重合体[別名:ポリクオタニウム-10]、アクリル酸アミドとジメチルジアリルアンモニウムクロリドから得られる4級アンモニウム塩の重合体[別名:ポリクオタニウム-7]、ジメチルジアリルアンモニウムクロリドとアクリル酸との共重合体[別名:ポリクオタニウム-22]、酢酸ビニルとビニルピロリドンの共重合体[別名:(VP/VA)コポリマー]、グアーガムに塩化グリシジルトリメチルアンモニウムを付加した4級アンモニウム塩[別名:グアーヒドロキシプロピルトリモニウムクロリド]、ポリエチレングリコール20000[別名:PEG-400]、ポリアクリル酸ナトリウム[別名:ポリアクリル酸Na]並びにヒドロキシエチルセルロース及びD-パントテニルアルコール[別名:パンテノール]等が挙げられる。 Conditioning agents include polymers of quaternary ammonium salts obtained by adding glycidyltrimethylammonium chloride to hydroxyethylcellulose [also known as polyquaternium-10], polymers of quaternary ammonium salts obtained from acrylic acid amide and dimethyldiallylammonium chloride, and Copolymer [also known as: polyquaternium-7], copolymer of dimethyldiallylammonium chloride and acrylic acid [also known as polyquaternium-22], copolymer of vinyl acetate and vinylpyrrolidone [also known as (VP/VA) copolymer], guar gum Quaternary ammonium salt added with glycidyltrimethylammonium chloride [also known as guar hydroxypropyltrimonium chloride], polyethylene glycol 20000 [also known as PEG-400], sodium polyacrylate [also known as Na polyacrylate], and hydroxyethyl cellulose and Examples include D-pantothenyl alcohol [also known as panthenol].
増粘剤としては、グアーガム、キサンタンガム、デンプン、ベヘニルアルコール、ステアリルアルコール、セテアリルアルコール、セタノール、ミリスチルアルコール、カルボキシビニルポリマー[別名:カルボマー]、ヒドロキシプロピルメチルセルロース、ポリビニルアルコール、ポリアクリル酸ナトリウム[別名:ポリアクリル酸Na]、デンプンにアクリル酸をグラフト重合したもののナトリウム塩[別名:アクリル酸Naグラフトデンプン]、ジメチルジステアリルアンモニウムヘクトライト[別名:ジステアルジモニウムヘクトライト]、タルク、ヤシ油脂肪酸N-メチルエタノールアミド[別名:コカミドメチルMEA]並びにジステアリン酸グリコール及びアクリル酸・メタクリル酸アルキル(炭素数10~30)共重合体[別名:(アクリレーツ/アクリル酸アルキル(C10-30))クロスポリマー]等が挙げられる。 Thickeners include guar gum, xanthan gum, starch, behenyl alcohol, stearyl alcohol, cetearyl alcohol, cetanol, myristyl alcohol, carboxyvinyl polymer [also known as carbomer], hydroxypropyl methylcellulose, polyvinyl alcohol, sodium polyacrylate [also known as poly Sodium acrylate], sodium salt of starch grafted with acrylic acid [also known as Na acrylate grafted starch], dimethyl distearylammonium hectorite [also known as disteardimonium hectorite], talc, coconut oil fatty acid N- Methylethanolamide [also known as cocamide methyl MEA], glycol distearate and acrylic acid/alkyl methacrylate (C10-30) copolymer [also known as (acrylates/alkyl acrylate (C10-30)) crosspolymer], etc. Can be mentioned.
美白剤としては、トラネキサム酸、アルブチン及びハイドロキノン等が挙げられる。 Examples of whitening agents include tranexamic acid, arbutin, and hydroquinone.
pH調整剤としては、乳酸、クエン酸、リン酸、リンゴ酸、酒石酸、塩酸、酢酸、水酸化ナトリウム、水酸化カリウム及びトリエタノールアミン等が挙げられる。 Examples of the pH adjuster include lactic acid, citric acid, phosphoric acid, malic acid, tartaric acid, hydrochloric acid, acetic acid, sodium hydroxide, potassium hydroxide, and triethanolamine.
着色料としては、青色1号、青色2号、緑色3号及び赤色1号等が挙げられる。 Examples of the coloring agent include Blue No. 1, Blue No. 2, Green No. 3, and Red No. 1.
清涼剤としては、メントール、ハッカ油、チモール、サリチル酸メチル及びカンフル等が挙げられる。 Cooling agents include menthol, peppermint oil, thymol, methyl salicylate, camphor, and the like.
紫外線散乱剤としては、酸化チタン及び酸化亜鉛等が挙げられる。 Examples of the ultraviolet scattering agent include titanium oxide and zinc oxide.
紫外線吸収剤としては、メトキシケイヒ酸エチルヘキシル、ジメチルパラアミノ安息香酸と2-エチルヘキシルアルコールとのエステル[別名:ジメチルPABAエチルヘキシル]及びt-ブチルメトキシジベンゾイルメタン等が挙げられる。 Examples of the ultraviolet absorber include ethylhexyl methoxycinnamate, ester of dimethyl para-aminobenzoic acid and 2-ethylhexyl alcohol [also known as dimethyl PABA ethylhexyl], and t-butylmethoxydibenzoylmethane.
防腐剤としては、フェノキシエタノール、o-シメン-5-オール、メチルパラベン、エチルパラベン、プロピルパラベン、イソプロピルパラベン、ブチルパラベン及びイソブチルパラベン等が挙げられる。 Examples of preservatives include phenoxyethanol, o-cymen-5-ol, methylparaben, ethylparaben, propylparaben, isopropylparaben, butylparaben, and isobutylparaben.
酸化防止剤としては、ビタミンE[別名:トコフェロール]、ジブチルヒドロキシトルエン[別名:BHT]、ブチルヒドロキシアニソール[別名:BHA]、グリチルリチン酸ジカリウム[別名:グリチルリチン酸2K]及びパルミチン酸アスコルビル、ローズマリー葉エキス等が挙げられる。 Antioxidants include vitamin E [also known as tocopherol], dibutylated hydroxytoluene [also known as BHT], butylated hydroxyanisole [also known as BHA], dipotassium glycyrrhizinate [also known as glycyrrhizic acid 2K], ascorbyl palmitate, and rosemary leaf. Examples include extracts.
本発明の皮膚用製剤に必要に応じて用いることができる公知の化粧料成分の種類とその含有量は、それぞれ以下の通りである。
両性界面活性剤(A)以外の両性界面活性剤、アニオン性界面活性剤、カチオン性界面活性剤、ノニオン性界面活性剤、水、油性成分、溶剤及び保湿剤は、皮膚用製剤の全重量に基づき、好ましいのはそれぞれ50重量%以下、さらに好ましいのは10重量%以下である。
キレート剤、コンディショニング剤、増粘剤及び美白剤及は、皮膚用製剤の全重量に基づき、好ましいのはそれぞれ30重量%以下、さらに好ましいのは10重量%以下である。
pH調整剤、清涼剤、着色料、紫外線散乱剤、紫外線吸収剤、防腐剤及び酸化防止剤は、皮膚用製剤の全重量に基づき、好ましいのはそれぞれ10重量%以下、さらに好ましいのは5重量%以下である。
The types and contents of known cosmetic ingredients that can be used as needed in the skin preparation of the present invention are as follows.
Amphoteric surfactants other than amphoteric surfactant (A), anionic surfactants, cationic surfactants, nonionic surfactants, water, oily components, solvents, and humectants are included in the total weight of the skin preparation. Based on the above, it is preferably 50% by weight or less, and more preferably 10% by weight or less.
The amount of the chelating agent, conditioning agent, thickener, and whitening agent is preferably 30% by weight or less, and more preferably 10% by weight or less, based on the total weight of the skin preparation.
The pH adjuster, cooling agent, coloring agent, ultraviolet scattering agent, ultraviolet absorber, preservative, and antioxidant are each preferably 10% by weight or less, more preferably 5% by weight, based on the total weight of the skin preparation. % or less.
皮膚用製剤は、両性界面活性剤(A)、リン酸の重縮合物及びその塩並びに任意の他の成分を攪拌機で混合することで製造できる。撹拌機としては、ヘンシェルミキサー、ボールミル、ジェットミル、ニーダー、プラネタリーミキサー、サンドミル、アトライター、リボンブレンダー、ディスパーミキサー及びホモミキサー等が挙げられ、ディスパーミキサーを好ましく用いることができる。 The dermatological preparation can be produced by mixing the amphoteric surfactant (A), the polycondensate of phosphoric acid and its salt, and any other ingredients with a stirrer. Examples of the stirrer include a Henschel mixer, a ball mill, a jet mill, a kneader, a planetary mixer, a sand mill, an attriter, a ribbon blender, a disper mixer, a homomixer, and the like, and a disper mixer is preferably used.
本発明の皮膚用製剤は、25℃で固状、液状又はペースト状であることが好ましく、取り扱い易さの観点からさらに好ましいのは液状である。 The skin preparation of the present invention is preferably solid, liquid or pasty at 25°C, and liquid is more preferred from the viewpoint of ease of handling.
本発明の皮膚用製剤は、洗髪料、頭皮料、化粧水、日焼け止め化粧料、パック及び医薬品として用いられることが好ましく、シャンプー、洗顔料、ローション、クリーム、ハンドクリーム、クレンジングオイル、コンディショナー、パック、メイク落としシート、汗拭きシート、髪の毛のふき取りシート並びに軟膏又は液状の医薬品として用いられることが更に好ましい。 The skin preparations of the present invention are preferably used as hair washes, scalp preparations, lotions, sunscreen cosmetics, packs, and pharmaceuticals, including shampoos, face washes, lotions, creams, hand creams, cleansing oils, conditioners, and packs. It is more preferable to use the composition as a make-up remover sheet, a sweat-wiping sheet, a hair-wiping sheet, an ointment, or a liquid medicine.
以下、実施例及び比較例により本発明をさらに説明するが、本発明はこれらに限定されるものではない。 The present invention will be further explained below with reference to Examples and Comparative Examples, but the present invention is not limited thereto.
<製造例1>
攪拌装置、還流冷却機、滴下漏斗、及び温度計を装備した2Lの4つ口フラスコにラウリルアミン[ニッサンアミンBB{日油(株)製、ニッサンアミンは日油(株)の登録商標である}]185gを仕込み、窒素置換したのちに70℃に昇温し、アクリル酸メチル[東亜合成(株)製]101gを滴下漏斗から3時間かけて滴下し同温度で反応を行った。その後、100℃に昇温し7時間反応を行い、同温度でゲージ圧が2.7kPaになるまで減圧し、残存したアクリル酸メチルを除去した。
得られた反応溶液に、32gの49重量%水酸化ナトリウム水溶液と964gの水を仕込んで150℃で6時間加水分解反応を行った。
得られた加水分解後の溶液がpH6.0になるように、pHを測定しながら乳酸を添加した。添加した乳酸の総重量は62.5gであった。
乳酸添加後の溶液を90℃で加温することにより、溶液中のメタノールを留去し、両性界面活性剤水溶液1を得た。
両性界面活性剤水溶液1から1gサンプリングを行い、サンプリングした溶液中に含まれる両性界面活性剤の同定を行い、その含量を実施例1と同様の方法によって測定した。
両性界面活性剤水溶液1は両性界面活性剤としてβ-ドデシルアミノプロピオン酸ナトリウムを29.00重量%含むものであった。
<Manufacture example 1>
Laurylamine [Nissanamine BB (manufactured by NOF Corporation, NissanAmine is a registered trademark of NOF Corporation) was placed in a 2 L four-necked flask equipped with a stirrer, reflux condenser, dropping funnel, and thermometer. }] After purging with nitrogen, the temperature was raised to 70° C., and 101 g of methyl acrylate [manufactured by Toagosei Co., Ltd.] was added dropwise from the dropping funnel over 3 hours, and the reaction was carried out at the same temperature. Thereafter, the temperature was raised to 100° C. and reaction was carried out for 7 hours, and the pressure was reduced at the same temperature until the gauge pressure reached 2.7 kPa to remove the remaining methyl acrylate.
The obtained reaction solution was charged with 32 g of a 49% by weight aqueous sodium hydroxide solution and 964 g of water, and a hydrolysis reaction was carried out at 150° C. for 6 hours.
Lactic acid was added while measuring the pH so that the resulting solution after hydrolysis had a pH of 6.0. The total weight of lactic acid added was 62.5 g.
By heating the solution after adding lactic acid at 90° C., methanol in the solution was distilled off, and an amphoteric surfactant aqueous solution 1 was obtained.
1 g of amphoteric surfactant aqueous solution 1 was sampled, the amphoteric surfactant contained in the sampled solution was identified, and its content was measured in the same manner as in Example 1.
Amphoteric surfactant aqueous solution 1 contained 29.00% by weight of sodium β-dodecylaminopropionate as an amphoteric surfactant.
<両性界面活性剤水溶液1のGCによる定量分析方法>
両性界面活性剤水溶液1(80g)に塩酸[35重量%水溶液、富士フィルム和光純薬(株)製]を加えてpH2にしたサンプルに石油エーテル[富士フィルム和光純薬(株)製]20gを加えて混合し、両性界面活性剤水溶液1に含まれるβ-ドデシルアミノプロピオン酸ナトリウムを石油エーテルに抽出した。
次いで、200mLの分液漏斗を用いて水層と油層に分離し、油層を取り出した。ロータリーエバポレーター(回転数50rpm/min)を用いて、60℃の温浴中、圧力0.09MPaで油層を3時間減圧し、石油エーテルを留去した。石油エーテルを留去した後の残留物の重量を記録した後、残留物からサンプリングした試料(0.03g)にN,N-ジメチルホルムアミドジメチルアセタール[東京化成工業(株)]1gを加え、60℃で15分加熱して、前記残留物に含まれるβ-ドデシルアミノプロピオン酸ナトリウムのメチルエステル化反応を行った。得られた反応混合物をGC分析の測定試料とした。
得られた反応混合物からGC測定用に秤量してサンプリングした試料にn-デカンの1重量%エタノール溶液を2g加えた後、さらにエタノール50mLを加えて試料溶液を作製しGCによる分析を行い、分析で得られたGCスペクトルのβ-ドデシルアミノプロピオン酸メチルとn-デカンとのピーク面積比から、残留物からGC測定用にサンプリングした試料に含まれるβ-ドデシルアミノプロピオン酸メチルの含有量を計算した。
β-ドデシルアミノプロピオン酸メチルの含有量を、β-ドデシルアミノプロピオン酸ナトリウムの分子量に基づいてβ-ドデシルアミノプロピオン酸ナトリウムの重量に換算することで両性界面活性剤水溶液1に含まれるβ-ドデシルアミノプロピオン酸ナトリウムの含有量を求めた。
<Quantitative analysis method by GC of amphoteric surfactant aqueous solution 1>
20 g of petroleum ether [manufactured by Fuji Film Wako Pure Chemical Industries, Ltd.] was added to a sample made by adding hydrochloric acid [35% by weight aqueous solution, manufactured by Fuji Film Wako Pure Chemical Industries, Ltd.] to pH 2 to amphoteric surfactant aqueous solution 1 (80 g). The mixture was added and mixed, and sodium β-dodecylaminopropionate contained in the amphoteric surfactant aqueous solution 1 was extracted into petroleum ether.
Next, the mixture was separated into an aqueous layer and an oil layer using a 200 mL separatory funnel, and the oil layer was taken out. Using a rotary evaporator (rotation speed: 50 rpm/min), the oil layer was depressurized at a pressure of 0.09 MPa for 3 hours in a 60° C. hot bath, and petroleum ether was distilled off. After recording the weight of the residue after distilling off the petroleum ether, 1 g of N,N-dimethylformamide dimethyl acetal (Tokyo Kasei Kogyo Co., Ltd.) was added to a sample (0.03 g) from the residue, and 60 The mixture was heated at ℃ for 15 minutes to carry out a methyl esterification reaction of sodium β-dodecylaminopropionate contained in the residue. The obtained reaction mixture was used as a measurement sample for GC analysis.
After adding 2 g of a 1% by weight ethanol solution of n-decane to a sample weighed and sampled from the obtained reaction mixture for GC measurement, 50 mL of ethanol was further added to prepare a sample solution, which was analyzed by GC. From the peak area ratio of methyl β-dodecylaminopropionate and n-decane in the GC spectrum obtained, calculate the content of methyl β-dodecylaminopropionate contained in the sample sampled for GC measurement from the residue. did.
By converting the content of methyl β-dodecylaminopropionate into the weight of sodium β-dodecylaminopropionate based on the molecular weight of sodium β-dodecylaminopropionate, the amount of β-dodecyl contained in the amphoteric surfactant aqueous solution 1 The content of sodium aminopropionate was determined.
[GC測定条件]
装置:GC-9A((株)島津製作所製)
検出器:FID
GCパックドカラム:SE-30(ジメチルポリシロキサン含有量5重量%、内径3.2mm、長さ2.1m、GLサイエンス(株)製)
カラム温度:80℃から280℃まで昇温(昇温速度:10℃/min)
サンプル注入量:5μL
[GC measurement conditions]
Equipment: GC-9A (manufactured by Shimadzu Corporation)
Detector: FID
GC packed column: SE-30 (dimethylpolysiloxane content 5% by weight, inner diameter 3.2 mm, length 2.1 m, manufactured by GL Science Co., Ltd.)
Column temperature: Raise the temperature from 80°C to 280°C (heating rate: 10°C/min)
Sample injection volume: 5μL
<実施例1~7及び比較例1~3>
製造例1で得られた両性界面活性剤水溶液1、リン酸の重縮合物及びその塩、副腎皮質ホルモン並びに水を表1に記載した割合で混合し、実施例1~7にかかる本願発明の皮膚製剤用の組成物及び比較例1~3にかかる比較用の皮膚製剤用の組成物を得た。
なお、表1において括弧内に記載した数字は、各原料から水を除いて残留する成分(有効成分と呼ばれることもある)の割合に換算した値である。
さらに、実施例1~7及び比較例1~3の皮膚製剤用の組成物のそれぞれについて、後述の方法によってヒスタミン放出抑制率の算出及び皮膚刺激性を測定し、表1に記載した。
<Examples 1 to 7 and Comparative Examples 1 to 3>
The amphoteric surfactant aqueous solution 1 obtained in Production Example 1, the polycondensate of phosphoric acid and its salt, adrenal cortical hormone, and water were mixed in the proportions shown in Table 1, and the preparations of the present invention according to Examples 1 to 7 were prepared. Compositions for skin preparations and comparative compositions for skin preparations according to Comparative Examples 1 to 3 were obtained.
Note that the numbers in parentheses in Table 1 are values converted to the proportion of the components (sometimes referred to as active ingredients) remaining after water is removed from each raw material.
Furthermore, for each of the compositions for skin preparations of Examples 1 to 7 and Comparative Examples 1 to 3, the histamine release inhibition rate was calculated and the skin irritation was measured by the method described below, and the results are listed in Table 1.
(ヒスタミン放出抑制率の算出方法)
ラット肥満細胞[RBL-2H3細胞(国立研究開発法人 医薬基盤・健康・栄養研究所 JCRB細胞バンク)]を、ウシ胎児血清(FBS、Sigma-Aldrich製)10%を含むEagle’s minimal essential medium(DMEM、ナカライテスク製)培地に対し、100,000cells/mLの密度で96ウェルプレート(Corning製)の各ウェルに100μL播種し、CO2インキュベーター[製品名:MCO-18AIC(SANYO製)]を使用して37℃、5%CO2条件下で24時間培養後、各ウェル内の上清を除去した。
更に、各ウェル中に残った溶液に450ng/mL DNP-IgE(Sigma-Aldrich製)を含むEagle’s minimal essential medium(DMEM、ナカライテスク製)培地を100μL添加し、37℃、5%CO2条件下で24時間培養し、各ウェル内の上清を除去した。
実施例1~7及び比較例1~3にかかる皮膚製剤用の組成物をそれぞれ精製水で60倍希釈したもの、及び比較対象としての精製水を、各ウェル中に残った溶液に100μLずつ添加し、37℃で10分間反応を行った。さらに、各ウェル内のDNP-BSA(Sigma―Aldrich製)の濃度が10μg/mLとなるようにDNP-BSAを添加し、さらに37℃で30分間反応を行い、反応後の上清を回収してヒスタミン放出量測定のサンプルとした。
ヒスタミン放出量は、前述のヒスタミン放出量測定のサンプルをHistamine ELISA Kit(Oxford Biomedical Research製)に記載の方法で処理した溶液の吸光度(620nm)をプレートリーダー[商品名:infinite 200Pro(TECAN製)]で測定し、得られた吸光度と検量線とを用いてを算出した。
各サンプルのヒスタミン放出量を、精製水を添加したサンプルのヒスタミン放出量で割った値を100倍してヒスタミン放出抑制率(%)を算出した。
(Calculation method of histamine release inhibition rate)
Rat mast cells [RBL-2H3 cells (JCRB cell bank, National Institute of Biomedical Innovation, Health and Nutrition)] were incubated in Eagle's minimal essential medium containing 10% fetal bovine serum (FBS, manufactured by Sigma-Aldrich). DMEM (manufactured by Nacalai Tesque) medium was seeded with 100 μL into each well of a 96-well plate (manufactured by Corning) at a density of 100,000 cells/mL, using a CO2 incubator [product name: MCO-18AIC (manufactured by SANYO)]. After culturing for 24 hours at 37°C and 5% CO2, the supernatant in each well was removed.
Furthermore, 100 μL of Eagle's minimal essential medium (DMEM, manufactured by Nacalai Tesque) containing 450 ng/mL DNP-IgE (manufactured by Sigma-Aldrich) was added to the solution remaining in each well, and the mixture was incubated at 37°C and 5% CO2. The cells were cultured for 24 hours under water, and the supernatant in each well was removed.
Add 100 μL of each of the compositions for skin preparations according to Examples 1 to 7 and Comparative Examples 1 to 3 diluted 60 times with purified water, and purified water for comparison to the solution remaining in each well. The reaction was then carried out at 37°C for 10 minutes. Furthermore, DNP-BSA was added so that the concentration of DNP-BSA (manufactured by Sigma-Aldrich) in each well was 10 μg/mL, and the reaction was further performed at 37°C for 30 minutes, and the supernatant after the reaction was collected. This was used as a sample for measuring the amount of histamine released.
The amount of histamine released was determined by treating the sample for measuring the amount of histamine released using the method described in the Histamine ELISA Kit (manufactured by Oxford Biomedical Research) and measuring the absorbance (620 nm) of the solution using a plate reader [product name: infinite 200Pro (manufactured by TECAN)]. was calculated using the obtained absorbance and a calibration curve.
The histamine release inhibition rate (%) was calculated by dividing the histamine release amount of each sample by the histamine release amount of the sample to which purified water was added and multiplying the value by 100.
(皮膚刺激性試験)
実施例1~7及び比較例1~3にかかる皮膚製剤用の組成物並びに比較対象としての精製水を、500μLヒト3次元培養表皮モデル[J-TEC製]に添加し、CO2インキュベーター[製品名:MCO-18AIC(SANYO社製)]を使用して37℃、5~10%CO2濃度の条件で24時間静置した。
静置後、ヒト3次元培養表皮モデルから皮膚製剤用の組成物を除去し、pH7のリン酸緩衝液[富士フィルム和光純薬(株)製]500μLでヒト三次元培養表皮モデルを3回洗浄後、3-(4,5-dimethylthiazol-2-yl)-2,5-Diphenyltetrazoliumbromide[富士フィルム和光純薬(株)製)]溶液(別名:MTT溶液)500μLを洗浄後のヒト三次元培養表皮モデル添加した。MTT溶液を添加したヒト3次元培養表皮モデルをCO2インキュベーター[製品名:MCO-18AIC(SANYO製)]を使用して25℃、5~10%CO2濃度の条件で3時間静置後、ヒト3次元培養表皮モデルを取り出した。
取り出したヒト3次元培養表皮モデルをイソプロピルアルコール[富士フィルム和光純薬(株)製]300μLに2時間浸漬し、浸漬後のイソプロピルアルコール溶液吸光度をマイクロプレートリーダー[商品名:infinite 200Pro(TECAN製)]を用い、570nmにおける吸光度を測定した。
精製水で上記処理を行った場合の吸光度をヒト3次元培養表皮モデルの細胞生存率を100%として、吸光度の相対値から各皮膚製剤用の組成物におけるヒト3次元培養表皮モデルの細胞生存率を算出した。
細胞生存率が60%より大きい場合は刺激性無、細胞生存率が60%以下の場合は刺激性有として評価した。
(Skin irritation test)
The compositions for skin preparations according to Examples 1 to 7 and Comparative Examples 1 to 3 and purified water for comparison were added to 500 μL human three-dimensional cultured epidermis model [manufactured by J-TEC], and placed in a CO2 incubator [product name :MCO-18AIC (manufactured by SANYO Corporation)] and allowed to stand for 24 hours at 37°C and a CO2 concentration of 5 to 10%.
After standing still, the composition for skin preparations was removed from the human three-dimensional cultured epidermis model, and the human three-dimensional cultured epidermis model was washed three times with 500 μL of a pH 7 phosphate buffer [manufactured by Fuji Film Wako Pure Chemical Industries, Ltd.]. After washing, 500 μL of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide [manufactured by Fuji Film Wako Pure Chemical Industries, Ltd.] solution (also known as MTT solution) was washed on the human three-dimensional cultured epidermis. Added model. After leaving the human three-dimensional cultured epidermis model to which MTT solution was added for 3 hours at 25°C and 5-10% CO2 concentration using a CO2 incubator [product name: MCO-18AIC (manufactured by SANYO)], human 3 A dimensional cultured epidermal model was taken out.
The removed human three-dimensional cultured epidermis model was immersed in 300 μL of isopropyl alcohol [manufactured by Fuji Film Wako Pure Chemical Industries, Ltd.] for 2 hours, and the absorbance of the isopropyl alcohol solution after immersion was measured using a microplate reader [trade name: infinite 200Pro (manufactured by TECAN)]. ] was used to measure the absorbance at 570 nm.
The cell survival rate of the human 3D cultured epidermis model in the composition for each skin preparation is calculated from the relative value of the absorbance when the above treatment is performed with purified water, assuming that the cell survival rate of the human 3D cultured epidermis model is 100%. was calculated.
When the cell survival rate was greater than 60%, it was evaluated that there was no irritation, and when the cell survival rate was less than 60%, it was evaluated that there was irritation.
なお、表1に記載した成分としては、以下のものを用いた。
・トリポリリン酸ナトリウム[燐化学工業(株)製]
・テトラポリリン酸ナトリウム[燐化学工業(株)製]
・ヘキサメタリン酸ナトリウム[燐化学工業(株)製]
・長鎖ポリリン酸ナトリウム(重合度30~1000)[燐化学工業(株)製]
・トリメタリン酸三ナトリウム[米山化学工業(株)製]
・デキサメタゾン[Sigma-Aldrich製]
In addition, as the components listed in Table 1, the following were used.
・Sodium tripolyphosphate [manufactured by Rin Kagaku Kogyo Co., Ltd.]
・Sodium tetrapolyphosphate [manufactured by Rin Kagaku Kogyo Co., Ltd.]
・Sodium hexametaphosphate [manufactured by Rin Kagaku Kogyo Co., Ltd.]
・Long-chain sodium polyphosphate (degree of polymerization 30-1000) [manufactured by Rin Kagaku Kogyo Co., Ltd.]
・Trisodium trimetaphosphate [manufactured by Yoneyama Chemical Industry Co., Ltd.]
・Dexamethasone [manufactured by Sigma-Aldrich]
<皮膚用製剤:実施例8~30及び比較例4~14>
製造例1で得られた本発明の両性界面活性剤水溶液1、リン酸の重縮合物及びその塩並びに後述する任意の他の成分を表2~10に記載した割合で混合し、実施例8~13及び比較例4~5にかかる皮膚用製剤であるシャンプー、実施例14にかかる皮膚用製剤であるポンプフォーマー用洗顔料、実施例15~16にかかるクリーム洗顔料、実施例17にかかるローション、実施例18にかかるクリーム、実施例19及び比較例6にかかるハンドクリーム、実施例20及び比較例7にかかるクレンジングオイル、実施例21及び比較例8にかかるコンディショナー、実施例22及び比較例9にかかるノンカチオンコンディショナー、実施例23及び比較例10にかかるUVケアクリーム、実施例24及び比較例11にかかるUVケアジェル、実施例25及び比較例12にかかるパック、実施例26及び比較例13にかかるメイク落としシート、実施例27にかかる汗拭きシート、実施例28にかかる髪の毛ふき取りシート並びに実施例29~30及び比較例14にかかる軟膏を作成した。さらに、これらの皮膚用製剤について後述の方法でかゆみ抑制効果を評価し、結果を表2~10に記載した。
<Skin preparations: Examples 8 to 30 and Comparative Examples 4 to 14>
The amphoteric surfactant aqueous solution 1 of the present invention obtained in Production Example 1, the polycondensate of phosphoric acid and its salt, and any other components described below were mixed in the proportions shown in Tables 2 to 10, and Example 8 -13 and Comparative Examples 4-5, the skin preparation shampoo according to Example 14, the skin preparation pump former facial cleanser according to Examples 15-16, the cream facial cleanser according to Example 17. Lotion, cream according to Example 18, hand cream according to Example 19 and Comparative Example 6, cleansing oil according to Example 20 and Comparative Example 7, conditioner according to Example 21 and Comparative Example 8, Example 22 and Comparative Example Non-cationic conditioner according to Example 9, UV care cream according to Example 23 and Comparative Example 10, UV care gel according to Example 24 and Comparative Example 11, pack according to Example 25 and Comparative Example 12, Example 26 and Comparative Example 13 A makeup removing sheet according to Example 27, a sweat wiping sheet according to Example 27, a hair wiping sheet according to Example 28, and an ointment according to Examples 29 to 30 and Comparative Example 14 were prepared. Furthermore, the itch suppression effect of these skin preparations was evaluated using the method described below, and the results are listed in Tables 2 to 10.
<シャンプーのかゆみ抑制効果>
普段から頭皮にかゆみを感じている20歳から60歳の日本人男女合計10名が、40℃のお湯で十分に髪を濡らした後、実施例8~13及び比較例4~5のシャンプー1gで頭皮を洗浄し、40℃のお湯で十分にすすいだ後、ヘアドライヤーで髪を5分間乾燥することを一日一回、毎日繰り返した。
使用開始7日目に、下記基準によって評価を行った。
・かゆみが弱まったと感じた人が5~10人 : 〇
・かゆみが弱まったと感じた人が1~4人 : △
・かゆみが弱まったと感じた人が0人 : ×
<Itching suppressing effect of shampoo>
A total of 10 Japanese men and women between the ages of 20 and 60 who regularly experience itching on their scalps thoroughly wet their hair with 40°C hot water and then applied 1 g of the shampoos of Examples 8 to 13 and Comparative Examples 4 to 5. After washing the scalp with water, rinsing thoroughly with hot water at 40°C, and drying the hair with a hair dryer for 5 minutes, this process was repeated once a day.
On the 7th day after the start of use, evaluation was performed according to the following criteria.
・5 to 10 people felt that the itch had lessened: ○ ・1 to 4 people felt that the itch had lessened: △
・0 people felt that the itching had lessened: ×
<ポンプフォーマー用洗顔料及びクリーム洗顔料のかゆみ抑制効果>
普段から皮膚にかゆみを感じている20歳から60歳の日本人男女合計10名が、40℃のお湯で十分に顔を濡らした後、実施例14~16のポンプフォーマー用洗顔料及びクリーム洗顔料1gで顔を洗浄し、40℃のお湯で十分にすすいだ後、タオルドライを5分間することを一日一回、毎日繰り返した。
使用開始7日目に、下記基準によって評価を行った。
・かゆみが弱まったと感じた人が5~10人 : 〇
・かゆみが弱まったと感じた人が1~4人 : △
・かゆみが弱まったと感じた人が0人 : ×
<Itching suppression effect of pump former facial cleanser and cream facial cleanser>
A total of 10 Japanese men and women between the ages of 20 and 60 who regularly feel itchy skin thoroughly wet their faces with 40°C hot water, and then applied the pump former facial cleansers and creams of Examples 14 to 16. After washing the face with 1 g of face wash, thoroughly rinsing with hot water at 40°C, and towel drying for 5 minutes, this process was repeated once a day.
On the 7th day after the start of use, evaluation was performed according to the following criteria.
・5 to 10 people felt that the itch had lessened: ○ ・1 to 4 people felt that the itch had lessened: △
・0 people felt that the itching had lessened: ×
<ローション、クリーム、ハンドクリーム及びクレンジングオイルのかゆみ抑制効果>
普段から皮膚にかゆみを感じている20歳から60歳の日本人男女合計10名が、実施例17~20及び比較例6~7のローション、クリーム、ハンドリーム及びクレンジングオイルを皮膚に塗布することを一日一回、毎日繰り返した。
使用開始7日目に、下記基準によって評価を行った。
・かゆみが弱まったと感じた人が5~10人 : 〇
・かゆみが弱まったと感じた人が1~4人 : △
・かゆみが弱まったと感じた人が0人 : ×
<Itch suppression effect of lotions, creams, hand creams, and cleansing oils>
A total of 10 Japanese men and women between the ages of 20 and 60 who regularly experience itching on their skin applied the lotions, creams, hand dreams, and cleansing oils of Examples 17-20 and Comparative Examples 6-7 to their skin. Repeated once a day, every day.
On the 7th day after the start of use, evaluation was performed according to the following criteria.
・5 to 10 people felt that the itch had lessened: ○ ・1 to 4 people felt that the itch had lessened: △
・0 people felt that the itching had lessened: ×
<コンディショナー及びノンカチオンコンディショナーのかゆみ抑制効果>
普段から頭皮にかゆみを感じている20歳から60歳の日本人男女合計10名が、40℃のお湯で十分に髪を濡らした後、10重量%に希釈したポリオキシエチレン(重合度2)ラウリルエーテル硫酸ナトリウム水溶液[エマール20C、花王(株)製(エマールは花王(株)の登録商標である)]1gで洗浄し、40℃のお湯で十分にすすいだ。次に実施例21~22及び比較例8~9のコンディショナー1gで頭髪に均一に塗布し、髪全体になじませた後、40℃の温水で十分にすすいだ後、ヘアドライヤーで髪を5分間乾燥した。前述の髪を洗浄、コンディショナーの塗布、すすぎ及び乾燥する作業を一日一回、毎日繰り返した。
使用開始7日目に、下記基準によって評価を行った。
・かゆみが弱まったと感じた人が5~10人 : 〇
・かゆみが弱まったと感じた人が1~4人 : △
・かゆみが弱まったと感じた人が0人 : ×
<Itch suppression effect of conditioner and non-cationic conditioner>
A total of 10 Japanese men and women between the ages of 20 and 60 who regularly experience itching on their scalps thoroughly wet their hair with 40°C hot water and then applied polyoxyethylene (polymerization degree 2) diluted to 10% by weight. It was washed with 1 g of sodium lauryl ether sulfate aqueous solution [Emar 20C, manufactured by Kao Corporation (Emar is a registered trademark of Kao Corporation)], and thoroughly rinsed with 40° C. hot water. Next, apply 1 g of the conditioners of Examples 21 to 22 and Comparative Examples 8 to 9 evenly to the hair, let it blend throughout the hair, rinse thoroughly with warm water at 40°C, and then dry the hair with a hair dryer for 5 minutes. Dry. The procedure of washing the hair, applying conditioner, rinsing and drying the hair as described above was repeated once a day every day.
On the 7th day after the start of use, evaluation was performed according to the following criteria.
・5 to 10 people felt that the itch had lessened: ○ ・1 to 4 people felt that the itch had lessened: △
・0 people felt that the itching had lessened: ×
<UVケアクリーム及びUVケアジェルのかゆみ抑制効果>
普段から皮膚にかゆみを感じている20歳から60歳の日本人男女合計10名が、実施例23~24及び比較例10~11のUVケアクリーム及びUVケアジェルで顔に塗布することを一日一回、毎日繰り返した。
使用開始7日目に、下記基準によって評価を行った。
・かゆみが弱まったと感じた人が5~10人 : 〇
・かゆみが弱まったと感じた人が1~4人 : △
・かゆみが弱まったと感じた人が0人 : ×
<Itching suppression effect of UV care cream and UV care gel>
A total of 10 Japanese men and women between the ages of 20 and 60 who regularly feel itchy skin applied the UV care creams and UV care gels of Examples 23-24 and Comparative Examples 10-11 to their faces for a day. Repeated once every day.
On the 7th day after the start of use, evaluation was performed according to the following criteria.
・5 to 10 people felt that the itch had lessened: ○ ・1 to 4 people felt that the itch had lessened: △
・0 people felt that the itching had lessened: ×
<パックのかゆみ抑制効果>
普段から皮膚にかゆみを感じている20歳から60歳の日本人男女合計10名が、実施例25及び比較例12のパックで10分間パックを一日一回、毎日繰り返した。
使用開始7日目に、下記基準によって評価を行った。
・かゆみが弱まったと感じた人が5~10人 : 〇
・かゆみが弱まったと感じた人が1~4人 : △
・かゆみが弱まったと感じた人が0人 : ×
<Itching suppression effect of the pack>
A total of 10 Japanese men and women between the ages of 20 and 60 who regularly feel itchy skin applied the packs of Example 25 and Comparative Example 12 for 10 minutes once a day.
On the 7th day after the start of use, evaluation was performed according to the following criteria.
・5 to 10 people felt that the itch had lessened: ○ ・1 to 4 people felt that the itch had lessened: △
・0 people felt that the itching had lessened: ×
<メイク落としシート、汗拭きシート及び髪の毛ふき取りシートのかゆみ抑制効果>
普段から皮膚にかゆみを感じている20歳から60歳の日本人男女合計10名が、実施例26~28及び比較例13のメイク落としシート、汗拭きシート及び髪の毛ふき取りシートでふき取りをすることを一日一回、毎日繰り返した。
使用開始7日目に、下記基準によって評価を行った。
・かゆみが弱まったと感じた人が5~10人 : 〇
・かゆみが弱まったと感じた人が1~4人 : △
・かゆみが弱まったと感じた人が0人 : ×
<Itching suppression effect of makeup remover sheet, sweat wipe sheet, and hair wipe sheet>
A total of 10 Japanese men and women between the ages of 20 and 60 who regularly feel itchy skin tried wiping it off with the make-up removal sheets, sweat wiping sheets, and hair wiping sheets of Examples 26 to 28 and Comparative Example 13. Repeated once a day, every day.
On the 7th day after the start of use, evaluation was performed according to the following criteria.
・5 to 10 people felt that the itch had lessened: ○ ・1 to 4 people felt that the itch had lessened: △
・0 people felt that the itching had lessened: ×
<軟膏のかゆみ抑制効果>
普段から皮膚にかゆみを感じている20歳から60歳の日本人男女合計10名が、実施例29~30及び比較例14の軟膏を皮膚に塗布することを一日一回、毎日繰り返した。
使用開始7日目に、下記基準によって評価を行った。
・かゆみが弱まったと感じた人が5~10人 : 〇
・かゆみが弱まったと感じた人が1~4人 : △
・かゆみが弱まったと感じた人が0人 : ×
<Itching suppressing effect of ointment>
A total of 10 Japanese men and women between the ages of 20 and 60 who regularly feel itchy skin repeatedly applied the ointments of Examples 29 to 30 and Comparative Example 14 to their skin once a day.
On the 7th day after the start of use, evaluation was performed according to the following criteria.
・5 to 10 people felt that the itch had lessened: ○ ・1 to 4 people felt that the itch had lessened: △
・0 people felt that the itching had lessened: ×
なお、表2~10に記載した成分としては、以下のものを用いた。
・トリポリリン酸ナトリウム[燐化学工業(株)製]
・テトラポリリン酸ナトリウム[燐化学工業(株)製]
・ヘキサメタリン酸ナトリウム[燐化学工業(株)製]
・長鎖ポリリン酸ナトリウム(重合度30~1000)[燐化学工業(株)製]
・トリメタリン酸三ナトリウム[米山化学工業(株)製]
・ポリオキシエチレン(重合度2)ラウリルエーテル硫酸ナトリウムの26重量%水溶液[商品名:ビューライトNA-25S{三洋化成工業(株)製(ビューライトは三洋化成工業(株)の登録商標である)}]
・ポリオキシエチレン(重合度2)ラウリルエーテル酢酸ナトリウムの28重量%水溶液[商品名:ビューライトLCA-25N{三洋化成工業(株)製}]
・ラウリルグリコールカルボン酸Naの29重量%水溶液[商品名:ビューライトSHAA{三洋化成工業(株)製}]
・N-ヤシ油脂肪酸アシル-L-グルタミン酸ナトリウムの29重量%水溶液[商品名:Plantapon Amino SCG-L{BASF社製(Plantaponはコグニス・アイピー・マネージメント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングの登録商標である)}]
・ラウロイル-L-グルタミン酸トリエタノールアミンの30重量%水溶液[商品名:アミソフト LT-12{味の素ヘルシーサプライ(株)製(アミソフトは味の素(株)の登録商標である)}]
・N-ラウロイルサルコシンナトリウム30重量%水溶液[商品名:ソイポン SLE{川研ファインケミカル(株)製(ソイポンは川研ファインケミカル(株)の登録商標である)}]
・N-ヤシ油脂肪酸アシルグリシンカリウム[商品名:アミライト GCK-11{味の素ヘルシーサプライ(株)製(アミライトは味の素(株)の登録商標である)}]
・オレフィン(炭素数14~16)スルホン酸ナトリウムの37%水溶液[商品名:リポランLJ-441{ライオン(株)製(リポランはライオン・スペシャリティケミカルズ(株)の登録商標である)}]
・コカミドプロピルベタインの30重量%水溶液[商品名:レボンHC-30W{三洋化成工業(株)製}]
・2-ヤシ油脂肪酸-N-ヒドロキシエチル-N-ヒドロキシエチルイミダゾリニウムベタインの43重量%水溶液[商品名:レボンCIB{三洋化成工業(株)製}]
・ラウリン酸[商品名:NAA-122{日油(株)製(NAAは日油(株)の登録商標である)}]
・ステアリン酸[商品名:NAA―172{日油(株)製}]
・パルミチン酸[商品名:NAA-160{日油(株)製}]
・1,3-ブチレングリコール[ナカライテスク(株)製]
・グリセリン[商品名:化粧品用濃グリセリン{花王(株)製}]
・ポリクオタニウム-22(40重量%水溶液)[商品名:MERQUAT280{ルブリゾール製(MERQUATはルブリゾル アドバンスド マテリアルズ,インコーポレイテッドの登録商標である)}]
・ポリクオタニウム-7(9重量%水溶液)[商品名:MERQUAT550(ルブリゾール製)]
・ポリクオタニウム-10[商品名:Sensomer 10M Polymer(ルブリゾール製)]
・ジメチコン[商品名:KF-96A-2CS{信越化学工業(株)製}]
・ビタミンE[商品名:D-α-トコフェロール{東京化成工業(株)製}]
・ヤシ油脂肪酸N-メチルエタノールアミド[商品名:アミノーンC-11S{花王(株)製(アミノーンは花王(株)の登録商標である)}]
・トリイソステアリン酸PEG-160ソルビタン[商品名:レオドールTW-IS399C{花王(株)製(レオドールは花王(株)の登録商標である)}]
・ジステアリン酸PEG-190[商品名:エマルミン862{三洋化成工業(株)製(エマルミンは三洋化成工業(株)の登録商標である)}]
・ジステアリン酸グリコール[商品名:EMALEX EG-di-S{日本エマルジョン(株)製(EMALEXは日本エマルジョン(株)の登録商標である)}]
・メントール[商品名:l-メントール{富士フィルム和光純薬(株)製}]
・クエン酸[富士フィルム和光純薬(株)製]
・水酸化カリウム[ナカライテスク(株)製]
・イソプレンジオール[(株)クラレ製]
・エタノール[富士フィルム和光純薬(株)製]
・キサンタンガム[Jungbunzlauer International AG製]
・ヒアルロン酸Na[商品名:ヒアルロン酸 FCH-120{キッコーマンバイオケミファ(株)製}]
・アクリル酸Naグラフトデンプン[商品名:サランジュールST-100MC{三洋化成工業(株)製(サランジュールは三洋化成工業(株)の登録商標である)}]
・ベヘニルアルコール[高級アルコール工業(株)製]
・ステアリルアルコール[商品名:ハイノール 18SS{高級アルコール工業(株)製(ハイノールは高級アルコール工業(株)の登録商標である}]
・イソステアリン酸[商品名:イソステアリン酸EX{高級アルコール工業(株)製}]
・トリ(カプリル酸/カプリン酸)グリセリル[商品名:TCG-M{高級アルコール工業(株)製}]
・ヘキサ(ヒドロキシステアリン酸/ステアリン酸/ロジン酸)ジペンタエリスリチル[商品名:コスモール168ARV{日清オイリオグループ(株)製(コスモールは日清オイリオグループ(株)の登録商標である)}]
・ホホバ油[商品名:脱臭ホホバオイルM{綿半トレーディング(株)製}]
・パルミチン酸エチルヘキシル[商品名:コーヨーPOC{交洋ファインケミカル(株)製}]
・シア脂[商品名:精製シアバター{生活の木(株)製}]
・トリエチルヘキサノイン[商品名:T.I.O{日清オイリオ(株)製}]
・水添ナタネ油アルコール[商品名:アルコールNO.20-B{高級アルコール工業(株)製}]
・シクロペンタシロキサン[商品名:KF-995{信越化学工業(株)製}]
・ミネラルオイル[商品名:Carnation{Sonneborn LLC製(Carnationはソンボーンエルエルシーの登録商標である)}]
・PEG-60水添ヒマシ油[商品名:HCO-60{日光ケミカルズ(株)製}]
・PPG-2セテス-12[商品名:アルファピュールHSG{三洋化成工業(株)製(アルファピュールは三洋化成工業(株)の登録商標である)}]
・オレイン酸ソルビタン[商品名:イオネットS-80{三洋化成工業(株)製(イオネットは三洋化成工業(株)の登録商標である)}]
・オレイン酸PEG-9[商品名:イオネットMO-400{三洋化成工業(株)製}]
・セトレス-5[商品名:エマルミン50{三洋化成工業(株)製}]
・フェノキシエタノール[商品名:ニューポールEFP{三洋化成工業(株)製(ニューポールは三洋化成工業(株)の登録商標である)}]
・メチルパラベン[商品名:Microcare MHB{ソー・ジャパン(株)製(Microcareはソー スペシャリティーズ(ユーケー)リミテッドの登録商標である)}]
・ベヘントリモニウムクロリド[商品名:VARISOFT BT 85 Pellets{Evonik Operations GmbH製(VARISOFTはエボニック ゴールドシュミット コーポレーションの登録商標である)}]
・セテアリルアルコール[商品名:コノール1668{新日本理化(株)製(コノールは新日本理化(株)の登録商標である)}]
・セチルアルコール[商品名:セタノール{高級アルコール工業(株)製}]
・ステアリン酸グリセリル[商品名:TG-C{三洋化成工業(株)製}]
・ヒドロキシプロピルメチルセルロース[商品名:食品添加物用メトローズ{信越化学工業(株)製}]
・酸化チタン[商品名:MICRO TITANIUM DIOXIDE MT-100TV{テイカ(株)製}]
・酸化亜鉛[商品名:MICRO ZINC OXIDE MZ-300{テイカ(株)製}]
・リンゴ酸ジイソステアリル[商品名:コスモール222{日清オイリオ(株)製}]
・メトキシケイヒ酸エチルヘキシル[商品名:Uvinul MC80{BASF(株)製(Uvinulはビーエーエスエフ ソシエタス・ヨーロピアの登録商標である)}]
・t-ブチルメトキシジベンゾイルメタン[商品名:Escalol 517{Asuland製(Escalolはアイエスピー インベストメンツ インコーポレーテッドの登録商標である)}]
・カルボマー[商品名:NTC-CARBOMER 380{日光ケミカルズ(株)製}]
・トラネキサム酸[富士フィルム和光純薬(株)製]
・イソプロピルメチルフェノール[商品名:ビオゾール{大阪化成(株)製(ビオゾールは大阪化成(株)の登録商標である)}]
・ワセリン[商品名:ノムコートW{日清オイリオグループ(株)製}]
The following components were used as listed in Tables 2 to 10.
・Sodium tripolyphosphate [manufactured by Rin Kagaku Kogyo Co., Ltd.]
・Sodium tetrapolyphosphate [manufactured by Rin Kagaku Kogyo Co., Ltd.]
・Sodium hexametaphosphate [manufactured by Rin Kagaku Kogyo Co., Ltd.]
・Long-chain sodium polyphosphate (degree of polymerization 30-1000) [manufactured by Rin Kagaku Kogyo Co., Ltd.]
・Trisodium trimetaphosphate [manufactured by Yoneyama Chemical Industry Co., Ltd.]
・26% by weight aqueous solution of polyoxyethylene (degree of polymerization 2) sodium lauryl ether sulfate [Product name: Viewlite NA-25S {manufactured by Sanyo Chemical Industries, Ltd. (Viewlite is a registered trademark of Sanyo Chemical Industries, Ltd.) )}]
・28% by weight aqueous solution of polyoxyethylene (degree of polymerization 2) sodium lauryl ether acetate [Product name: Viewlite LCA-25N {manufactured by Sanyo Chemical Industries, Ltd.}]
・29% by weight aqueous solution of sodium lauryl glycol carboxylate [Product name: Viewlite SHAA {manufactured by Sanyo Chemical Industries, Ltd.}]
・29% by weight aqueous solution of sodium N-coconut oil fatty acid acyl-L-glutamate [Product name: Plantapon Amino SCG-L {manufactured by BASF (Plantapon is a registered trademark of Cognis IP Management Gesellschaft mit Beschrenchtel Haftsung) be)}]
・30% by weight aqueous solution of triethanolamine lauroyl-L-glutamic acid [Product name: Amisoft LT-12 {manufactured by Ajinomoto Healthy Supply Co., Inc. (Amisoft is a registered trademark of Ajinomoto Co., Inc.)}]
・30% by weight aqueous solution of sodium N-lauroyl sarcosine [Product name: Soipon SLE {manufactured by Kawaken Fine Chemical Co., Ltd. (Soipon is a registered trademark of Kawaken Fine Chemical Co., Ltd.)}]
・N-coconut oil fatty acid acylglycine potassium [Product name: Amilite GCK-11 {manufactured by Ajinomoto Healthy Supply Co., Inc. (Amilite is a registered trademark of Ajinomoto Co., Inc.)}]
・37% aqueous solution of sodium olefin (carbon number 14-16) sulfonate [Product name: Liporan LJ-441 {manufactured by Lion Co., Ltd. (Liporan is a registered trademark of Lion Specialty Chemicals Co., Ltd.)}]
・30% by weight aqueous solution of cocamidopropyl betaine [Product name: Levon HC-30W {manufactured by Sanyo Chemical Industries, Ltd.}]
・43% by weight aqueous solution of 2-coconut oil fatty acid-N-hydroxyethyl-N-hydroxyethylimidazolinium betaine [Product name: Levon CIB {manufactured by Sanyo Chemical Industries, Ltd.}]
・Lauric acid [Product name: NAA-122 {manufactured by NOF Corporation (NAA is a registered trademark of NOF Corporation)}]
・Stearic acid [Product name: NAA-172 {manufactured by NOF Corporation}]
・Palmitic acid [Product name: NAA-160 {manufactured by NOF Corporation}]
・1,3-Butylene glycol [manufactured by Nacalai Tesque Co., Ltd.]
・Glycerin [Product name: Concentrated glycerin for cosmetics {manufactured by Kao Corporation}]
・Polyquaternium-22 (40% by weight aqueous solution) [Product name: MERQUAT280 {manufactured by Lubrizol (MERQUAT is a registered trademark of Lubrizol Advanced Materials, Inc.)}]
・Polyquaternium-7 (9% by weight aqueous solution) [Product name: MERQUAT550 (manufactured by Lubrizol)]
・Polyquaternium-10 [Product name: Sensor 10M Polymer (manufactured by Lubrizol)]
・Dimethicone [Product name: KF-96A-2CS {manufactured by Shin-Etsu Chemical Co., Ltd.}]
・Vitamin E [Product name: D-α-tocopherol {manufactured by Tokyo Chemical Industry Co., Ltd.}]
・Coconut oil fatty acid N-methylethanolamide [Product name: Aminone C-11S {manufactured by Kao Corporation (Aminone is a registered trademark of Kao Corporation)}]
・PEG-160 sorbitan triisostearate [Product name: Rheodor TW-IS399C {manufactured by Kao Corporation (Rheodor is a registered trademark of Kao Corporation)}]
・PEG-190 distearate [Product name: Emulmin 862 {manufactured by Sanyo Chemical Industries, Ltd. (Emulin is a registered trademark of Sanyo Chemical Industries, Ltd.)}]
・Glycol distearate [Product name: EMALEX EG-di-S {manufactured by Nippon Emulsion Co., Ltd. (EMALEX is a registered trademark of Nippon Emulsion Co., Ltd.)}]
・Menthol [Product name: l-menthol {manufactured by Fuji Film Wako Pure Chemical Industries, Ltd.}]
・Citric acid [manufactured by Fuji Film Wako Pure Chemical Industries, Ltd.]
・Potassium hydroxide [manufactured by Nacalai Tesque Co., Ltd.]
・Isoprene diol [manufactured by Kuraray Co., Ltd.]
・Ethanol [manufactured by Fuji Film Wako Pure Chemical Industries, Ltd.]
・Xanthan gum [manufactured by Jungbunzlauer International AG]
・Hyaluronic acid Na [Product name: Hyaluronic acid FCH-120 {manufactured by Kikkoman Biochemifa Co., Ltd.}]
・Sodium acrylate grafted starch [Product name: Salandur ST-100MC {manufactured by Sanyo Chemical Industries, Ltd. (Sarandur is a registered trademark of Sanyo Chemical Industries, Ltd.)}]
・Behenyl alcohol [manufactured by Kyukyu Alcohol Kogyo Co., Ltd.]
・Stearyl alcohol [Product name: Hynol 18SS {manufactured by Kyukyu Alcohol Industries Co., Ltd. (Hinol is a registered trademark of Kyukyu Alcohol Industries Co., Ltd.})
・Isostearic acid [Product name: Isostearic acid EX {manufactured by Kyukyu Alcohol Kogyo Co., Ltd.}]
・Tri(caprylic acid/capric acid) glyceryl [Product name: TCG-M {manufactured by Kyukyu Alcohol Kogyo Co., Ltd.}]
・Hexa(hydroxystearic acid/stearic acid/rosin acid) dipentaerythrityl [Product name: Cosmol 168ARV {manufactured by Nisshin Oilio Group Co., Ltd. (Cosmol is a registered trademark of Nisshin Oilio Group Co., Ltd.)}]
・Jojoba oil [Product name: Deodorized jojoba oil M {manufactured by Watahan Trading Co., Ltd.}]
・Ethylhexyl palmitate [Product name: Koyo POC {manufactured by Koyo Fine Chemical Co., Ltd.}]
・Shea butter [Product name: Refined shea butter {manufactured by Life Tree Co., Ltd.}]
・Triethylhexanoin [Product name: T.I.O {manufactured by Nisshin Oilio Co., Ltd.}]
・Hydrogenated rapeseed oil alcohol [Product name: Alcohol NO. 20-B {Kyoku Alcohol Industry Co., Ltd.}]
・Cyclopentasiloxane [Product name: KF-995 {manufactured by Shin-Etsu Chemical Co., Ltd.}]
・Mineral oil [Product name: Carnation {manufactured by Sonneborn LLC (Carnation is a registered trademark of Sonneborn LLC)}]
・PEG-60 hydrogenated castor oil [Product name: HCO-60 {manufactured by Nikko Chemicals Co., Ltd.}]
・PPG-2 Seteth-12 [Product name: Alphapur HSG {manufactured by Sanyo Chemical Industries, Ltd. (Alphapur is a registered trademark of Sanyo Chemical Industries, Ltd.)}]
・Sorbitan oleate [Product name: Ionet S-80 {manufactured by Sanyo Chemical Industries, Ltd. (Ionet is a registered trademark of Sanyo Chemical Industries, Ltd.)}]
・PEG-9 oleic acid [Product name: Ionet MO-400 {manufactured by Sanyo Chemical Industries, Ltd.}]
・Setress-5 [Product name: Emulmin 50 {manufactured by Sanyo Chemical Industries, Ltd.}]
・Phenoxyethanol [Product name: Newport EFP {manufactured by Sanyo Chemical Industries, Ltd. (Newport is a registered trademark of Sanyo Chemical Industries, Ltd.)}]
・Methylparaben [Product name: Microcare MHB {manufactured by So Japan Co., Ltd. (Microcare is a registered trademark of So Specialties (UK) Limited)}]
・Behentrimonium chloride [Product name: VARISOFT BT 85 Pellets {manufactured by Evonik Operations GmbH (VARISOFT is a registered trademark of Evonik Goldschmidt Corporation)}]
・Cetearyl alcohol [Product name: Conol 1668 {manufactured by Shin Nippon Rika Co., Ltd. (Conol is a registered trademark of Shin Nippon Rika Co., Ltd.)}]
・Cetyl alcohol [Product name: Cetanol {manufactured by Kyukyu Alcohol Industries Co., Ltd.}]
・Glyceryl stearate [Product name: TG-C {manufactured by Sanyo Chemical Industries, Ltd.}]
・Hydroxypropyl methylcellulose [Product name: Metrose for food additives {manufactured by Shin-Etsu Chemical Co., Ltd.}]
・Titanium oxide [Product name: MICRO TITANIUM DIOXIDE MT-100TV {manufactured by Teika Co., Ltd.}]
・Zinc oxide [Product name: MICRO ZINC OXIDE MZ-300 {manufactured by Teika Co., Ltd.}]
・Diisostearyl malate [Product name: Cosmol 222 {manufactured by Nisshin Oilio Co., Ltd.}]
・Ethylhexyl methoxycinnamate [Product name: Uvinul MC80 {manufactured by BASF Corporation (Uvinul is a registered trademark of BASF Societas Europe)}]
・t-Butylmethoxydibenzoylmethane [Product name: Escalol 517 {manufactured by Asuland (Escalol is a registered trademark of ISP Investments, Inc.)}]
・Carbomer [Product name: NTC-CARBOMER 380 {manufactured by Nikko Chemicals Co., Ltd.}]
・Tranexamic acid [manufactured by Fuji Film Wako Pure Chemical Industries, Ltd.]
・Isopropyl methylphenol [Product name: Biosol {manufactured by Osaka Kasei Co., Ltd. (Biosol is a registered trademark of Osaka Kasei Co., Ltd.)}]
・Vaseline [Product name: Nomcoat W {manufactured by Nisshin Oilli Group Co., Ltd.}]
表1に記載した通り、両性界面活性剤(A)とリン酸の重縮合物及び/又はその塩を含む皮膚製剤用の組成物は、ヒスタミンの放出抑制効果に優れ、皮膚刺激性が少ない。
また、表2~10に記載した通り、両性界面活性剤(A)とリン酸の重縮合物及び/又はその塩を含む皮膚用製剤は、かゆみ抑制効果に優れる。
As described in Table 1, a composition for skin preparation containing an amphoteric surfactant (A) and a polycondensate of phosphoric acid and/or a salt thereof has an excellent effect of suppressing histamine release and has little skin irritation.
Furthermore, as shown in Tables 2 to 10, skin preparations containing the amphoteric surfactant (A) and the polycondensate of phosphoric acid and/or its salt have excellent itch-suppressing effects.
本発明の皮膚製剤用の組成物は、ヒスタミンの放出抑制に対する効果に優れ、低皮膚刺激性であるため、化粧料や皮膚外用剤の原料に適する。また、本発明の皮膚用製剤はかゆみ止め効果に優れるため、化粧料や皮膚外用剤に好適である。
The composition for skin preparations of the present invention is excellent in suppressing the release of histamine and has low skin irritation, so it is suitable as a raw material for cosmetics and external skin preparations. Furthermore, the skin preparation of the present invention has an excellent anti-itch effect and is therefore suitable for cosmetics and external skin preparations.
Claims (4)
リン酸の重縮合物及び/又はその塩とを
含有する皮膚製剤用の組成物。
A composition for skin preparation containing a polycondensate of phosphoric acid and/or a salt thereof.
リン酸の重縮合物及び/又はその塩とを
含有する皮膚用製剤。
The skin preparation according to claim 3, wherein the total weight proportion of the polycondensate of phosphoric acid and its salt in the skin preparation is 0.01 to 10% by weight.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2022105644A JP2024005458A (en) | 2022-06-30 | 2022-06-30 | Composition for skin formulation, and skin formulation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2022105644A JP2024005458A (en) | 2022-06-30 | 2022-06-30 | Composition for skin formulation, and skin formulation |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2024005458A true JP2024005458A (en) | 2024-01-17 |
Family
ID=89539794
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2022105644A Pending JP2024005458A (en) | 2022-06-30 | 2022-06-30 | Composition for skin formulation, and skin formulation |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2024005458A (en) |
-
2022
- 2022-06-30 JP JP2022105644A patent/JP2024005458A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP7020941B2 (en) | Cosmetics | |
JP4331584B2 (en) | Oily base and cosmetics and skin external preparations containing the same | |
JP4589050B2 (en) | Diesters and oils, and cosmetics and skin external preparations | |
JP5107560B2 (en) | Cyclohexanedicarboxylic acid diester and cosmetic or skin external preparation containing the same | |
JP7079827B2 (en) | External skin composition containing an oily moisturizer | |
JP6033587B2 (en) | Polyester and cosmetics using the same | |
JP5143354B2 (en) | Oligomer ester and cosmetics and skin external preparations containing these | |
JP5726469B2 (en) | Hair cosmetic containing γ-lactone derivative | |
JP5334720B2 (en) | Oily base and cosmetics and skin external preparations containing the same | |
JP4815164B2 (en) | Moisturizer and cosmetic and skin external preparations containing the same | |
JP6313961B2 (en) | Oil-in-water emulsion composition | |
JP7084117B2 (en) | Cosmetics or skin external preparations containing 1,4-anhydroerythritol | |
JP2020176067A (en) | Cosmetics containing phosphatidylinositol or topical skin preparations | |
JP2020002055A (en) | Cosmetics containing novel malate esters | |
JP2009035500A (en) | Cosmetics and external preparation for skin | |
EP3166583B1 (en) | Cosmetic use of spiculisporic acid as a deodorant active agent | |
JP4815166B2 (en) | Oily base and cosmetics and skin external preparations containing the same | |
JP5602456B2 (en) | Ascorbic acid derivative | |
JP2020158397A (en) | Cosmetic containing cyclic carbonic acid ester | |
JP7195989B2 (en) | Erythritan derivative and cosmetics containing the same | |
JP6887826B2 (en) | Cosmetic composition | |
JP2024005458A (en) | Composition for skin formulation, and skin formulation | |
JP7345325B2 (en) | Cosmetics containing esterified hard lanolin fatty acids | |
JP2010229074A (en) | Ascorbic acid derivative | |
WO2023100459A1 (en) | Surfactant composition for cosmetic and cosmetic |